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ABSTRACT
INVESTIGATION OF MEMBRANE RECEPTORS’ OLIGOMERS USING FLUORESCENCE
RESONANCE ENERGY TRANSFER AND MULTIPHOTON MICROSCOPY
IN LIVING CELLS
by
Ashish K. Mishra
The University of Wisconsin-Milwaukee, 2017
Under the Supervision of Professor Valerica Raicu

Investigating quaternary structure (oligomerization) of macromolecules (such as proteins and
nucleic acids) in living systems (in vivo) has been a great challenge in biophysics, due to molecular
diffusion, fluctuations in several biochemical parameters such as pH, quenching of fluorescence
by oxygen (when fluorescence methods are used), etc.

We studied oligomerization of membrane receptors in living cells by means of Fluorescence
(Förster) Resonance Energy Transfer (FRET) using fluorescent markers and two photon excitation
fluorescence micro-spectroscopy. Using suitable FRET models, we determined the stoichiometry
and quaternary structure of various macromolecular complexes. The proteins of interest for this
work are : (1) sigma-1 receptor and (2) rhodopsin, are described as below.

(1) Sigma-1 receptors are molecular chaperone proteins, which also regulate ion channels. S1R
seems to be involved in substance abuse, as well as several diseases such as Alzheimer’s.
We studied S1R in the presence and absence of its ligands haloperidol (an antagonist) and
pentazocine +/- (an agonist), and found that at low concentration they reside as a mixture
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of monomers and dimers, and that they may form higher order oligomers at higher
concentrations.

(2) Rhodopsin is a prototypical G protein coupled receptor (GPCR) and is directly involved in
vision. GPCRs form a large family of receptors that participate in cell signaling by
responding to external stimuli such as drugs, thus being a major drug target (more than
40% drugs target GPCRs). Their oligomerization has been largely controversial.
Understanding this may help understanding the functional role of GPCRs oligomerization,
and may lead to the discovery of more drugs targeting GPCR oligomers. It may also
contribute toward finding a cure for Retinitis Pigmentosa, which is caused by a mutation
(G188R) in rhodopsin, a disease which causes blindness and has no cure so far. Comparing
healthy rhodopsin’s oligomeric structure with that of the mutant, may give cues to find the
cure.
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Chapter 1: Introduction
The main objective of this chapter is to present the general framework of the research described in
this thesis. It is divided into three sections, as follow: section 1 includes levels of protein structures
and types of bonds associated with different levels of protein structures; section 2 reviews
characteristics and properties of G Protein-Coupled Receptors (GPCRs); and section 3 describes
the structure and functions of a sigma-1 receptor (S1R).

1.1 Protein structure
Proteins are structurally the most complex molecules on Earth. They evolved through billions of
years to get their current level of sophistication. Proteins consist of one of more arrays of amino
acid residues and come in a variety of shapes and sizes. They perform a vast variety of functions
in living organisms. Most proteins are between 50 and 2000 amino acids long [1]. The average
protein size for humans is 375 amino acids, and the average amino acid molecular weight is 100
Da (1 Da = 1.67 × 10 −27 kg), which brings the average human protein molecular weight to 37.5
kDa [2].
Most proteins fold into unique three-dimensional structures. Some of them do it on their
own, based on the chemical and physical interactions of constituent amino acids, while others need
assistance from specialized molecules called molecular chaperones [3] – a type of protein that
assists in protein folding. Protein structure is generally divided into four levels: primary,
secondary, tertiary and quaternary. The sequence of amino acids (or the amino acid chain) is called
primary structure. The portion of a protein molecule which folds to form a locally organized
structure, such as alpha helix or beta sheet (see below), is called secondary structure. The full
three-dimensional structure of a molecule is called tertiary structure. The association of two or
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more protein molecules for functional purposes is called quaternary structure. Each of these
structures will be described in detail, below.

1.1.1 Physical interactions in protein structures
Covalent forces mediate formation of the basic (primary) structure of proteins. Van der Waals radii
and other constraints limit bond angles in a protein molecule. There are three types of forces
shaping the protein structure: hydrogen bonds, electrostatic attractions and Van der Waals forces.
These forces are about 3 to 300 times weaker than covalent forces, which cause the primary
structure of proteins. However, when many weak monovalent bonds act together (in parallel), they
provide a definitive shape and stability to a part of the polypeptide chain. Another effect that plays
a role in protein folding is hydrophobicity. Hydrophobicity is the physical property of a molecule
which makes it repel from a mass of water. Therefore, such molecules tend to minimize their
exposure to water, such as embedding themselves in plasma membranes, or attaching to other
hydrophobic surfaces [4, 5]. There are two types of amino acids: polar and nonpolar. Nonpolar
residues are forced to group together in an aqueous medium in order to minimize their disruptive
effect on the hydrogen-bonded network of water molecules. So that nonpolar amino acids of the
proteins tend to be on the interior of a protein molecule to minimize interaction with water
molecules, while the polar amino acids tend to form hydrogen bonds with water and other polar
amino acids, and polar parts of backbone (polypeptide chain).

1.1.2 Primary structure
There are several thousands of proteins known and each has its unique sequence of amino acids
(i.e., primary structure). Primary structure is a linear structure of amino acids. This gives each
protein a unique identity. The amino acids in the primary structure are linked to each other by the
peptide bonds. They form a polypeptide backbone, which is a repeated structure of the atoms along
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with the core of polypeptide chain. The peptide bonds are covalent in nature. Primary structure is
constructed during a phase of protein (bio)synthesis, which is called translation.
This repeated chain of three atoms (amide N, alpha carbon Calpha and carbonyl C) is also
called the protein backbone. By convention, the protein sequence is reported, starting from N
(amine) group and ending at C (carboxyl) group. The unbranched chains of amino acids are called
polypeptides. However, the amino acid can also cross-link, often by disulfide bonds.
Proteins (or polypeptides) are polymer chains. The monomeric units of these biopolymers
are amino acids (referred to an amino acid residue in biochemistry). Short chains of amino acids
are linked covalently by peptide (amine) bonds, which form between the carboxyl (COOH) group
of one amino acid and the amine (NH2) group of another amino acid (see figure 1.1).
A shown in figure 1.1, there are twenty-two amino acids, that comprise all of the proteins.
The position of each amino acid in a protein determines the structure and shape of each protein
molecule, and describes its function in a cell.
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Figure 1.1. The twenty amino acids found in proteins. There are an equal number of polar and non-polar
side chains. However, some side chains listed here are long enough to have some non-polar properties. This
figure is adapted, with permission, from [1].

In the alpha amino acid (also called amino acid residue), each residue contains a backbone and a
side chain. The side chain is unique to each amino acid. Amino acid sequence partly decides the
shape of a protein.

1.1.3 Secondary structure
Amino acids in the primary structure interact with their near neighbors via hydrogen bonds. This
interaction gives the linear chain of amino acids (primary structure) [2, 6, 7], a local structure
called secondary structure. There are two types of secondary structure found; (1) α helixes and (2)
β sheets or β barrels, as shown in figure 1.2.
Secondary structures are also called protein domains. Twisting a single polypeptide chain
around itself (which forms a rigid cylindrical shape), creates an alpha helix. For each fourth peptide
of the chain, a hydrogen bond is formed between the carboxyl group and the neighboring amine
group of the chain. Each turn of the helix contains 3.6 amino acids. Alpha helixes are found in the
abundance of membrane proteins such as transporter proteins and receptors. The transmembrane
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domains (which fall within the lipid bilayer) of these proteins usually consist of alpha helixes,
which largely contain amino acids with nonpolar side chains. Another type of secondary structure
is called structural motif, which is a three-dimensional structure common to several different
proteins. An example of structural motif is motif is coiled-coil which is created by coiling of
several alpha helixes together. The hydrophilic backbone is shielded from the hydrophobic
environment of the membrane by hydrogen bonding to itself, forming an alpha helix and by
protruding nonpolar side chains.
In some other proteins, consisting of coiled-coils, most of the nonpolar side chains are on
the same side, which causes many alpha helixes to twist around each other to shield nonpolar side
chains inward, giving these proteins a particular rigid structure, e.g., alpha-keratin, which form
intracellular fibers.
The core of the most proteins are arranged in beta sheets. These beta sheets are formed
either from the regions of polypeptide backbone, running in a same direction or in an opposite
direction, termed as parallel or antiparallel beta sheets respectively. In both cases, these
participating backbone segments are held tightly by hydrogen bonds between peptides of
neighboring sheets, which provide the sheets with a very rigid structure. A single protein can
contain multiple alpha helixes and beta sheets.
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Figure 1.2. An example of protein secondary structure. (a): The positions of the amino acids in the αhelix are shown with the helical backbone in gray and blue. The dashed lines represent hydrogen bonds
between hydrogen and oxygen atoms on nearby amino acids. The small white circle represents hydrogen
atoms. (b): A simplified rendition of the α-helix, showing only the atoms in helical backbone. (c): An
antiparallel β-sheet. Two polypeptide chains are arranged side by side, with hydrogen bonds (dashed line)
between them. The green and white planes show that the β-sheet is pleated. The chains are antiparallel in
the sense that the amino terminus of one and the carboxyl terminus of the other amino acids are at the top.
The arrows run from the amino to carboxyl terminus of the two β-strands. The arrows indicate that the two
β-strands, running from amino to carboxyl terminals, are in the opposite directions. Parallel β -sheets, in
which the b-strands run in the same direction, also exists. This figure is adapted, with permission, from [8].

Alpha helix and beta-pleated sheets are the most common forms of the secondary structure.
Another type of secondary structure is a turn. These turns connect alpha helix and beta-pleated
sheets in a protein.

1.1.4 Tertiary structure
How proteins fold into an overall three-dimensional structure, is called tertiary structure. Tertiary
structures consist of a single polypeptide chain (backbone) and several secondary structures or
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protein domains. Proteins fold into a lowest energy conformation, which are the conformation with
minimum free energy. Many proteins fold into a roughly spherical looking shape, could be defined
as the globular shaped proteins. There are several classes of globular proteins because there are
many ways of folding into a roughly spherical shape.
Scientists, often need to denature proteins using certain chemical (e.g., detergents) or
physical agents to purify them out of their native cell environment. The denaturing process breaks
non-covalent bonds, thereby linearizing the polypeptides. But after the purification, when
detergents are removed, these proteins refold (renature) to form shapes of single conformation,
which minimize the energy. This proves that the amino acids and their positions in the polypeptides
have the complete information needed to form a three-dimensional stable structure and do not need
necessarily any external help to fold. However, there are proteins called molecular chaperones (for
example, the sigma-1 receptor, which is investigated in this thesis) which assist other proteins in
folding. The key reason for the need of molecular chaperones is the crowded
cytoplasmic/endoplasmic environment when the proteins are formed, in which their hydrophobic
regions can associate with those of other proteins around, rather than folding locally into secondary
structures. This process forms larger non-functional aggregates and not the desired single proteins.
Molecular chaperones prevent the proteins from forming such large aggregates at the secondary
structural level, and enhances the reliability of protein folding. Although proteins are complex in
structure, there are multiple ways of representing their structure, for instance, polypeptide
backbone model, ribbon model, and wire models representing amino acid side chains, and solid
spheres representing amino acid residues.
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1.1.5 Quaternary structure
A large fraction of cellular proteins associate in groups of two or more proteins forming a proteincomplex. The structure of the proteins association complexes at this level is called quaternary
structure. A quaternary structure is stabilized with noncovalent interactions and disulfide bonds.
Each subunit of the quaternary structure is called a monomer. When two monomers associate, their
quaternary structure is called a dimer. Association of more than two monomers is called an
oligomer. The oligomer of three and four subunits are named trimer and tetramer respectively.
Similarly, for the oligomers of order higher than four; penta, hexa, octa, deca, etc. -mer
nomenclature is used. The association of like proteins is called homo-oligomer (or homo dimer in
case of two proteins). And in the case of the complexes formed of subunits from different species,
their structure is called hetero-oligomer. This dissertation research work focuses on investigating
the quaternary structure of two membrane proteins, which are sigma-1 receptor and rhodopsin.

1.1.6 Protein domains
Besides the above-mentioned levels of protein structure, there is another unit of protein structure
called protein domain, which is of vital importance as divulged by studies of evolution,
conformation and function of proteins. Domains are secondary structures of proteins, which are
also called motifs. A protein domain, a contiguous part of protein can fold independently of the
rest of the protein molecule and form a compact stable structure.
There are several such domains, which are common in many proteins. These folded
domains are mostly independent of folding of other domains of the same protein. Therefore, each
domain is like an independent subunit when it comes to folding.
A protein domain generally contains 40 to 350 amino acids. A domain is the modular unit
from which many proteins are constructed. Different domain often has different functional roles,
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like functions in signaling pathways, regulatory roles, participating in catalytic activities, etc. A
short protein can be made of a single domain, or a large protein can have several dozens of domains
linked by short, relatively unstructured part of polypeptide chain, which act as flexible pivots
between the domains.
Proteins [2, 9] are divided into three categories based on their tertiary structure, that are as
follows:
•

Globular proteins [10]

•

Fibrous proteins [11]

•

Membrane proteins [4, 11]

Membrane proteins, which are more relevant to this dissertation work, are described below.

1.1.7 Membrane proteins
Membrane portions, as the name suggest, are located in the cell plasma membranes. Plasma
membranes of cells are very thin layers (~ 5-10 nm) which consist of a bi-layered matrix of
phosphor-lipids and contains proteins superficially or fully integrated into the bi-layer.
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Figure 1.3. Three views of a cell membrane. (a): An electron micrograph of a plasma membrane (of a
human red blood cell) seen in cross section. (b) and (c) show two-dimensional and three-dimensional views
of a cell membrane and the general disposition of its lipid and protein constituents. This figure is reproduced
with permission from [2].

There are three types of membrane proteins:
•

peripheral membrane proteins

•

integral membrane proteins

•

glycosyl-phosphatidylinositol-anchored (GPI) membrane proteins

Peripheral proteins are temporarily attached to membranes, which can detach with an interaction
of polar regent. The integral proteins just sit in the membrane while GPI proteins are attached to
membranes through covalent bonds.

1.2 G Protein-coupled receptors (GPCRs)
The GPCRs are the largest family of receptors in the human body [12] and constitute a preferred
target for therapeutic drugs. More than 40% drugs target GPCRs [13]. Their structural diversity
11

allows them to control many physiological activities. GPCRs bind with a variety of extracellular
molecules, called ligands, such as proteins or peptides, enzymes, nucleotides and amines. The
understanding\ of GPCRs’ secondary structure is important because this helps in locating receptorligand binding pocket. When a ligand binds to a receptor, the receptor undergoes a conformational
change, which activates the signaling pathway or cascade [14] .
The GPCR superfamily is classified in subfamilies denoted by A to F, ⍺, β γ, and δ, or by
numbers 1 to 5. Since the GPCRs are so diverse in their primary structure, a phylogenetic
classification is used [15]. Phylogenetic classification is based on evolutionary ancestry,
generating tree like classification, called cladograms., which are group of organisms that include
ancestor species and its descendants.

Figure 1.4. Schematic illustrations of a G protein-coupled receptor (GPCR). The GPCR consists of a
cytosolic region, a ligand-binding extracellular region and seven transmembrane domains. The receptor is
associated with a trimeric GTP-binding protein (G protein) consisting of three subunits called α, β and γ.(a)
When no signal molecule is present; the G protein binds to GDP and is inactive. (b) Upon binding of a
signal protein to the ligand-binding site, a conformational change of the receptor occurs. This enables the
receptor to interact with the α subunit of the associated G protein, which then exchanges its bound GDP to
GTP. This activates the G protein and causes the βγ subunit to dissociate, thus enabling it to relay the signal
by regulating the activity of additional intracellular signaling proteins.
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1.2.1 GPCR structure
First high-resolution crystal structure of a GPCR was presented by Palczewski and colleagues in
year 2000 when they succeeded to crystalize bovine rhodopsin [16]. GPCRs have seven
hydrophobic transmembrane regions, commonly represented as helix I, helix II and so on up to
helix VII, which is the common for all members of the GPCR superfamily.

Figure 1.5: Ribbon drawings of rhodopsin. (a): Parallel to the plane of the membrane (stereo view), (b):
A view into the membrane plane is seen from the cytoplasmic. This figure is reproduced with permission
from [5].

The GPCRs are among the oldest proteins, which are found in five of the six kingdoms of life
(except in Archaea). However, the GPCRs in plantae and bacteria do not interact with G proteins.
Hence, although the names suggest, interaction with G proteins is not the common basis to all the
GPCRs. However, those found in Animalia, Fungi and Protozoa are coupled with G proteins, but
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there is almost no sequence similarity between the GPCRs found in Protozoa or Fungi and in
Animalia.
One of the reasons for evolutionary success of GPCRs to metazoans (their natural
selection) was metazoans’ ability to expand, specialize and efficiently communicate, which leads
to the structural diversity of the GPCRs [17, 18].
The GPCR structure knowledge can be applied to structure-based drug discovery [19].
GPCR Researches have shown, in the absence of a ligand, that the GPCRs can exist in a dynamic
equilibrium of inactive (R) and active (R*) states (in the presence of G protein, the active state can
also convert to signaling states), and the distribution of these states can vary drastically. Binding
of an agonist can shift the equilibrium towards active state (characterized by large scale structural
change towards receptor’s intracellular side) and binding of an antagonist can shift the equilibrium
towards inactive state [20-22].

1.2.2 G protein binding and signaling
In the activation process, one of the major changes happens in the receptor’s intercellular side,
that is helix V swings away in coordination with helix VI. These two helixes are hypothesized to
be in direct or indirect contact with G proteins. This phenomenon was proposed as a global toggle
switch [23]. The movement of helix III and VII may also occur but their role in G proteins signaling
is not clear.
Ligand-dependent activation of the GPCRs is very intriguing because binding of ligands
to the vastly diverse extracellular pockets produces large-scale conformational changes on the
intracellular side. Understanding ligand-dependent activity is important to selectively and
efficiently design drugs [24-26].
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1.2.3 Allosteric modulation of GPCRs
The GPCR signaling, which is triggered by binding of an agonist or antagonist ligand to a GPCR,
can be affected by a number of endogenous or exogenous modulators such as regulatory proteins,
lipids, sterols and ions [24, 27, 28]. This phenomenon is called allosteric modulation.

1.2.4 GPCR dimerization and oligomerization
The growing numbers of publications indicate that the GPCRs exist as dimer or oligomer and these
dimers or oligomers may be important for G protein activation for at least some GPCR families
[29-36]. GPCR dimerization and oligomerization has been extensively studied by using numerous
techniques such as the Förster Resonance Energy Transfer (FRET), Bioluminescence Resonance
Energy Transfer (BRET), cross-linking, time resolved spectroscopy and molecular simulations
[37, 38]. The results of dimerization/oligomerization studies are systematically collected in a
database, which is GPCR-OKB [39]. Crystallographic studies have revealed parallel dimers with
substantial protein-protein interface for several receptors, including the array of dimers for
rhodopsin [40], as shown in figure 1.6, κ-opioid [41] and µ-opioid [42] receptors.
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Figure 1.6. Images showing organizations and topography of the cytoplasmic surface of rhodopsin.
(a) Topography obtained using atomic-force microscopy (AFM), showing the paracrystalline arrangement
of rhodopsin dimers in the native disc membrane (b) Magnification of a region of the topography in a,
showing rows of rhodopsin dimers. This figure is reproduced with permission from [40].

Overall, there are two clusters of symmetric interfaces in the GPCRs based on the crystal
structures, which agree with the biochemical data for rhodopsin [43], serotonin [44] and dopamine
D2 [45], among other GPCRs. One of them (interface A) engages helixes I, II and VIII, and the
other type (interface B) involves helixes V and VI (see figure 1.7).
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Figure 1.7. Two major types of symmetric dimer interfaces observed in GPCR structures. (a) A
representative structure of dimer interfaces with contacts via helices I, II, VIII is shown here for κ-opioid,
PDB code 3DJH. This Interface has also been observed within μ-opioid, rhodopsin and opsin structures.
(b) Another cluster of dimer interface involves contacts via helices IV, V, VI (cyan and yellow) for CXCR4
complex PDB code 3OE0. Similar orientation of subunits has also been observed in μ-opioid structure,
PDB code 3DKL, with an extensive interface formed via helices V and VI. This figure is, adopted with
permission, from [34].

Complementary insights into GPCR structure and function are obtained through using molecular
simulations and modeling [46, 47]. Advanced molecular dynamics simulations of longer temporal
durations (~ 10 ms), have allowed for large conformational changes to be investigated, thus
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capturing the receptor dynamics, which is not possible using the crystal structures. Further
structure, biophysical and computational studies, including time resolved single molecule studies
will help in characterizing the GPCRs, and finding more allosteric sites for selective modulations.
The GPCR superfamily contains at least 799 human GPCRs [48], however there are fewer
which could be considered as drug-targets for diseases because of their physiological functions.
There is a large cluster of GPCRs, which does not seem to represent potential drug target, is
sensory receptors, for instance, olfactory receptors (there are 388 receptors in this class only),
rhodopsin (or opsin) receptors (but that doesn’t mean all other members of the rhodopsin family
couldn’t be drug targets), etc. At least 46 GPCRs have already been successfully targeted by drugs.
The GPCRs can be divided into to three main families: i) Rhodopsin (more than 39 GPCRs), ii)
Secretin (4 GPCRs) and iii) Glutamate (3 GPCRs) [49]. However, there are still more than 300
receptors, which have not been used as drug targets, and about half of them are orphan receptors
whose ligands are unknown. This means that they do not have any other GPCRs, which are close
to them in primary structure. Since the clusters of receptors based on phylogenetic classifications
bind with similar ligands, these orphan receptors could be useful for those types of drugs which
are very different in molecular structure than those already being used.
So far, only a small fraction of human GPCRs have been used as drug targets, such as, 17%
of peptide or protein binding, 29% of biogenic amine binding, 20% of lipid like binding [50], etc.
Biogenic amine binding receptors have been used the most as drug targets because they are used
to treat cardiovascular diseases. Peptide receptors are the least utilized in term of their druggability.
But due to their specificity and physiological roles, such as regulation of body weight, immune
system related and pain sensation; they could be future drug targets. This is why it is likely that
GPCR family will continue to get attention from the drug-developers. To better understand and
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utilize the structural diversity and functionality of GPCRs, detailed knowledge of their secondary,
tertiary and quaternary structure is needed.

1.3 Sigma-1 receptor (S1R)
Psychostimulant abuse has been a serious social problem in industrialized and developing
countries [51, 52]. However, identifying an effective pharmacological cure has been elusive so far.
Sigma-1 Receptor (S1R) is one of the major physiological substances implicated in the substance
abuse issues. S1R has been known to interact with several drugs, for instance, cocaine and
methamphetamine, interacting with them in brain and heart. Therefore, the receptor appears to be
a logical target for the substance abuse therapy development efforts.
S1R is a membrane-bound, ligand-mediated molecular chaperone which interacts with
various ion gated channels and GPCRs [53, 54]. Prior to the sigma receptor family identification,
researchers considered the sigma receptors as one of the opioid receptors because some of the most
common opioid ligands, e.g., naloxone, which is an antagonist to opioid receptors, also interacted
with sigma receptors [40]. In 1976, Martin reported that the effect of N-allylnormetazocine ((-)ANMC) or alazocine and benzomorphan could only be seen for some of the opioid family
receptors, which led to categorize them in a new family [55, 56], which was named as sigma
receptor family. Sigma-1 receptor is a member of sigma receptor family with the only other
member being sigma-2 receptor. Sigma-2 receptor was discovered to be different than S1R, based
on ligand selectivity in the receptor binding assay [57].
Since the discovery of sigma-1 receptor, many preclinical studies have implicated sigma1 receptor in several diseases including amyotrophic lateral sclerosis (ALS) [58], neurogenic pain
[59], addiction to methamphetamine [60], cocaine [61], and alcohol [62], amnesia [63], depression
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[64], Alzheimer’s disease [65], schizophrenia [66], stroke [67], retinal neural degeneration [68],
HIV and immunity [69], and cancer [70].
Involvement of S1R was demonstrated in the cases of HIV infection and schizophrenia by
molecular biological silencing of the receptor. S1R suppresses the production of reactive oxidation
stress (ROS) in retina, lung, liver, and cultured mammalian cells [71-73].
Nanoparticles coupled with Sigma-1 Receptor ligand have shown potential for targeted
delivery of antitumor drugs in animals [74], however, any clinical study reporting their testing
with cancer patients is not reported.
The mammalian S1R receptor was first cloned in 1996 from guinea pig [75]. The cloning
was performed by radioactive labeling followed by protein purification processes. Sigma-2
receptor has not been cloned yet. Sigma-1 receptor is a small (28 kDa, 223 amino acids)
transmembrane protein which is mainly localized in the endoplasmic reticulum (ER) regions. It is
especially enriched in the mitochondria associated membranes (MAM). Localization studies have
also reported their presence in neuron nuclear, mitochondrial and plasma membrane of the central
nervous system (CNS) and in CNS-associated immune and endocrine tissues. The varied sites at
which S1Rs are present, suggest their activity via multiple physiological and pathological
pathways.
A model for the S1R structure is shown in Figure 1.9. As per this model, S1R consists of
three domains, out of which two are transmembrane regions. The folding of the receptor into the
three domains was assumed to make a ligand-binding pocket.
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Figure 1.8. Models of the sigma-1 receptor ligand binding region. A model of the sigma-1 receptorbinding region was proposed by Chu et al. [76]. Three domains of the receptor are shown. Two of them
(the longer domains in the figure) are transmembrane. The locations of C and N terminuses were reported
as D188 and H154 respectively.

The mechanism of S1R action has been difficult to understand due to the absence of similarity of
its sequence to any other known mammalian proteins. Cloning of S1R has helped advance this
understanding and provided insight into potential avenues for future investigation that will
hopefully lead to a better understanding of relationships between the S1R and the aforementioned
diseases. However, the current level of research has not reached to give a good understanding of a
link between diseases and the mechanism of action of S1R.
S1Rs reside in ER membranes, although their interaction with the ion channels in plasma
membranes has been reported [77]. The most researched mechanism of the S1R activity is related
to its interaction with ion channels, especially calcium and potassium ion channels. A possible
explanation to this is given that the overexpression of S1R agonists might cause translocation of
the receptor from ER to the plasma membrane, where it was reported to interact with the ion
channels. Ligand mediated S1R modulation of Ca2+ channels began the investigation of molecular
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action of S1R historically, and since then it has become the main areas of investigating the
receptor’s molecular action. In the presence of micromolar concentration of S1R ligand
haloperidol, the calcium ion concentration increased in colon cancer cells and mammary
adenocarcinoma cells [78]. By contrast, in the presence of another sigma receptor ligand
pentazocine, the Ca2+ channel current decreased [79]. An important study reported that the S1R
agonists potentiate N-Methyl-D-aspartic acid (NMDA)-induced neuronal firing, while haloperidol
blocks the potentiation [63, 80]. S1R colocalization with potassium channels is shown in Figure
1.10.

Figure 1.9. Sigma-1 receptor colocalization. Endogenous sigma-1 receptors colocalize with Kv1.4
potassium channel. (a) Sigma-1 receptors alone. (b) Potassium channels alone. (c) The overlap of sigma1 receptors and potassium Kv1.4 channels. This figure is reproduced, with permission, from [84].

Using cultured frog pituitary cells, it was shown that S1R ligand (+) pentazoncine
decreased outbound current of potassium, while the presence of the receptor’s antagonist NE100,
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blocked the decrease [81]. Similar studies suggested that ligand mediated S1R regulate sodium
[82] and chloride [83] channels.
S1R is also indicated in regulatory pathways for cell survival or cell death. In general, S1R
agonists promote cell survival and the receptor’s antagonists lead to cell death. The S1R
antagonist, rimcazole inhibited tumor survival [70, 85].
S1R were also found to exist in lipid rafts at the ER membranes [86]. Lipid rafts are
proposed to be cholesterol-enriched microdomains which serve as a platform for ion channels,
receptors and kinases [87]. Exact relation between S1R and lipid drafts is not known but it has
been shown that the overexpression of S1R caused reconstitution of lipid rafts [88].
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Chapter 2: Förster resonance energy transfer (FRET) theory and
the kinetic model of FRET
The key objective of writing this chapter is to provide an overview of the FRET theory and the
kinetic model of FRET for oligomeric complexes, as this is the key concept upon which the whole
dissertation is based. This chapter has been organized in three sections. The first section describes
FRET, the second section gives an overview of Förster’s theory, and the third section explains the
kinetic theory of FRET.

2.1 Fluorescence
FRET is a process of non-radiate energy transfer from an optically excited donor to an
unexcited acceptor of energy, via a process of dipole-dipole interaction. Although, in principle can
be applied to a broad range of electromagnetic radiation, FRET is popularly used in the visible
range of the electromagnetic spectrum to investigate interactions of biological macromolecules.
IN most studies, both molecules involved in FRET, i.e., the donor and the acceptor, are fluorescent.
Therefore, the FRET acronym also stands for Fluorescence Resonance Energy Transfer [1, 2].
The term fluorescence came into existence when George G. Stokes observed in 1852 that
when mineral fluorspar (calcium fluoride) was exposed to electromagnetic radiation in ultraviolet
region, it would emit visible light. Stokes’ study of fluorescence led to the formulation of Stokes’
law, which states that the wavelength of fluorescent light is always greater than the wavelength of
excitation. Thus, for any fluorescent molecule, the wavelength of emission is larger than the
wavelength of absorption. Molecules that display fluorescence are called fluorophores or
fluorochromophores [3-5].
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2.1.1 Jablonski diagram
The Jablonski diagram, shown in figure 2.1, is a schematic depiction of the energy levels in a
fluorescent molecule, giving different energy states and their vibrational sub-divisions in the order
of increasing energy in the vertical direction. States of different spin-multiplicity are arranged in
horizontal columns. This diagram helps in understanding of resonance energy transfer, and
difference between fluorescence and phosphorescence. The difference between the two types of
luminescence will be discussed later in this chapter.

Figure 2.1 Jablonski diagram, showing energy-states and interstate crossing diagram. This
diagram shows absorbance of light and its emission as fluorescence or phosphorescence. Interstate
crossing occurs when the molecule de-excites via travelling to the triplet state, giving off
phosphorescence.

FRET is a technique which reports proximity of two neighboring molecules (for their
distance <10 nm). It is a very sensitive proximity reporter since FRET depends on the 6th power
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of the reciprocal of intermolecular distance. Investigation of GFP [6]-based FRET pairs such as
GFP2 and YFP, and advancement in FRET fluorescence imaging technologies, have established
FRET as a very powerful technique in many areas, especially biological sciences.

2.1.2 Fluorescence vs phosphoresce
Phosphorescence [7] occurs when an excited state electron enters to a triplet state [8, 9] via
intersystem crossing [10], and from there it’s de-excitation to the ground state is forbidden
classically because it requires its spin to flip in order to re-emit energy, but quantum mechanically
there is some probability for this transition to happen [9]. However, due to much weaker
probability than that for the fluorescence events, it could take seconds to hours for
phosphorescence to re-emit [11].

2.1.3 Rate of de-excitation (Γ)
When laser of suitable wavelength is shone on a fluorescent molecule, an electron of the outer
shell of its atom is kicked to a singlet excited state, and from there, it first goes through vibrational
relaxation (which are non-radiative), to trickle down to the lowest vibration state of that singlet
state and then it can de-excite via multiple radiative (Γ 𝑟,𝐷 ) and non-radiative (Γ 𝑛𝑟,𝐷 ) pathways.

2.2 FRET
FRET is frequently used to measure both intra-molecular and inter-molecular distances in living
cells [12-14]. When an excited dipolar molecule is near to an unexcited dipolar molecule, then a
non-radiative energy transfer can take place, from the excited molecule (donor) to the unexcited
molecule (acceptor) without involving photons, and this process is called a resonance energy
transfer or RET. When this energy transfer happens between the molecules, which have their
emission wavelength peaks in the visible spectrum, their emission is called fluorescence and the
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phenomenon is called Fluorescent Resonance Energy Transfer or Förster Resonance Energy
Transfer (FRET) [15-22].
The electric field E of an excited dipole (donor) with a charge 𝑞 𝐷 interacts with the electric
field of another unexcited dipole (acceptor) of charge 𝑞 𝐴 , as 𝑞 𝐴 .E, and vise-versa. This causes the
transition dipole moments (t.d.m.) of the two molecules to interact with each other, called dipoledipole coupling [23, 24]. This dipole-dipole coupling can cause the two dipoles to reorient and, in
the process, energy is transferred from the excited donor to the acceptor molecule. The energy
transfer via dipole-dipole coupling is a non-radiative pathway of energy transfer.[25, 26].
There are three spatial regions of the electric field due to a dipole, near field (where E is
proportional to 𝑟 −2, far field (which varies as 𝑟 −1 ), and the region between near and far field.
When the acceptor molecule is in the range of the near field, its interaction with the E field of the
donor is the strongest, and for the resonance energy transfer, only the near field interaction is strong
enough to cause relative change in the dipole orientation. There are both classical and quantum
theories to explain this non-radiative energy transfer. J. Perrin [27] first proposed a classical theory
of FRET.
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Figure 2.2 Energy transfer between donor and acceptor molecule. Donor excitation λDex (blue
arrow) takes donor from its ground state S0 to its (first) excited state S1, where the excited molecule
settles through vibration relaxation, and then is de-excited giving off donor fluorescence Гr,D
(green arrow) at λDem. In the presence of an acceptor, the donor can also be de-excited by
transferring its energy via FRET to the acceptor. Excited acceptor after going through vibration
relaxation, de-excites via acceptor emission Гr,A (yellow arrow) at λAex. Both donor and acceptor
can also be de-excited via non-radiate pathways Гnr,D and Гnr,A respectively.

Förster suggested that, since energy conservation cannot be violated, energy transfer from
a donor transition dipole to an acceptor dipole can only be possible when there is an equal
difference of the energies between the excited and the ground states of the two species. However,
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he had also observed that, even though there needs to be same frequency absorbed as emitted,
which is a condition of resonance, there is no single frequency of transfer; instead, there is a range
of frequencies or band of frequency at which an acceptor can absorb photons.
A combination of a FRET donor and acceptor are called a FRET pair. A good choice of a
FRET pair is based on the following factors:
1. Large spectral overlap
2. Large Stokes shift
3. High quantum yield

2.2.1 Spectral overlap
The overlap between the donor emission and the acceptor excitation (or absorption) is called
spectral overlap. A good overlap of the bandwidths (spectra) of donor emission and acceptor
absorption results in a higher energy transfer efficiency and hence stronger FRET signal. For that
purpose, the choice of the FRET pair or donor and acceptor molecules is critical.

Figure 2.3 Spectral overlap of donor emission and acceptor absorption. Blue line shows emission
spectrum of the donor (Turquoise) fused to rhodopsin and expressed in Chinese hamster Ovary (CHO)
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cells, measured in our lab, and the red dotted curve shows the absorption (excitation) spectrum of sYFP2,
which is an acceptor of energy when in the vicinity of an excited Turquoise molecule. The sYFP2 spectrum
is replotted with the data extracted from literature [17].

There are many good FRET pairs have been used in the proximity or interaction studies [18, 19,
21, 28-30]. The choice also depends on the imaging system used, which includes the compatibility
with the laser and the detection camera.

2.2.2 Stokes shift
The Stokes shift or Stokes distance is the distance between the maxima of the bands of fluorescent
excitation and emission of the same electron [20, 25, 31]. It applies to both donor and acceptor
molecules, and each fluorophore has a distinct Stokes shift. A large Stokes shift is needed to
resolve the fluorescence of emissions of the donor and the acceptor.

2.2.3 Quantum yield (QY)
The quantum yield [32, 33] ] of fluorescence is given by the following equation
𝑄𝑢𝑎𝑛𝑡𝑢𝑚 𝑌𝑖𝑒𝑙𝑑 = # 𝑜𝑓 𝑝ℎ𝑜𝑡𝑜𝑛 𝑒𝑚𝑖𝑡𝑡𝑒𝑑⁄# 𝑜𝑓 𝑝ℎ𝑜𝑡𝑜𝑛 𝑎𝑏𝑠𝑜𝑟𝑏𝑒𝑑 .

(2.1)

Values of the quantum yield ranges between 0 and 1. Measuring quantum yield is rather difficult.
There are several criteria to be considered for accurate determination of the quantum yield,
including effects of concentration, which can cause self-quenching, and the effect of solvent on
the quantum yields. Some good methods for measuring the quantum yields of fluorescence were
described by Brouwer A.M. [33] .

2.2.4 Origin and properties of fluorescent proteins
The Green fluorescent protein (GFP) was first isolated form the jellyfish Aquorea Victoria[34, 35]
Later it was mutated to give several spectral variants, for example, CFP, YFP, red fluorescent
proteins, etc [6, 36-41] Scientists Roger Chen, Y.Tsien, Osamu Shimomura, and Martin Chalfie
were awarded Nobel prize in chemistry in 2008 for the discovery and development of GFP.
38

Both natural and synthetic (when fluorophores are attached chemically, also called dyes)
variations of fluorescent proteins are used. Fluorescence photons have several properties such as:
•

Spectrum

•

Lifetime

•

Polarization

The above properties are exploited for fluorescence imaging analysis. There are several
applications of FRET such as:
•

Single molecule tracking, for which a very sensitive detection and fast image acquisition
is used.

•

Fluorescent correlation spectroscopy (FCS), which tracks fluorescence fluctuations over
time.

2.3 Förster theory
The FRET efficiency, E, derived by Förster is given by the following expression:
𝐸=

1
,
1 + (𝑟⁄𝑅0 )6

(2.2)

where r is the distance between the two molecules, and Ro is the Förster radius, which is the
distance for which 50% of the donor energy is transferred via FRET, and Ro [5, 42, 43] and is
defined as
𝑅0 6 =

9(𝑙𝑛10) 𝑘 2 𝑄𝐷
𝐽,
128 𝜋 5 𝑁𝐴 𝑛4

(2.3)

where J is the spectral overlap integral (defined below), and 𝑘 is the orientation factor and, which
is given by
𝑘 = µ̂ 𝐴 . µ̂ 𝐷 − 3(µ̂ 𝐷 . 𝑅̂)(µ̂ 𝐴 . 𝑅̂𝐷𝐴 ),
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(2.4)

where µ̂ 𝐴 and µ̂ 𝐷 are the dipole moments of the donor and acceptor dipoles respectively. R is the
displacement vector between the two dipoles. The orientation factor (𝑘) can also be expressed in
terms of the angles by the following
𝑘 2 = (cos 𝜃𝜏 − 3 cos 𝜃𝐷 cos 𝜃𝐴 )2 = (sin 𝜃𝐷 sin 𝜃𝐴 cos 𝛷 − 2 cos 𝜃𝐷 sin 𝜃𝐴 )2 ,

(2.5)

where 𝜃𝜏 is the angle between the donor and acceptor dipoles. The remaining variables of the
above equations are defined in the figure legend of Figure 2.4. The isotropic average value of 𝑘 2
is 2/3 [44, 45].
The spectral overlap integral in equation (2.3), depends on the spectral overlap of the donor
emission spectrum and acceptor excitation spectrum and is given by:
𝐽=

∫ 𝑓𝐷 (𝜆) 𝜖𝐴 (𝜆)𝜆4 𝑑𝜆
= ∫ 𝑓𝐷 (𝜆) 𝜖𝐴 (𝜆)𝜆4 𝑑𝜆,
∫ 𝑓𝐷 (𝜆) 𝑑𝜆

(2.6)

where 𝜆 is the wavelength, 𝑓𝐷 is the donor intensity at wavelength 𝜆 and 𝑓𝐷 is the average donor
intensity over the wavelength range, and 𝜖𝐴 is the permittivity of the medium [25].
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Figure 2.4 The schematic diagram of the transition dipole directions. θD and θA are the angles
for the donor (D) and acceptor (A) dipole orientations, with reference to the line joining D and A
(along 𝑟) respectively in their respective planes. The two planes intersect each other at an angle
Φ, whereas θ𝜏 is the angle between the instantaneous directions of the two dipoles.

Förster reckoned that, since the energy conservation cannot be violated, energy transfer
from a donor dipole to acceptor dipole can only be possible when there is the same difference
between the excited and the ground state energy levels of the two species. Since the same
frequency is accepted, as emitted, which is a condition of resonance. Nevertheless, Förster
observed that there is no single frequency of transfer; instead, there is a range of frequencies (or
wavelengths), which gives spectrum of emission and excitation, for the donor and acceptor of the
energy respectively. Especially in the solutions, the excitation and the emission spectrums of
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energy further broaden, because of the physical interaction of the fluorescent molecules with their
environment, specifically, their collision with the other solution molecules.
From the equation given in the FRET section above, it can be noted that the rate of energy transfer
is dependent on factors that are as follows:
•

Distance between donor and acceptor

•

Spectral overlap

•

Relative dipole orientation

By means of depolarization and de-quenching of fluorescence, J Perrin and F Perrin [46, 47]
observed intermolecular energy migration, which was found in solutions of moderate
concentration where majority of the molecules were not associated to each other.
When a polarized light excites a fluorescent molecule, the excited molecules will be arranged
anisotropically that is having directionality. However, in times between subsequent excitations,
the molecules will rearrange themselves isotropically by Brownian rotational motion (diffusion),
which is on the scale of 10-8 sec, giving an unpolarized fluorescent emission.
On the other hand, in the viscous solutions, there is not always enough time for the excited
molecules to change their orientation completely to be isotropically distributed before they emit.
Hence, this is to say that the fluorescence is partially polarized. The maximum value of the degree
of depolarization is up to 50% and it has been found that even increasing concentration of the
solution lead to very small changes in depolarization [48].
Oscillating electric charge causes coupling with a radiation field, thus the emission of energy
occurs in the surrounding region. Mutual electrostatic force of two charged molecules causes
coupling of the oscillators of adjacent molecules. At the same frequencies, this lead to transfer of
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energy, in the same fashion, as energy is transferred in coupled pendulums, where the pendulum
in motion transfers its energy mechanically to the other pendulum, which was initially in rest.
In the case of resonance energy transfer (this coupling is called mutual coupling), where the
coupling is considerably weaker than the coupling between charge and radiation field, the emission
of energy occurs only from the primarily excited oscillator. In the first case coupling of charge
with the radiation field, the excitation and the emission is reciprocated by both the molecule
participating in the coupling, i.e., when the second molecule emits after being excited by the E
field of the first one, the emission of the second one can re-excite the first molecule leading to
multiple excitations and de-excitations. Furthermore, in FRET excitations, the re-excitations are
distance dependent. The two excitations merge at a distance, which was computed by Perrin by
the following equation
𝑑0 ~

𝑐
= 𝜆⁄2𝜋
𝜔

(2.7)

Using quantum mechanical approach, the mean duration of emission is given by
𝜏 = ℎ 𝑐 3 ⁄2𝜋𝑀2 𝜔3 ,

(2.8)

where h is Plank’s constant.
Also, the interaction energy of the two oscillators is equal to the electrostatic energy of
both dipoles, given by the following equation
𝑈 ~ 𝑀2 ⁄𝑑 3 ,

(2.9)

where d is the distance between the two oscillators.
From here, transfer of the entire energy occur in a time of
𝑡0 = ~ ℎ⁄2𝜋𝑈 ~ ℎ 𝑑 3 ⁄2𝜋 𝑀2
For critical distance 𝑑0 , the transfer time is equal to the lifetime [43], i.e.
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(2.10)

𝑡0 = 𝜏

(2.11)

On computing, the distance d0 comes equal to 1000 Å, for molecules which absorb at λ= ~ 6000
Å, which is much larger than the distance obtained from concentration quenching (λ = 50 Å). This
is an inconsistency in Perrin’s method, which was noticed by Förster because the condition of
exact resonance was not met for the energy transfer. For a spectrum of a dye, it is not a short line
but a broad band. The reason behind the broad band is coupling of the electronic motion with the
atomic motion within the molecule and with the surrounding solvent. Another reason for the
broadness is that emission (fluorescence) spectrum is shifted from the absorption of the same
molecule by Stokes’ Law and the two show very little overlap [42, 43, 49].
Protein-protein interaction is important to several biological processes, including signal
transduction. There have been several theories and model presented to study the kinetics of proteinprotein interaction. One of them is probing the kinetics via FRET, or kinetic model of FRET. For
a dimeric complex, it has been relatively easier to see consistency between theory and observation,
however, for a complex of more than two monomers, it gets complicated. There are two main tasks
of this model that are as follows:
•

Determination of intermolecular distances

•

Investigating the stoichiometry of the protein complexes.

The first can be determined with the measurement of FRET efficiency E and Förster Radius
Ro, which is the distance at which the FRET efficiency drops to half of its maximum value. These
have been determined using both life time FRET (FLIM) and intensity dependent FRET. Results
of FLIM are concentration dependent while intensity dependent FRET is concentration dependent.
For the stoichiometry determination, intensity based FRET is more suitable because it can give the
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ration of donor and acceptor tagged molecules for any quantifiable region of interest such as pixel.
Also, it can give the ratio of interacting to total number of molecules.
Due to the complexity of oligomeric determination, the advancement in this research field
has been slow over last several decades. A model was given for homo oligomeric species [50]
which was inspired from the crosslinking model used by Milligan and the others [51]. Raicu et al
[52] extended this model to include free monomers and then used it calculate fraction yeast
oligomers and average number of the monomers in a oligomer, which was found to be a dimer.
This theory makes assumptions that the rate of energy transfer to all the acceptors by a nearby
donor is same, and there is negligible energy transfer to the distant monomers of the complex [53].
In oligomeric complexes of the order greater than two (bigger than dimer) there are more than one
pathways of the energy transfer from each donor. And, if there are more than one donors, then they
can excite acceptor molecule in parallel, quasi parallel process, in which each donor has non-zero
probability of exciting the same acceptor. However truly parallel (in time) transfer of energy from
multiple donors to the same acceptor will violate basic quantum mechanics postulates.
Different methods are used to estimate FRET efficiency, such as acceptor photobleaching
[54, 55] , and acceptor stimulated emission [24, 56]. For the oligomer of size bigger than dimers,
the multiple pathways for energy transfer from donor to acceptor are available. The FRET
efficiency between a donor and an acceptor (DA) pair is called pairwise FRET efficiency (Ep).
When there are only FRET oligomers present in a mixture, then the average FRET efficiency is
called true FRET efficiency. However, when there is the presence of donor only or acceptor only
complexes (which don’t participate in FRET), then the average FRET efficiency is called apparent
FRET efficiency (Eapp), assuming the fret complexes are there for functional purposes and remain
changed in their geometry throughout the measurement of FRET. At this stage of modeling, the
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nonspecific interaction between the donors and the acceptors of different complexes is not
considered due to crowding or motion [57, 58], which could be more significant at higher
concentrations.
FRET efficiency of a dimeric complex is defined based on two types of physical quantities
that are as follows:
•

Spectroscopic quantities like quantum yields of donor and acceptor, in the presence
and absence of the other acceptor or donor, respectively,

•

The lifetime or fluorescent intensity, which are experimentally measurable.

FRET is considered only as non-radiative energy transfer and homo FRET (one between
two donor or acceptor molecules) and this is not considered in this part of the kinetic theory.

2.3.2 Relationship between quantum yield (Q) and FRET efficiency (Eapp)
Quantum yield of donor is defined as rate of deexcitation by the means of photon emission divided
total rate of deexcitation. The Quantum yields of donor and acceptor in the absence of acceptor or
donor is given by [22] the following two equations

and

𝑄 𝐷 = 𝛤 𝑟,𝐷 ⁄(𝛤 𝑟,𝐷 + 𝛤 𝑛𝑟,𝐷 ),

(2.12)

𝑄 𝐴 = 𝛤 𝑟,𝐴 ⁄(𝛤 𝑟,𝐴 + 𝛤 𝑛𝑟,𝐴 )

(2.13)

When there is an acceptor in the vicinity of a donor (less than 10 nm) and their spectral profiles
match (donor emission and acceptor excitation have overlaps), and the orientation of the transition
dipoles is such that there is a dipole coupling between the donor and acceptor molecule, then these
conditions present another nonradiative pathway for donor energy transfer to the acceptor via
FRET. The quantum yield of the donor in the presence of the acceptor is given by
𝑄 𝐷𝐴 = 𝛤 𝑟,𝐷 ⁄(𝛤 𝑟,𝐷 + 𝛤 𝑛𝑟,𝐷 + 𝛤 𝐹𝑅𝐸𝑇 ),
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(2.14)

and, the apparent FRET efficiency is defined by the following
𝐸𝑎𝑝𝑝 = 𝛤 𝐹𝑅𝐸𝑇 ⁄(𝛤 𝑟,𝐷 + 𝛤 𝑛𝑟,𝐷 + 𝛤 𝐹𝑅𝐸𝑇 ),

(2.15)

where 𝛤 𝑟,𝐷 and 𝛤 𝑟,𝐴 are the rates of donor and acceptor deexcitation respectively. 𝛤 𝑛𝑟,𝐷 is the
non-radiative rate of donor excitation and 𝛤 𝐹𝑅𝐸𝑇 is the rate of the energy transferred via FRET.

2.3.2 Fluorescence lifetime
Time taken by a fluorophore to return to ground state from a excited state is the deexcitation
lifetime, and denoted by τ. The excited molecule emits a photon in the process, when this happens
in visible spectrum, it is called fluorescence lifetime. The lifetime can range from picosecond to
nanoseconds [5].
The lifetime for donor and acceptor species, is given by the following two equations
τ𝐷 = 1⁄(𝛤 𝑟,𝐷 + 𝛤 𝑛𝑟,𝐷 ),

(2.16)

and,
τ𝐴 = 1⁄(𝛤 𝑟,𝐴 + 𝛤 𝑛𝑟,𝐴 )

(2.17)

However, the lifetime for the donor and acceptor changes when FRET occurs. The donor lifetime
in the presence of acceptor is given by the following equation [28]:
τ𝐷𝐴 = 1⁄(𝛤 𝑟,𝐷 + 𝛤 𝑛𝑟,𝐷 + 𝛤 𝐹𝑅𝐸𝑇 )

(2.18)

From the above equations, it can be seen that the donor life time shortens in the presence of the
acceptor.

2.4 The kinetic model of FRET
In a multimeric complex, when a donor molecule has several pathways of transferring the energy
via FRET, i.e., it transfers energy to more than one acceptor within a few nanometer distance, the
quantum yield of the 𝑖th donor is given by the Kinetic Theory of FRET [52].
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Figure 2.5 Illustration for donor de-excitation pathways (Γ). Donor (D) losing energy via radiative
𝜞𝒓,𝑫 , non-radiative 𝜞𝒏𝒓,𝑫 (e.g., thermal energy lost through vibrational relaxations), and nonradiative
energy transfer via FRET 𝜞𝑭𝑹𝑬𝑻
to neighboring acceptors (A). 𝒊 and 𝒋 are the indexes for donor and
𝒊,𝒋
acceptor positions [20, 52].
𝐷𝐴
𝑄𝑖,𝑘,𝑛,𝑞
= 𝛤 𝑟,𝐷 ⁄(𝛤 𝑟,𝐷 + 𝛤 𝑛𝑟,𝐷 + ∑

𝑛−𝑘
𝑗=1

𝐹𝑅𝐸𝑇
𝛤𝑖,𝑗,𝑞
),

(2.19)

where 𝑛 is the number of monomers in the complex, 𝑘 is the number of donors, hence the number
of acceptors is (𝑛 − 𝑘) , and 𝑗 is a summation index for acceptors, and

𝐹𝑅𝐸𝑇
𝛤𝑖,𝑗,𝑞
=

6

0
(𝛤 𝑟,𝐷 + 𝛤 𝑛𝑟,𝐷 )⁄(𝑅𝑖,𝑗,𝑞
⁄r𝑖,𝑗,𝑞 ) is the rate constant for a donor-acceptor pair.

Using the above equation, and the relationship between quantum yield and FRET
efficiency, 𝐸𝑖,𝑘,𝑛,𝑗 can be generalized for the 𝑖th donor of complex of 𝑛 molecules and k donors
𝐸𝑖,𝑘,𝑛,𝑗 =

𝐹𝑅𝐸𝑇
𝑟,𝐷
∑𝑛−𝑘
+ 𝛤 𝑛𝑟,𝐷 )
𝑗=1 𝛤𝑖,𝑗,𝑞 ⁄(𝛤

,
𝐹𝑅𝐸𝑇
𝑟,𝐷 + 𝛤 𝑛𝑟,𝐷 )
1 + ∑𝑛−𝑘
𝑗=1 𝛤𝑖,𝑗,𝑞 ⁄(𝛤

(2.20)

and the apparent FRET efficiency per donor (𝐸𝑎𝑝𝑝 ) for the complex is simply the average FRET
efficiency of all donors, as in the equation below
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𝐸𝑎𝑝𝑝 = ∑

𝑘

𝐸𝑖,𝑘,𝑛

𝑖=1

(2.20)

Using equation 2.20, 𝐸𝑎𝑝𝑝 equations can be written for the quaternary structures of various
stoichiometry and shape, such as trimers, tetramers, hexamers etc. A few of them are shown in the
figure below.

Figure 2.6 Efficiencies predicted for different oligomer shapes and sizes [28]. For any given
structure, all the Eapp expression are related by a single parameter, which is pairwise FRET
efficiency or Ep.
Using the equations 2.17 and 2.18, the Eapp expression for a parallelogram tetramer, with a
special case being rhombic tetramer (as shown in the second row of Figure 2.6), is derived below.
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2.4.1 Theoretical FRET efficiency for a parallelogram tetramer model
Let us consider a tetramer (i.e., n = 4) consisting of 𝑛𝐷 donors and 𝑛𝐴 acceptors placed in the
corners of a parallelogram of sides 𝑟1 and 𝑟2 . Figure 2.7 demonstrates such a tetramer (DDAD)
with 𝑛𝐷 = 3 and 𝑛𝐴 = 1. If 𝑟1 and 𝑟2 are the two sides of the parellogram and α is the angle
between the two sides of the parellogram then the digonal 𝑟𝑑1 and 𝑟𝑑2 are given by:
𝑟𝑑1 = (𝑟1 2 + 𝑟2 2 + 2𝑟1 𝑟2 cos 𝛼)1⁄2 ,

(2.21)

𝑟𝑑1 = (𝑟1 2 + 𝑟1 2 − 2𝑟1 𝑟2 cos 𝛼)1⁄2 ,

(2.22)

and,

Also, the pairwise FRET efficiency [28, 59] between donor 𝑖 = 1 and acceptor 𝑗 = 1 is given by
𝐸1 =

𝑅
( 0)

6

𝑟1

,

(2.23)

1
( 𝑟0 ) = 1−𝐸
.

(2.24)

𝑅
1+( 0 )

6

𝑟1

where, 𝑅0 is Forster radius. From Eq. (1.2)
6

𝑅

𝐸

1

1

Therefore
6

𝑅

𝐸

𝑟

6

1
(𝑟 0 ) = 1−𝐸
(𝑟1 ) ,
1

𝑘

(2.25)

𝑘

where, 𝑘 can take values 2, 𝑑1 and 𝑑2.
Now, the apparent FRET efficiency for the configuration shown in Figure 2.7 is given by
1

1

3

3

𝐸𝑎𝑝𝑝 = ∑3𝑖=1 𝐸𝑖𝑗 = (𝐸11 + 𝐸21 + 𝐸31 ),

(2.26)

Recognizing 𝐸11 as 𝐸1 and using Eq. (1.3)
6

𝐸21 =

𝑅
( 0)
𝑟𝑑1

6

𝑅
1+( 0 )

=

𝑟𝑑1
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6
𝐸1
𝑟
( 1)
1−𝐸1 𝑟𝑑1

1+

6
𝐸1
𝑟
( 1)
1−𝐸1 𝑟𝑑1

,

(2.27)

Figure 2.7 Configuration of a parallelogram shaped tetramer model representing three
donors and one acceptor. 𝑟1 and 𝑟2 represent the two sides of the parellogram, α is the angle
between two side of the parellogram, 𝑟𝑑1 and 𝑟𝑑2 are the two diagonals of the parellogram. 𝑖
represents the donors while 𝑗 the acceptors. 𝑟𝑑1 is short diagonal distance while 𝑟𝑑2 is the long
diagonal distance.

Similary,
𝐸31 =

𝑅
( 0)

6

𝑟2

𝑅
1+( 0 )

6

=

𝑟2

𝐸 1 𝑟1 6
( )
1−𝐸1 𝑟2

1+

𝐸 1 𝑟1 6
( )
1−𝐸1 𝑟2

,

(2.28)

Pluging Eq. (2.6) and Eq. (2.7) into Eq. (2.5), we get
1

𝐸𝑎𝑝𝑝 = 3 [𝐸1 +
and,

1

𝐸𝑎𝑝𝑝 = 3 [𝐸1 +

6
𝐸1
𝑟
( 1)
1−𝐸1 𝑟𝑑1

1+

6
𝐸1
𝑟
( 1)
1−𝐸1 𝑟𝑑1

𝑟 6
𝐸1 ( 1 )
𝑟2

𝑟 6
1−𝐸1 +𝐸1 ( 1 )
𝑟2

+

𝐸 1 𝑟1 6
( )
1−𝐸1 𝑟2

1+

𝐸 1 𝑟1 6
( )
1−𝐸1 𝑟2

],

(2.29)

6

+

𝑟
𝐸1 ( 1 )
𝑟𝑑2

6

𝑟
1−𝐸1 +𝐸1 ( 1 )

],

(2.30)

𝑟𝑑2

Equations (2.27) and (2.28) give is the expression for apparent FRET efficency in terms of the
sides of the parellogram, the diagonals and pairwise FRET efficiency. Similarly, the FRET
efficencicy expressions for the other six possible configurations can be derived and there
expressions are tabulated in Table 2.1.
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1.

Configurations

Geometric

Configuration #

Table 2.1. Parallelogram tetramer configurations, and their FRET efficiencies.

FRET Efficiency Per Donor

0

2.
𝐸1 ,

3.

4.
𝐸1 ,

5.

𝑟 6
𝐸1 ( 1 )
𝑟2

𝐸1 (

𝑟1 6
)
𝑟𝑑2

𝑟 6
𝐸1 ( 1 )
𝑟2

𝐸1 (

𝑟1 6
)
𝑟𝑑1

,
𝑟 6
𝑟 6
1 − 𝐸1 + 𝐸1 ( 1 ) 1 − 𝐸1 + 𝐸1 ( 1 )
𝑟2
𝑟𝑑2

,
𝑟1 6
𝑟 6
1 − 𝐸1 + 𝐸1 ( ) 1 − 𝐸1 + 𝐸1 ( 1 )
𝑟2
𝑟𝑑1

6.
7.

8.

9.

10.

𝑟 6
𝑟 6
𝑟 6
𝑟 6
𝐸1 [( 1 ) + ( 1 ) ]
𝐸1 [( 1 ) + ( 1 ) ]
𝑟2
𝑟𝑑1
𝑟2
𝑟𝑑2
,
𝑟1 6
𝑟1 6
𝑟1 6
𝑟 6
1 − 𝐸1 + 𝐸1 [( ) + ( ) ] 1 − 𝐸1 + 𝐸1 [( ) + ( 1 ) ]
𝑟2
𝑟𝑑1
𝑟2
𝑟𝑑2

𝑟1 6
𝑟 6
) ]
𝐸1 [1 + ( 1 ) ]
𝑟𝑑1
𝑟𝑑2
,
𝑟1 6
𝑟 6
1 − 𝐸1 + 𝐸1 [1 + ( ) ] 1 − 𝐸1 + 𝐸1 [1 + ( 1 ) ]
𝑟𝑑1
𝑟𝑑2
𝐸1 [1 + (

11.
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𝑟 6
𝑟 6
𝐸1 [1 + ( 1 ) ]
𝐸1 [1 + ( 1 ) ]
𝑟2
𝑟2
,
𝑟1 6
𝑟 6
1 − 𝐸1 + 𝐸1 [1 + ( ) ] 1 − 𝐸1 + 𝐸1 [1 + ( 1 ) ]
𝑟2
𝑟2

12.

13.

𝑟 6
𝑟 6
𝐸1 [1 + ( 1 ) + ( 1 ) ]
𝑟2
𝑟𝑑2
𝑟 6
𝑟 6
1 − 𝐸1 + 𝐸1 [1 + ( 1 ) + ( 1 ) ]
𝑟2
𝑟𝑑2

14.

15.

𝑟 6
𝑟 6
𝐸1 [1 + ( 1 ) + ( 1 ) ]
𝑟2
𝑟𝑑1
𝑟 6
𝑟 6
1 − 𝐸1 + 𝐸1 [1 + ( 1 ) + ( 1 ) ]
𝑟2
𝑟𝑑1

16.

17.

N/A

Similarly, Eapp expressions can be computed for any other geometry. Eapp expressions for
parallelogram hexamer and circular octamers are presented in Appendix A.
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Chapter 3: Technology for FRET imaging
This chapter covers the description of the technology used in FRET imaging. The chapter is
divided into three sections. The first section focuses on the major classical methods used for FRET
imaging, the second section focuses on optical micro-spectroscopy (OptiMiS), a powerful imaging
technology developed by Raicu lab and used as a part of imaging technology in the next two
chapters of this thesis, while the last part of the chapter details a method of calculating the pixel
level FRET efficiencies of the images generated with the help of spectral FRET-based microscopy.

3.1 Review of classical methods
Optical imaging, like fluorescence imaging, are the powerful investigation tools, in biological and
biomedical samples, because they are minimally incursive, and can be performed on the living
cells or tissues, without causing any damage to them. There are four main parameters which
characterize fluorescence: wavelength, lifetime, and polarization. Fluorescence imaging is often
performed for investigating the biological samples, and the four parameters mentioned above, or
their combinations are used to generate contrasts in image pixels. Fluorescence detection
sensitivity extends to single molecules with the help of sophisticated technology in bioengineering
and microscopy.
Traditional biochemical or biophysical methods did not provide access to assembly of
protein complexes in their natural environment. Thus, the researches using those methods were
not conducted under physiological conditions, and therefore always raised doubts as to whether
those interactions also exist in live cells. Fluorescence-based techniques, deploying wide field,
confocal or multiphoton microscopy, have provided with tools to look into living cells. The other
technological developments, which were crucial to in vivo observations, occurred due to the
success in molecular biology engineering, which enabled with genetically encoded fluorescent
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labels [1-9]. Development in optical and computational techniques helped in image acquisition.
These technological developments led several sophisticated studies ranging from gene expression
to intercellular signaling [5, 10-12].
Biochemistry of living systems includes the study of the structural hierarchy of organelle,
cells, tissues and living beings. Biological phenomena are based on fundamental physicochemical
processes of molecular binding, association, dissociation and conformal changes, diffusion, etc.
Fluorescence microscopy is specifically suitable because it presents contrast due to its sensitivity,
specificity, and modulation between the ground and the excited states of molecules.
FRET microscopy relies on the signal received in donor and acceptor channels. If FRET
occurs, the donor signal will be quenched as well as the acceptor channel signal will be sensitized
or increased [13-19]. This can not only give colocalization of donors and acceptors but also provide
stoichiometry and shape of molecular association [15, 16, 19].
Diffraction is the limit to conventional optical microscopy. FRET provides a spatial
resolution, which far exceeds the diffraction limited resolution. Moreover, FRET is also
compatible with super resolution techniques, for instance, Total Internal Reflection Fluorescence
(TIRF) microscopy.
There are several types of microscopy, including wide field [20-24], confocal [25-31],
multi-photon [32-39] and Total Internal Reflection Fluorescence (TIRF) microscopy [40-44],
which can be used to measure FRET. Although the wide field microscopy is a popular microscopy,
it is not very unsuitable for FRET studies, because, in the wide field microscopy, the light reaching
the detector comes from a thick specimen region causing blur and low spatial resolution. Basic
principles and functions of some popular FRET technologies, which include fluorescence lifetime
imaging, fluorescence photobleaching, changes in optical polarization, are given below.
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3.2 Fluorescence lifetime imaging microscopy (FLIM)
FLIM is based on the difference in the exponential decay rates of the fluorophores in the absence
and presence of diverse types of fluorophores within FRET range (<10 nm). This method depends
on the lifetime rather than the intensity of the fluorophores because it does not need high excitation
intensity. Due to lower intensity, this method produces lesser scattering in thick samples than
intensity-based methods. The concept of fluorescence lifetime is defined below.
Quantum yield (𝑄), as defined previously, is the ratio of photon emitted to photons
decayed, can also be written in terms of decay rates (or rate of deexcitation)
𝑄 = 𝛤 𝑟 ⁄(𝛤 𝑟 + 𝛤 𝑛𝑟 )

(4.1)

Lifetime (τ) is measure of average time spent in excited state, given as
τ = 1⁄(𝛤 𝑟 + 𝛤 𝑛𝑟 )

(4.2)

Intensity at a time t is given in term of lifetime as
𝐼(𝑡) = 𝐼(0). 𝑒 −𝑡⁄𝜏

(4.3)

Quantum yield is proportional to fluorescence lifetime as
𝑄 = τ⁄ τ𝑟 ,

(4.4)

where τ𝑟 =1⁄𝛤 𝑟
Measurement of fluorescence lifetime depends on the intensity of excitation, rather than
the concentration of fluorophores, on which emission intensity will depend. Thus, regarding this,
the lifetime method is more robust than the intensity-based method. In theory, determining
fluorescence lifetime provides one of the most direct measurements of FRET. However, measuring
lifetime accurately is rather challenging.
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Fluorescence lifetime images are basically the fluorescence emission intensity maps, where
the intensities are determined from the lifetime τ (as shown in figure 3.1). And, this allows one to
compare the two images with different fluorophores. FLIM techniques can be classified into time
domain and frequency domain techniques; point scanning and wide field scanning techniques,
photon counting, and analog counting techniques.

Figure 3. 1 The diagram shows the exponential nature of fluorescence decay. Fluorescence lifetime
(𝛕) is the time taken into the decay of fluorescence intensity to 1/e times the initial intensity.

Among all the fluorescence parameters, it is the decay (rate) constant which provides with the most
direct insight into the molecular interaction of a fluorophore. However, the rate constants and
hence the fluorescence lifetimes depend on the type of fluorophore, its conformation and how it
interacts with its environment. It also depends on whether the fluorescence is collected through a
few gates (filters) or many channels and whether this happens simultaneously or sequentially.
Virtually, all these methods are in use, which results in many instrumental principles. Different
principles differ in their photon efficiency, a minimum number of photons required for accuracy,
multi-wavelength capability, and optical sectioning capability, etc.
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3.1.1.1 Time-correlated single-photon counting (TCSPC)
TCSPC [45-48] is a well-established technique, based on fluorescence lifetime which can be used
for FRET as well as other measurements, such as those involving the time of flight. Measurement
of TCSPC depends on counting single photo, and it requires a reference light source. It’s a
statistical method which requires a high repetitive light source to obtain enough photons for a
precision in the statistical data.

Figure 3. 2 A schematic of time-correlated single photon counting (TCSPC) FLIM. This figure is
adapted with permission from [49].

TCSPC electronics can be compared to a stopwatch with two inputs. A schematic of this method
is shown in figure 3.2. The clock starts with the signal input and ends with the signal output. Time
spend in this start-stop event will be recorded in the memory histogram and increases its memory
value. In this histogram, the x-axis represents time and the y-axis represents the number of events
(photon detections) counted over a time interval. The histogram counts versus channels represent
the fluorescence intensity versus time.

3.1.2 Photobleaching methods
Live cell imaging with dye-labeled proteins or organelle dyes provided new insights into the
dynamics of cellular compartments. Because it takes longer, often several pulses of laser to
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photobleach a fluorescent species, usually photobleaching methods required fixed specimens.
However live cell imaging study, with the help of photobleaching method, of proteins or other cell
organelle has been indirectly reported, which have potential to give dynamics of cellular
compartments [3, 50, 51]. However, successful photobleaching experiment of fluorescent proteins
in living cells including acceptor and donor photobleaching methods remains a challenge.

3.1.2.1 Donor-photobleaching FRET
Photobleaching method of FRET is often applied to fixed specimen because it takes longer to
photobleach than just excite molecules. Only the molecules, which are in the excited state, have a
chance of photobleaching. Statistically, only a small portion of molecules is in the excited state.
Typically, the molecules with longer lifetime have greater chance to photobleach.
Experimentally, it has been found that photobleaching time is inversely proportional to
fluorescence lifetime. Donors of resonance energy transfer will exhibit longer lifetime in the
absence of resonance energy transfer that means in the absence of acceptors, as compared to when
they transfer a portion of their excitation energy via FRET. Thus, donors will be photobleached
faster in the resonance energy transfer. In fact, FRET protects them from photobleaching in a way.
By measuring rate of photobleaching in the donor only sample, as well as in the donors and
acceptors sample, the FRET can be estimated [5, 7, 9, 52].
Since it takes relatively long time to photobleach molecules compared to the other methods
of FRET determination, the photobleaching methods are more suitable when temporal data is not
important. And, the photobleaching does not affect anything else in the context of the FRET study.
In some respects, photobleaching method sounds like intensity-based methods, however fitting the
time constants involving multiple components into the photobleaching curve poses additional
challenges.
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3.1.2.2 Acceptor-photobleaching FRET
This method [3, 5, 11, 12, 45] uses donor dequenching in the presence of acceptor, which can use
the donor fluorescence intensities before and after destroying the acceptors. Choice of the donoracceptor pair is important for this method. A desirable choice would be an acceptor, which can be
easily photobleached and a donor, which is relatively stable. After the acceptor is photobleached,
it can no longer share donor energy. Acceptor photobleaching requires a single sample, and it
directly relates FRET to both donor and acceptor molecules.
For quantitative FRET measurements, corrections are needed for the bleed through, that is,
there is an overlap in the emission wavelength ranges of the donor and acceptor. One of the
methods is to use acceptor emission filter when donor signal is measured and use a donor emission
signal filter for measuring the acceptor emission.
For quantitative FRET determination, the concentration of the fluorophores is also
required. For that purpose, three different samples and three different filters are used. The three
samples are; donor only, acceptor only and donor-acceptor sample. The three filters include the
above mentioned two filters and the third filter for the acceptor direct-excitation. Emission of all
three samples are passed through these filters, one at a time, and then the data is manipulated
using arithmetic for the crossovers and other factors, for instance, the uncontrolled variations in
the concentrations.

3.1.3 Fluorescence-polarization FRET
The application of fluorescence polarization has unique advantages over other fluorescence-based
methods [53, 54]. Polarization is a fundamental property of light. Fluorescent polarization was
first described by Perrin [55]. When the plane of an electric field or magnetic field oscillation
vector does not change during the propagation of light, it is considered as a plane polarized light.
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In fluorescent polarization study, plane polarized light is used for exciting the sample. Fluorescent
molecules are transient dipole moments. When the electric field of excitation light and the direction
of molecular dipole moment are parallel to each other, the maximum absorption of energy happens.
When they are perpendicular to each other, then no light is absorbed. Emission dipole moment can
be different than the dipole moment of an excited molecule. And the direction of electric field
oscillation of emission is parallel to the direction of the instantaneous dipole moment at the
emission state. When an unpolarized light is used for excitation due to the random nature of the
molecular dipole moments in a sample, the polarization effect is lost due to averaging out.

Figure 3.3 The basic principle of fluorescence polarization. Two polarizers are used, one each for the
excitation of, and the emission from the sample. The first polarizer allows only the plane polarized light to
the sample, and the second polarizer, which has its axis parallel to the first, detects the fraction of the
emission light which remains parallel to the excitation light.

A monochromatic beam illuminates the fluorophores within the sample. A linear polarizer located
in the illumination beam attenuates the randomly oriented polarization states except for those in
one plane, thereby generating linearly polarized light. This plane of polarized light also becomes
the reference plane. Depending upon the orientation of their absorption dipoles, individual
fluorophore molecules are preferentially excited.
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The emission from the fluorescent sample can be considered as another light source, which
is composed of the combination of signals from the emission dipoles of individual fluorophores
molecules. If the absorption and emission dipole moments of all the fluorophores were to be
aligned with the electric field vector of the illumination beam, then the emission signal would also
be plane polarized. However, this is typically not the case. Therefore, the emission signal is
partially depolarized due to the random orientation of the fluorophores, even if the fluorophores
are completely static.
As the molecules move during the time window of detection, the emission becomes even more
depolarized. A polarizer placed in front of the detector is used to detect the intensity of emission
light in a given plane of polarization. The intensity measurement made with the emission polarizer
oriented orthogonal to the electric field of illumination beam (the reference plane) is denoted as
⊥ I and when the emission polarizer is rotated by 90 degrees with respect to the ⊥ I measurement
direction, || I measurement is made. figure 3.3 shows the polarization of an unpolarized light.
Using 𝐼∥ , and 𝐼⊥ , two interchangeable ratio parameters are used to express the degree of
depolarization of emission light, as given by the following equations
𝐼∥ − 𝐼⊥
𝐼∥ + 𝐼⊥

(4.5)

𝐼∥ − 𝐼⊥
𝐼∥ + 2𝐼⊥

(4.6)

𝑝=

𝑟=

where p is polarization ratio and r is emission anisotropy. 𝐼∥ and 𝐼⊥ are intensities measured parallel
to and perpendicular to the direction of polarization of the excited light. The depolarization is
caused by rotation diffusion. Rotational diffusion can be caused by the interaction of the molecules
with the environment and the FRET.
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One of the advantages of fluorescent polarization method is that the measurements are of
ratiometric quality. Hence, they do not depend on the intensity of the excitation light or the
concentration of the fluorophores. The measurement of fluorescent polarization or anisotropy
study adds another dimension to fluorescent measurements. It, in some ways, compliments timeresolved microscopy i.e. FLIM. There are several methods to study hetero-FRET but to measure
homo-FRET there are no other suitable method than using fluorescence polarization [48, 51, 54,
56-61].

3.2 Optical micro-spectroscopy (OptiMiS)
OptiMiS is an imaging technology originally developed by Raicu lab [18] and currently
commercialized by Aurora Spectral Technology, Wisconsin. OptiMiS uses an ElectronMultiplying Charged Couple Detector (EMCCD) camera for high sensitivity detection of the
faintest fluorescence signals and femtosecond lasers for two-photon excitation, which provides
image-sectioning capability and a dramatic reduction of the number of molecules at each image
pixel. This technology has been used by our group and others [15, 16, 18, 19, 62-66] for FRET
imaging and in determination of the quaternary structure of proteins.
OptiMiS offers a spectral resolution of ~1 nm, with 200 available wavelength channels,
which are generated using a grating, placed in front of the emission light. A single scan is sufficient
to generate the above-mentioned spectral resolution. Image acquisition of a single pixel with the
help of OptiMiS is faster than diffusion scale of biological samples, however, the entire image
acquisition takes longer than the broadband microscopes. This is due to the fact that to generate
spectral resolution, it requires as many photons for each wavelength as the total number of photons
needed in the broad bandwidth imaging methods.
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The entire image acquisition became much faster in the newer version of OptiMiS which
is capable of imaging the sample per line [67] as compared to its previous version which was
equipped with raster (or point) scanning [18] only. An image of 440 by 300 pixels at the highest
available resolution of 1 nm can be scanned in about 10 seconds. And, relatively lower spectral
resolution images like 2, 5, or 10 nm, can be acquired at even faster rates.
Also, the line-scan has reduced photobleaching effect when compared to point scan version
of OptiMiS, because the line-scan requires lower excitation power and allows for longer
integration time per pixel to generate the similar (point-scan) image contrast [67].

3.2.1 OptiMiS set-up
A schematic of OptiMiS and associated technology is shown in figure 3.4. Light from a modelocked femtosecond Ti: Sapphire laser is passed through a cylindrical mirror which expands the
spot width of the light into a line. The line profile of the beam then falls on scanning mirrors (using
mirror galvanometers), and thereafter the laser line reflects from a pair of mirrors (M1 and M2),
and in between passes through a scanning lens. After reflecting from the M2 mirror, the light
passes through the objective lens of the microscope, which in result focuses it onto the sample and
excites an entire array of points falling on the line of excitation.
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Figure 3.4: The schematic of OptiMis as a part of the two-photon microscopy system. The excitation
source is a mode-locked femtosecond duration Ti: Sapphire laser. The pulsed laser beam is focused to a
diffraction-limited spot via an NA 1.43 oil immersion objective, and the location of this beam focus is
scanned within a sample of interest by a pair of computer-controlled galvos. The back-emitted fluorescence
is collected by the objective and is incident upon an EM-CCD device. Highlighted here is probably what is
the crux of the instrument, a transmission grating placed in the path of the emission which separates the
emitted light into different wavelengths before it is incident upon the cooled EM-CCD detection scheme.
This figure is adapted with permission from [67].

The fluorescent light emission coming out of the emission passes through the microscope objective
again and, after reflecting from the mirror M2, it passes through a grating and a relay lens. The
grating disperses the emission light into its wavelength components and relay lens inverts the
image and extends the optical tube. A dichroic mirror is also used before the relay lens to block
the excitation light out of the final output (emission light). The fluorescent emission falls on the
pixel of the EMCCD camera.
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3.2.2 Multi-wavelength imaging using optiMiS
The image can also be captured using a built-in feature of OptiMiS, which allows for imaging at
two or more wavelengths. With the help of two wavelength measurements, concentrations can be
estimated.[14].
Concentration information is especially helpful when investigating quaternary structure by
FRET measurements. Knowing donor and acceptor attached molecules concentration is critically
important for intensity based methods. Several analysis methods can exploit the concentrationdependent FRET information, for example, the variation in FRET due to the concentrationdependent equilibrium constants, or FRET dependence on acceptor molar fraction which is the
ratio of the number of the acceptors to the total number of donors and acceptor. Application of
these methods will be further discussed in Chapter 6. There are two main functions of OptiMiS,
that are as follows:
•

Scanning (hardware)

•

Image reconstruction (software)

The scanning part of OptiMiS includes cylindrical mirror and scanning mirror along with other
optical components used between the objective and the EMCCD camera as mentioned above. The
image reconstruction is the sophisticated software part, which has evolved over time. The grating
converts each point on the sample into a line i.e. breaks the emission signal into the wavelength
components. Therefore, after scanning each line on the sample, we get a two-dimensional image.
After scanning the area of interest, which can be set into the pre-scan settings of the
OptiMiS module, images of all the line exposures are reconstructed to produce an image for each
wavelength. The total number of images is equal to the ratio of the total number of available
channels (200) to the chosen spectral resolution. For example, the highest spectral resolution (one)
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provides with 200 spectral images with a wavelength separation of ~ 1 nm. This gives a spectrum
for each pixel of the image (or EMCCD camera), also shown in figure 3.5.

Figure 3.5: Spectral imaging of membrane region of a yeast cell expressing GFP2. Top left image
shows the spectral signal corresponding to a line of the yeast cell as shown by the horizontal arrows. The
pixel level emission spectrum (right) corresponds to just one pixel as shown by the red arrow. The figure is
adapted with permission from [68].

A single pixel emission signal is split into wavelength channels. Thus, a point (voxel) on an object
on sample plane converts into a line of wavelength components. The wavelengths information
corresponding to a single pixel provides a spectrum for that pixel. If more than one fluorescence
markers are in the sample voxel, then the emission spectrum of the pixel has a composite spectrum,
which is a sum of the individual spectrums of all the fluorescence species in that point volume
(voxel) of the sample.
With a prior knowledge of emission spectrums of each participating fluorescent species in
that voxel, the composite emission spectrum can be resolved into its components, giving a fraction
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of the individual presence of each fluorescent marker at pixel (or voxel, at sample level) level. The
separating of the total spectrum into its individual components is called spectral unmixing which
will be discussed in more detail in chapters 5 and 6.
OptiMiS TruLine is capable of both point and line scans. However, the line- scan is about 300
times more sensitive than the point-scan.

3.3 Using FRET to determine quaternary structure
Various methods are used to determine the shape and size of macromolecular complexes or
quaternary structure. These complexes are called oligomers. The complex of two monomers is
called dimer. The most sought quaternary structures are of protein complexes. X-ray
crystallography, nuclear magnetic resonance, immunoprecipitation are a few examples of the
various methods used to investigate the quaternary structure. However, these methods are mainly
suitable for in-vitro analysis.
Investigation of oligomeric stoichiometry and structure in living systems such as in live
cell cultures (in vivo) is complex because of the diffusion and rapid spatial and temporal
fluctuations of other parameters such as pH of the system.
There are several FRET-based methods which researchers have used to detect the
association of the macromolecules. These methods include acceptor photobleaching, sensitized
emission, spectral FRET imaging, Fluorescence Lifetime Imaging (FLIM), and polarization
anisotropy imaging. These methods have been described in chapter 4. However, most of these
methods struggle predicting the quaternary structure of more than two monomers. Many FRETbased methods claimed their finding of “at least” dimers, because of mere detection of FRET
guarantees association of monomers, of the same or different type of macromolecules, unless it’s
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due to the crowding of the molecules. However, experimentally differentiating among the presence
of dimers or oligomers, or the mixture of different oligomeric species is non-trivial.
Nevertheless, spectral FRET methods have been able to predict both stoichiometry and
structure of various macromolecules oligomers. The only successful methods for investigating
oligomeric structure in living cells is pixel-level spectral FRET measurement method, given by
Raicu and coworkers [15, 16, 18, 19, 62, 69]. In this method, the distribution of FRET efficiencies
is simulated giving FRET models for the various stoichiometries. These models are fitted to the
observed experimental FRET efficiency distribution, to determine the best-fit model.
The mathematical framework including equations describing this method is given below.
Photon emission intensity of donors in the presence of the acceptors (𝐹 𝐷𝐴 ) and the acceptor
emission intensity in the presence of the donors (𝐹 𝐴𝐷 ) are given by the following two equations
𝐹 𝐷𝐴 = 𝐹 𝐷 (𝜆𝑒𝑥 ) − 𝐹 𝐷 (𝐹𝑅𝐸𝑇),

(4.4)

where 𝐹 𝐷 (𝜆𝑒𝑥 ) is the donor emission intensity which would have been in the absence of the
acceptors, at the excitation wavelength 𝜆𝑒𝑥 , and 𝐹 𝐷 (𝐹𝑅𝐸𝑇) is the donor energy lost due to FRET,
and,
𝐹 𝐴𝐷 = 𝐹 𝐴 (𝜆𝑒𝑥 ) + 𝐹 𝐴 (𝜆𝐹𝑅𝐸𝑇 ),

(4.5)

where 𝐹 𝐴 (𝜆𝑒𝑥 ) is the acceptor emission due to the acceptor direct excitation at the wavelength
𝜆𝑒𝑥 , and 𝐹 𝐴 (𝐹𝑅𝐸𝑇) is the acceptor emission intensity gained due to FRET.
Apparent FRET efficiency can be defined for the case of donor dequenching (Dq), in the terms of
donor energy transferred via FRET and the total donor emission intensity in the absence of the
FRET, as the following
𝐷𝑞
𝐸𝑎𝑝𝑝
=

𝐹 𝐷 (𝐹𝑅𝐸𝑇)
𝐹𝐷 (𝜆𝑒𝑥 )
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(4.6)

The FRET efficiency can also be defined for acceptor sensitized emission (Ase) by the excited
donor, as the following;
𝐴 𝑠𝑒
𝐸𝑎𝑝
=

𝐹 𝐴 (𝐹𝑅𝐸𝑇)
𝐹 𝐴 (𝜆𝑒𝑥 )

(4.7)

To apply the FRET efficiency equations (4.6) or (4.7), from a single excitation scan we need to
have the ability to decompose, the total emission spectrum of donors and acceptors which have the
FRET information embedded to it, into the donor and acceptor emission counts (𝑘 𝐷𝐴 and 𝑘 𝐴𝐷 ).
This can be done if there is a complete spectral information available for the donor and acceptor
at the pixel level, i.e., donor only and acceptor only spectrum needs to be acquired separately under
the same experimental conditions which are used for collecting the composite emission spectrum
of the donor and acceptor. The composite spectrum is unmixed using the normalized spectral
integral 𝑤 𝐷 and 𝑤 𝐴 for the donor and acceptor. The unmixing method also involves their
respective quantum yields 𝑄 𝐷 and 𝑄 𝐴 .
The donor emission intensity in the presence of acceptor and vice versa can be given by
equations (4.5) and (4.6) as below
.

𝐹 𝐷𝐴 = ∫𝜆

𝑒𝑚

𝑖 𝐷 (𝜆𝑒𝑚 ) 𝑑𝜆𝑒𝑚 = 𝑘 𝐷𝐴 𝑤 𝐷 ,

(4.8)

where 𝑖 𝐷 (𝜆𝑒𝑚 ) is the emission intensity of the donors and 𝑘 𝐷𝐴 is the donor emission count in the
presence of the acceptor, and 𝑤 𝐷 is the integral of the donor emission spectrum, normalized to the
maximum emission intensity, and\
.

𝐹 𝐴𝐷 = ∫𝜆

𝑒𝑚

𝑖 𝐴 (𝜆𝑒𝑚 ) 𝑑𝜆𝑒𝑚 = 𝑘 𝐴𝐷 𝑤 𝐴 ,

(4.9)

where 𝑖 𝐴 (𝜆𝑒𝑚 ) is the emission intensity of the acceptor and 𝑘 𝐴𝐷 is the acceptor emission count in
the presence of the donor, and 𝑤 𝐴 is the integral of the donor emission spectrum, normalized to
the maximum emission intensity.
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𝐹 𝐷 (𝐹𝑅𝐸𝑇) and 𝐹 𝐴 (𝐹𝑅𝐸𝑇) can be related to each other by the following equations. The
total number of excitations (𝑁 𝐹𝑅𝐸𝑇 ) transferred to the acceptor via FRET by the donor is given by
equation (3.7). Which is based on the simple fact, a fraction of the excitations received by the
acceptor would have been lost by the donor if there was no FRET (in the absence of the acceptor).
This fraction is equal to the quantum yield of the donor (𝑄 𝐷 ).
𝑁 𝐹𝑅𝐸𝑇 𝑄 𝐷 = 𝐹 𝐷 (𝐹𝑅𝐸𝑇)

(4.10)

Acceptor will also emit only a fraction of energy transferred to it via FRET, and the fraction being
equal to the quantum yield of the acceptor (𝑄 𝐴 ), as given by equation (3.8).

𝑁 𝐹𝑅𝐸𝑇 𝑄 𝐴 = 𝐹 𝐴 (𝐹𝑅𝐸𝑇)

(4.11)

Eliminating 𝑁 𝐹𝑅𝐸𝑇 using equations (4.10) and (4.11) gives the relationship between the energy
lost by the donor and gained by the acceptor due to FRET between them, as the following;
𝐹 𝐷 (𝐹𝑅𝐸𝑇) =

𝑄𝐷 𝐴
𝐹 (𝐹𝑅𝐸𝑇)
𝑄𝐴

(4.82)

The acceptor direct excitation at the excitation wavelength used for the FRET measurements could
be minimized by using a suitable donor-acceptor pair and by exciting at a suitable wavelength,
which excites donor significantly while acceptor direct excitation is minimal. Hence the acceptor
emission due to its direct excitation can be ignored. With this approximation, equation (4.12)
changes as the following;
𝐹 𝐷 (𝐹𝑅𝐸𝑇) =
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𝑄 𝐷 𝐴𝐷
𝐹
𝑄𝐴

(4.13)

Finally combining the above-mentioned equations, the FRET efficiency expression can be
deduced as;
𝐷𝑞
𝐸𝑎𝑝𝑝
=

𝐹 𝐷 (𝐹𝑅𝐸𝑇)
=
𝐹𝐷 (𝜆𝑒𝑥 )

1
𝑘𝐷𝐴 𝑤 𝐷
1 + 𝐴 𝐴𝐷 𝐴
𝑄 𝑘 𝑤
𝑄𝐷

(4.14)

The above FRET efficiency expression can be applied at the pixel level, with the information of
elementary spectrums of the donor and spectrum and their respective quantum yields. With this
information, only a single scan is required to calculate the FRET efficiencies at each pixel of the
image. The single scan also helps in avoiding photobleaching.
This method has evolved to get more information and a better estimate for the FRET
efficiencies. With two-wavelength excitation scans, more information can be collected. For
example, the concentrations of donor and acceptor can be determined with the help of standard
solutions of the fluorescent proteins [14, 66, 70] Also, the approximation made by ignoring the
acceptor direct excitation, while using the single scan method, is not needed anymore for the two
wavelength scanning, making this method more accurate for FRET determination. The twowavelength method is discussed in more details in chapter 6.

77

References
[1] R.B. Sekar, A. Periasamy, Fluorescence resonance energy transfer (FRET) microscopy imaging of live
cell protein localizations, J Cell Biol, 160 (2003) 629-633.
[2] J. Lippincott-Schwartz, E. Snapp, A. Kenworthy, Studying protein dynamics in living cells, Nature
reviews. Molecular cell biology, 2 (2001) 444-456.
[3] G. Valentin, C. Verheggen, T. Piolot, H. Neel, M. Coppey-Moisan, E. Bertrand, Photoconversion of YFP
into a CFP-like species during acceptor photobleaching FRET experiments, Nature methods, 2 (2005) 801801.
[4] R.Y. Tsien, The green fluorescent protein, Annual review of biochemistry, 67 (1998) 509-544.
[5] J. Roszik, J. Szöllősi, G. Vereb, AccPbFRET: an ImageJ plugin for semi-automatic, fully corrected analysis
of acceptor photobleaching FRET images, BMC bioinformatics, 9 (2008) 1.
[6] A.H. Clayton, N. Klonis, S.H. Cody, E.C. Nice, Dual-channel photobleaching FRET microscopy for
improved resolution of protein association states in living cells, European Biophysics Journal, 34 (2005)
82-90.
[7] M. Tramier, M. Zahid, J.C. Mevel, M.J. Masse, M. Coppey‐Moisan, Sensitivity of CFP/YFP and
GFP/mCherry pairs to donor photobleaching on FRET determination by fluorescence lifetime imaging
microscopy in living cells, Microscopy research and technique, 69 (2006) 933-939.
[8] T. Nagai, K. Ibata, E.S. Park, M. Kubota, K. Mikoshiba, A. Miyawaki, A variant of yellow fluorescent
protein with fast and efficient maturation for cell-biological applications, Nature biotechnology, 20 (2002)
87-90.
[9] L. Jürgens, D. Arndt‐Jovin, I. Pecht, T.M. Jovin, Proximity relationships between the type I receptor for
Fcεe (FcεeRI) and the mast cell function‐associated antigen (MAFA) studied by donor photobleaching
fluorescence resonance energy transfer microscopy, European journal of immunology, 26 (1996) 84-91.
[10] P. Van Roessel, A.H. Brand, Imaging into the future: visualizing gene expression and protein
interactions with fluorescent proteins, Nature cell biology, 4 (2002) E15-E20.
[11] Y. Gu, W. Di, D. Kelsell, D. Zicha, Quantitative fluorescence resonance energy transfer (FRET)
measurement with acceptor photobleaching and spectral unmixing, Journal of microscopy, 215 (2004)
162-173.
[12] E. Van Munster, G. Kremers, M. ADJOBO‐HERMANS, T.W. Gadella, Fluorescence resonance energy
transfer (FRET) measurement by gradual acceptor photobleaching, Journal of microscopy, 218 (2005) 253262.

78

[13] N.P. Mahajan, K. Linder, G. Berry, G.W. Gordon, R. Heim, B. Herman, Bcl-2 and Bax interactions in
mitochondria probed with green fluorescent protein and fluorescence resonance energy transfer, Nature
biotechnology, 16 (1998) 547-552.
[14] A.K. Mishra, M. Gragg, M. Stoneman, G. Biener, J.A. Oliver, P. Miszta, S. Filipek, V. Raicu, P. Park,
Quaternary structures of opsin in live cells revealed by FRET spectrometry, Biochemical Journal, (2016)
BCJ20160422.
[15] A.K. Mishra, T. Mavlyutov, D.R. Singh, G. Biener, J. Yang, J.A. Oliver, A. Ruoho, V. Raicu, The sigma-1
receptors are present in monomeric and oligomeric forms in living cells in the presence and absence of
ligands, Biochem J, 466 (2015) 263-271.
[16] S. Patowary, E. Alvarez-Curto, T.R. Xu, J.D. Holz, J.A. Oliver, G. Milligan, V. Raicu, The muscarinic M3
acetylcholine receptor exists as two differently sized complexes at the plasma membrane, Biochem J, 452
(2013) 303-312.
[17] V. Raicu, D.R. Singh, FRET spectrometry: a new tool for the determination of protein quaternary
structure in living cells, Biophys J, 105 (2013) 1937-1945.
[18] V. Raicu, M.R. Stoneman, R. Fung, M. Melnichuk, D.B. Jansma, L.F. Pisterzi, S. Rath, M. Fox, J.W. Wells,
D.K. Saldin, Determination of supramolecular structure and spatial distribution of protein complexes in
living cells, Nat Photon, 3 (2009) 107-113.
[19] D.R. Singh, M.M. Mohammad, S. Patowary, M.R. Stoneman, J.A. Oliver, L. Movileanu, V. Raicu,
Determination of the Quaternary Structure of a Bacterial ATP-Binding Cassette (ABC) Transporter in Living
Cells, Integrative biology : quantitative biosciences from nano to macro, 5 (2013) 312-323.
[20] B.K. Kobilka, G protein coupled receptor structure and activation, Biochimica et biophysica acta, 1768
(2007) 794-807.
[21] A.G. Gilman, G proteins: transducers of receptor-generated signals, Annual review of biochemistry,
56 (1987) 615-649.
[22] M. Rodbell, Proteins in membrane transduction, Nature, 284 (1980) 17.
[23] A. Wise, K. Gearing, S. Rees, Target validation of G-protein coupled receptors, Drug discovery today,
7 (2002) 235-246.
[24] K. Palczewski, T. Kumasaka, T. Hori, C.A. Behnke, H. Motoshima, B.A. Fox, I. Le Trong, D.C. Teller, T.
Okada, R.E. Stenkamp, Crystal structure of rhodopsin: AG protein-coupled receptor, Science (New York,
N.Y.), 289 (2000) 739-745.
[25] J.J. Ruprecht, T. Mielke, R. Vogel, C. Villa, G.F. Schertler, Electron crystallography reveals the structure
of metarhodopsin I, The EMBO journal, 23 (2004) 3609-3620.

79

[26] K.D. Ridge, N.G. Abdulaev, M. Sousa, K. Palczewski, Phototransduction: crystal clear, Trends in
biochemical sciences, 28 (2003) 479-487.
[27] P. Liebman, G. Entine, Lateral diffusion of visual pigment in photoreceptor disk membranes, Science
(New York, N.Y.), 185 (1974) 457-459.
[28] R.A. Cone, Rotational diffusion of rhodopsin in the visual receptor membrane, Nature, 236 (1972) 3943.
[29] C. Wey, R. Cone, M.A. Edidin, Lateral diffusion of rhodopsin in photoreceptor cells measured by
fluorescence photobleaching and recovery, Biophysical journal, 33 (1981) 225.
[30] V.I. Govardovskii, D.A. Korenyak, S.A. Shukolyukov, L.V. Zueva, Lateral diffusion of rhodopsin in
photoreceptor membrane: a reappraisal, (2009).
[31] B. Wu, E.Y. Chien, C.D. Mol, G. Fenalti, W. Liu, V. Katritch, R. Abagyan, A. Brooun, P. Wells, F.C. Bi,
Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists, Science
(New York, N.Y.), 330 (2010) 1066-1071.
[32] W.R. Zipfel, R.M. Williams, W.W. Webb, Nonlinear magic: multiphoton microscopy in the biosciences,
Nature biotechnology, 21 (2003) 1369-1377.
[33] B.M. Binder, T.M. O'Connor, M.D. Bownds, V.Y. Arshavsky, Phosphorylation of non-bleached
rhodopsin in intact retinas and living frogs, Journal of Biological Chemistry, 271 (1996) 19826-19830.
[34] D. Fotiadis, Y. Liang, S. Filipek, D.A. Saperstein, A. Engel, K. Palczewski, Atomic-force microscopy:
rhodopsin dimers in native disc membranes, Nature, 421 (2003) 127-128.
[35] D. Fotiadis, Y. Liang, S. Filipek, D.A. Saperstein, A. Engel, K. Palczewski, The G protein‐coupled receptor
rhodopsin in the native membrane, FEBS letters, 564 (2004) 281-288.
[36] A. Krebs, C. Villa, P.C. Edwards, G.F. Schertler, Characterisation of an improved two-dimensional p22
1 2 1 crystal from bovine rhodopsin, Journal of molecular biology, 282 (1998) 991-1003.
[37] P.S.-H. Park, S. Filipek, J.W. Wells, K. Palczewski, Oligomerization of G protein-coupled receptors: past,
present, and future, Biochemistry, 43 (2004) 15643-15656.
[38] G.-J. Kremers, J. Goedhart, E.B. van Munster, T.W. Gadella, Cyan and yellow super fluorescent
proteins with improved brightness, protein folding, and FRET Förster radius, Biochemistry, 45 (2006) 65706580.
[39] F.J. Kim, I. Kovalyshyn, M. Burgman, C. Neilan, C.C. Chien, G.W. Pasternak, Sigma 1 receptor
modulation of G-protein-coupled receptor signaling: potentiation of opioid transduction independent
from receptor binding, Molecular pharmacology, 77 (2010) 695-703.

80

[40] K.A. Gromek, F.P. Suchy, H.R. Meddaugh, R.L. Wrobel, L.M. LaPointe, U.B. Chu, J.G. Primm, A.E.
Ruoho, A. Senes, B.G. Fox, The Oligomeric States of the Purified Sigma-1 Receptor Are Stabilized by
Ligands, The Journal of biological chemistry, 289 (2014) 20333-20344.
[41] T.-P. Su, T. Hayashi, T. Maurice, S. Buch, A.E. Ruoho, The sigma-1 receptor chaperone as an interorganelle signaling modulator, Trends in pharmacological sciences, 31 (2010) 557-566.
[42] F.J. Moss, P.I. Imoukhuede, K. Scott, J. Hu, J.L. Jankowsky, M.W. Quick, H.A. Lester, GABA transporter
function, oligomerization state, and anchoring: correlates with subcellularly resolved FRET, The Journal of
general physiology, 134 (2009) 489-521.
[43] A. Pal, A.R. Hajipour, D. Fontanilla, S. Ramachandran, U.B. Chu, T. Mavlyutov, A.E. Ruoho,
Identification of regions of the sigma-1 receptor ligand binding site using a novel photoprobe, Molecular
pharmacology, 72 (2007) 921-933.
[44] T. Zimmermann, J. Rietdorf, A. Girod, V. Georget, R. Pepperkok, Spectral imaging and linear un-mixing
enables improved FRET efficiency with a novel GFP2-YFP FRET pair, FEBS letters, 531 (2002) 245-249.
[45] T. Karpova, C. Baumann, L. He, X. Wu, A. Grammer, P. Lipsky, G. Hager, J. McNally, Fluorescence
resonance energy transfer from cyan to yellow fluorescent protein detected by acceptor photobleaching
using confocal microscopy and a single laser, Journal of microscopy, 209 (2003) 56-70.
[46] W. Becker, Advanced time-correlated single photon counting techniques, Springer Science & Business
Media, 2005.
[47] W. Becker, Fluorescence lifetime imaging--techniques and applications, Journal of microscopy, 247
(2012) 119-136.
[48] M.A. Rizzo, D.W. Piston, High-contrast imaging of fluorescent protein FRET by fluorescence
polarization microscopy, Biophysical journal, 88 (2005) L14-L16.
[49] D.W. Piston, M.A. Rizzo, FRET by fluorescence polarization microscopy, Methods in cell biology, 85
(2008) 415-430.
[50] E.L. Snapp, Photobleaching Methods to Study Golgi Complex Dynamics in Living Cells, Methods in cell
biology, 118 (2013) 195-216.
[51] E.A. Jares-Erijman, T.M. Jovin, FRET imaging, Nature biotechnology, 21 (2003) 1387-1395.
[52] G. Szentesi, G. Vereb, G. Horváth, A. Bodnár, Á. Fábián, J. Matkó, R. Gáspár, S. Damjanovich, L. Mátyus,
A. Jenei, Computer program for analyzing donor photobleaching FRET image series, Cytometry Part A, 67
(2005) 119-128.
[53] A.L. Mattheyses, A.D. Hoppe, D. Axelrod, Polarized fluorescence resonance energy transfer
microscopy, Biophys J, 87 (2004) 2787-2797.

81

[54] D.W. Piston, M.A. Rizzo, FRET by Fluorescence Polarization Microscopy, in: Methods in Cell Biology,
vol. Volume 85, Academic Press, 2008, pp. 415-430.
[55] J. Perrin, Fluorescence et induction moleculaire par resonance, CR Hebd. Seances Acad. Sci, 184
(1927) 1097-1100.
[56] J.A. Levitt, D.R. Matthews, S.M. Ameer-Beg, K. Suhling, Fluorescence lifetime and polarizationresolved imaging in cell biology, Current opinion in biotechnology, 20 (2009) 28-36.
[57] D.W. Piston, G.-J. Kremers, Fluorescent protein FRET: the good, the bad and the ugly, Trends in
biochemical sciences, 32 (2007) 407-414.
[58] J.J. Burbaum, N.H. Sigal, New technologies for high-throughput screening, Current Opinion in
Chemical Biology, 1 (1997) 72-78.
[59] B. Valeur, M.N. Berberan-Santos, Molecular fluorescence: principles and applications, John Wiley &
Sons, 2012.
[60] Y. Yan, G. Marriott, Analysis of protein interactions using fluorescence technologies, Current opinion
in chemical biology, 7 (2003) 635-640.
[61] S. Weiss, Measuring conformational dynamics of biomolecules by single molecule fluorescence
spectroscopy, Nature structural biology, 7 (2000) 724-729.
[62] S. Patowary, Luca F. Pisterzi, G. Biener, Jessica D. Holz, Julie A. Oliver, James W. Wells, V. Raicu,
Experimental Verification of the Kinetic Theory of FRET Using Optical Microspectroscopy and Obligate
Oligomers, Biophysical Journal, 108 (2015) 1613-1622.
[63] D.R. Singh, Q. Cao, C. King, M. Salotto, F. Ahmed, X.Y. Zhou, E.B. Pasquale, K. Hristova, Unliganded
EphA3 dimerization promoted by the SAM domain, Biochem J, 471 (2015) 101-109.
[64] D.R. Singh, E.B. Pasquale, K. Hristova, A small peptide promotes EphA2 kinase-dependent signaling
by stabilizing EphA2 dimers, Biochimica et biophysica acta, 1860 (2016) 1922-1928.
[65] D.R. Singh, F. Ahmed, C. King, N. Gupta, M. Salotto, E.B. Pasquale, K. Hristova, EphA2 Receptor
Unliganded Dimers Suppress EphA2 Pro-tumorigenic Signaling, The Journal of biological chemistry, 290
(2015) 27271-27279.
[66] M.R. Stoneman, J.D. Paprocki, G. Biener, K. Yokoi, A. Shevade, S. Kuchin, V. Raicu, Quaternary
structure of the yeast pheromone receptor Ste2 in living cells, Biochimica et biophysica acta, (2016).
[67] G. Biener, M.R. Stoneman, G. Acbas, J.D. Holz, M. Orlova, L. Komarova, S. Kuchin, V. Raicu,
Development and experimental testing of an optical micro-spectroscopic technique incorporating true
line-scan excitation, International journal of molecular sciences, 15 (2014) 261-276.
[68] OptiMisTM Trueline, in, vol. 2016, Aurora Spectral Technologies, LLC,.

82

[69] A.K. Mishra, M. Gragg, M. Stoneman, G. Biener, J.A. Oliver, P. Miszta, S. Filipek, V. Raicu, P. Park,
Quaternary structures of opsin in live cells revealed by FRET spectrometry, Biochem J, (2016).
[70] C. King, M. Stoneman, V. Raicu, K. Hristova, Fully quantified spectral imaging reveals in vivo
membrane protein interactions, Integr Biol (Camb), 8 (2016) 216-229.

83

Chapter 4: Testing of the kinetic theory of FRET
The Kinetic theory of FRET, as defined in Chapter 2 [1], was tested using FRET-based techniques
described in chapter 3. Here, I am reviewing two main studies done in order to validate the theory
by experimental methods.

4.1. Overview
The kinetic theory of FRET is based on the average of FRET efficiency of all individual donors
transferring energy to the acceptors within the complex of a multimeric complex [1-4]. An excited
donor can lose energy via radiative deexcitation i.e. the emission of photons, or via nonradiative
deexcitation i.e. the interaction with the surrounding environment, or by FRET with nearby
acceptors. FRET opens additional pathways for losing the energy of the donors with nearby
acceptors kinetically.
There are several methods which provide with FRET efficiencies but interpreting the
experimentally obtained FRET efficiencies with various methods had been a challenge. To validate
the kinetic theory of FRET, we need standards with known FRET efficiencies which can be
compared with the FRET efficiencies extracted from experiments by performing FRET
measurements over those constructs. In order to test the kinetic theory of FRET, one can use the
obligate constructs of different kinds separately and then in some carefully chosen combinations,
to observe how the experimentally extracted results of FRET efficiencies compare with those
deduced using the kinetic theory of FRET.
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4.2 Experimental testing of the kinetic theory
4.2.1 Using genetic constructs as standards for FRET efficiencies
The emergence of several spectral variants of green fluorescent protein and advancement in genetic
engineering made it logical to prepare genetic constructs of various shapes and stoichiometry using
suitable FRET pairs, to test the experimentally obtained FRET efficiencies. These constructs can
be used as FRET reference or standards, and they can be easily distributed or replicated. These
FRET standards, also called the artificial constructs or obligate FRET complexes, were first
prepared by Vogel et al., in the year 2006, at Laboratory of Molecular Physiology, National
Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland [5]. Several constructs were
prepared with varying lengths of the linkers among the fluorescent molecules.
Cerulean (CFP variant) and Venus (YFP variant), were chosen ad FRET pair, where
Cerulean and Venus are the donor and acceptor of energy respectively. Three Cerulean-Venus
dimers of the linker lengths of 5,17 and 33 amino acids were constructed and called C5V, C17V,
and C32V respectively. In all the constructs, the A206K mutation was introduced to create a
monomeric form of the fluorescent protein. For the constructs of three different linker lengths, the
donor fluorescence lifetime was measured by Vogel et al., and it was found to decrease as the
linker size shortened, confirming an increase in FRET as the distance between the donor and
acceptor pair decreased. This was consistent with the results found from the spectral FRET.
Donor’s lifetime was compared in the situation of the absence and presence of an acceptor.
The Cerulean chromophore is surrounded by a β barrel so that it would not be affected by other
environmental factors. Thus, the change in the lifetime in the presence of Venus chromophores
will confirm the occurrence of the FRET. With this assumption that the lifetime of Cerulean will
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not change when attached to another protein because of the β barrel, when Venus is attached to it,
the shortening of the lifetime was directly attributed to FRET.
Nevertheless, when Cerulean was attached to other non-fluorescent proteins, its lifetime is
altered making it not very suitable reference as a Cerulean monomer. Therefore, using this for the
lifetime of Cerulean alone, and to compare with the lifetime of Cerulean-Venus FRET pair, may
raise some concerns. To fix this issue, a mutant of Venus was generated by mutating Tyrosine 67
in Venus, to Cysteine (Y67C mutation). This mutant was called Amber. Amber folds correctly but
does not fluoresces [5]. Since Amber is non-fluorescent, it was used as a control molecule. Amber
was used in combination with Cerulean to make Cerulean-Amber pair as a standard donor only
construct.

Figure 4.1 Artificial genetic constructs as FRET standards. Blue barrel represents donor (Cerulean),
yellow represents acceptor (Venus), and gray represents Amber (non-fluorescent control).
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Constructs of several sizes shapes are devised by using the above-mentioned three types of
molecules including dimers, trimers, and tetramers [5]. Four different configurations of a tetramer
as shown in figure 4.1. The distances among the fluorescent molecules are known. Using their
relative distances, quantum yields (QD or QA), average value of the orientation factor (equal to
2/3), as well as their overlap integral (as described in chapter 2), Förster radius could be predicted
and hence, the apparent FRET efficiency (Eapp) for each type of complex was estimated.
These constructs were then tested using different methods of FRET measurements, such as
fluorescence lifetime spectroscopy [6, 7], sensitized acceptor emission [2, 8-13], and spectral
imaging [14]. All valid FRET methods should provide the same FRET efficiency. The predicted
values of FRET efficiencies were then compared with the experimentally extracted FRET
efficiencies values, by applying standard methods of FRET measurements. It was to found that the
measured FRET efficiencies were within the acceptable range of calculated FRET efficiencies of
these FRET standards. Therefore, the results of these measurements were in good agreement with
the theory of FRET. These tests proved these constructs to be good references for the FRET
studies.

4.2.2 Reported discrepancies between the kinetic theory and experiment
In 2009, Koushik et al [3] reported the results of their testing of the kinetic theory of FRET by
measuring ensemble FRET efficiencies of the two different shapes of the constructs which were
trimers and tetramers, each of them containing single donor (Cerulean) and two or three
acceptors (Venus), for the trimers and tetramers respectively [3]. Amber was used as a
placeholder. Individual donor-acceptor pair FRET efficiencies were measured within these
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complexes by mutating the acceptors one by one using the point mutation method, which made
them non-fluorescent.
The study found that the amount of energy transferred to the acceptors was significantly
greater than what was predicted by the kinetic theory of FRET, taking into account all the donoracceptor pairs. Therefore, they stated, their results proved the kinetic theory to be incorrect or
there existed some additional pathway of energy transfer between the donor and the acceptor
besides FRET. The results of this study are shown in the table below.

Table 4.1 Measured FRET efficiencies for the constructs with two acceptors. The FRET
efficiencies for three different trimeric constructs consisting Cerulean (as a donor or D) and
Venus (as an acceptor or A), are shown with the standard errors, for three methods of FRET
measurements. Amber, the non-fluorescent control is shown as N. Numbers of cells (n) used for
each type of constructs and for each measurement type, are also shown. This table is
reproduced with permission from [3].

FRET Constructs
FRET Methods
FRET efficiency (sRET)

ADA

NDA

0.44± 0.08

0.36± 0.09

0.64± 0.05

mean±SD, n=26

mean±SD, n=26

mean±SD, n=16

0.38± 0.03

0.69± 0.05

mean±SD, n=82

mean±SD, n=52

mean±SD, n= 59

0.96± 0.09

0.95± 0.097

1.96± 0.17

mean±SD, n=82

mean±SD, n=52

mean±SD, n=59

FRET efficiency (E-FRET) 0.45± 0.04

A/D (E-FRET)

ADN
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Figure 4. 2 Results of the measurements of the intramolecular FRET efficiencies. This shows the
dependence of FRET efficiencies on the donor to acceptor ratio and the distance between the donors and
the acceptors, (a) for the trimers, and (b) for the tetramers. The figure is reproduced with the permission
from [3]. Where D, A, and N stand for Donor (Cerulean), Acceptor (Venus) and Neutral (Amber).
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The table 4.1 and the figure 4.2 show the discrepancy in the kinetic theory of FRET. The FRET
increased in the presence of more acceptors but it was less than what was predicted by the kinetic
theory of FRET. The discrepancy was reported by both, one and two-photon excitations, and by
using either laser or arc lamp as the excitation source, and, by using two FRET methods, spectral
FRET [12-17] and acceptor desensitization FRET [8, 18].
Various possibilities were suggested for the anomaly shown between the above-described
results and the theory, which include the Venus or the Amber behaving differently in different
constructs. For example, the folding time of these proteins was observed to be different in the
presence of different protein partners forming the constructs. Also, an occult energy transfer,
which is not accounted in the kinetic theory of FRET, was considered.

4.2.3 Experimental confirmation of the kinetic theory of FRET
In 2015, the results of another experimental study were published for testing the kinetic theory of
FRET by Patowary et al., using two-photon excitation and spectral FRET [2]. This study did not
find any such discrepancy as previously reported. In this work, kinetic theory of FRET was tested
using linked fluorescent proteins in cytoplasm and plasma membrane regions. This work was done
using optical micro-spectroscope (OptiMiS) and two-photon excitation (TPE). The technology of
OptiMiS is included in chapter 3. In this study, cytoplasmic and membrane-bound obligate
fluorescent dimers and oligomers were used to the theory. Their method was based on the concept
that the FRET efficiency of a multimeric complex can be computed by averaging the FRET
efficiencies of the FRET dimers of donor-acceptor dimers of the different intermolecular distances,
which are present in the multimeric complex.
Kinetic theory predicts average (apparent) FRET efficiency per donor (Eapp), within a
multimeric complex. Each donor in a multimeric complex may have multiple FRET pathways,
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when there are more than one acceptors are present in the complex. An equivalent scenario could
be created by constructing the dimers of one donor and one acceptor for each donor-acceptor
disposition in the complex. When the experimentally obtained FRET efficiencies of all possible
FRET dimers within the complex is averaged, it should be equal to the Eapp of the multimeric
complex given by the kinetic theory of the FRET, within an acceptable range of standard errors.
Constructs were prepared with a blue fluorescent protein variant Cerulean [19] and a
yellow variant Venus [20]. Cerulean served as a donor of the energy and Venus served as an energy
acceptor. Three different lengths of dimeric constructs used for this study were 5, 17 and 32 amino
acids long. The shorter the linker, higher the FRET efficiency should be. C5V is expected to have
the highest FRET efficiency followed by C17V and the lowest is for C32V.
The two proteins were excited using the two-photon microscopy. Cerulean has an
excitation peak at 820 nm and an emission maximum at 475 nm, while Venus has an excitation
peak at 940 nm and an emission maximum at 528 nm. For the dimer pair of Cerulean and Venus,
the mixture should have an equal ratio of donor and acceptor. The relative intensity of the two
components in the composite spectra should be a function of the distance between them. This
means that closer the donor (D) and acceptor (A) from each other, higher the FRET is, thereby;
the ratio of donor to acceptor will be lower.
Human Embryo Kidney (HEK 293) cells were transfected with these constructs. Spectral
imaging was performed and analyzed at pixel level [14, 21]. The samples were excited with 800,
and 970 nm of two-photon excitations. There were two peaks in the emission spectrum, at 475 and
528 nm, which are the Cerulean and Venus emission peaks respectively. This confirmed the
presence of Cerulean and Venus in the samples. Also, Venus peak was always higher for the
samples of three different linker sizes than the Cerulean peaks, which has informed that there was
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always some energy transferred in the form of FRET from donor to acceptor. The 528 peak was
highest for the C5V, then for the C17V and shortest for the C32V, which confirmed that shorter
the linker, higher the energy transferred via FRET is.
Besides, the 528 nm Venus emission peak also increased for each sample when the
excitation wavelength was increased. This is happened due to the direct excitation of acceptors as
the increase in the excitation wavelength brought it closer to the acceptor excitation peak and more
acceptors were excited directly.

Figure 4. 3 The schematic for obligate FRET constructs. Dimers (a) & (b) and trimer (c) are connected
by flexible linkers and their one end is attached to the membrane by a 32 amino acids linker.

The results of the above study are summarized in the table below.
Table 4.2 Average of Measured Apparent FRET efficiencies (Eapp) of the cytoplasmic
constructs. The predicted mean ± SE value for the ADA construct is also listed. The numbers of
the cells are shown in parentheses. The table is reproduced with permission from [2].
Eapp
Constructs

Measured

Predicted

DA

0.368± 5 0.015 (54)

—

AD

0.254± 5 0.012 (48)

—

92

0.515 ±5 0.009 (48)

ADA

0.480 ±5 0.033

Here, a small but statistically significant difference was reported for the ADA trimer. The
predicted value of the Eapp (𝐸𝑝𝑟𝑒𝑑𝑖𝑐𝑡𝑒𝑑 )was calculated using the equations (2.2) and error in the
𝐸𝑝𝑟𝑒𝑑𝑖𝑐𝑡𝑒𝑑 was calculated using equation (4.1), as shown below
𝑛−1

𝐸𝑝𝑟𝑒𝑑𝑖𝑐𝑡𝑒𝑑 = ∑ 𝐸𝑗,

(4.1)

𝑗=1

where 𝐸𝑗 is the FRET efficiency contribution of the 𝑗th acceptor. For a complex, which has more
than one donor, the following equation is used to calculate average FRET efficiency
𝐸𝑝𝑟𝑒𝑑𝑖𝑐𝑡𝑒𝑑 = ∑
𝑗

𝐸𝑗 ⁄(1 − 𝐸𝑗 )
1 + ∑𝑗(𝐸𝑗 ⁄(1 − 𝐸𝑗 ))

(4.2)

Using the method of propagation of error, error in 𝐸𝑝𝑟𝑒𝑑𝑖𝑐𝑡𝑒𝑑 can be calculated, as given by the
following equation
∑𝑗
𝛿𝐸𝑝𝑟𝑒𝑑𝑖𝑐𝑡𝑒𝑑 = 𝐸𝑝𝑟𝑒𝑑𝑖𝑐𝑡𝑒𝑑

𝛿𝐸𝑗
(1 − 𝐸𝑗 )

2

𝛿𝐸𝑗
𝛿𝐸𝑗
{∑𝑗
} {1 + ∑𝑗
}
(1 − 𝐸𝑗 )
(1 − 𝐸𝑗 )

(4.3)

The cytoplasmic construct used to test the kinetic theory of FRET were NDAN, ADNN,
and NDNA. N stands for non-fluorescent entities, which are just placeholders. Average FRET
efficiencies for these constructs were measured and plotted as logarithmic of the total donor
concentration. It was found that the FRET efficiency for each construct increased only slightly as
the expression level increased.
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Figure 4.4 Measured FRET efficiencies (Eapp) of the tetrameric constructs and their comparison
with their predicted values. (a) Apparent FRET efficiency for the four different cytoplasmic constructs
ADAA, ADNN, NDAN, and NDNA. (b) The difference of measured and predicted FRET efficiencies
plotted again log value of average donor expression level. The figure is adapted with permission from [2].

From the above-shown figure, the difference in the measured and the predicted FRET
efficiencies is smaller than what was reported earlier as the discrepancy in the kinetic theory of
FRET. This study shows that the kinetic theory of FRET is not violated by the experimental results
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using acceptor sensitized emission FRET, when compared to the measured values of the FRET
efficiencies for the FRET constructs expressed in the living cells.

4.3 Testing the kinetic theory of FRET using numerical simulations
To further put the kinetic theory to test, King et al [22] utilized numerical simulations on membrane
protein receptors forming constitutive monomers, dimers or oligomers for different values of
surface density. The surface density was calculated as the ratio of total receptor concentration and
the membrane surface area. The simulations used 2700 data points with randomly chosen total
values for the total concentration and with a variable acceptor molar fraction. Several distinct sizes
of oligomers, besides monomers, ranging from dimers to hexamers were used for the simulations.
For each order of the oligomerization, the simulation results were fitted with the theoretical curves
obtained for each case using two different models which were:
1. Veatch and Stryer model proposed in 1977 [23]
2. Kinetic theory of FRET proposed by Raicu in 2007 [1] and as described in 4.2.3.
The study specially deals with proximity FRET or nonspecific FRET which occurs due to
the crowding of macromolecules. Reduced Chi-square minimization was used to account for the
concentration-dependent proximity FRET. Random noise of the Gaussian distribution was also
incorporated into the simulations.
It was found that the Veatch and Stryer model did not predict the correct size of oligomers
for the case of dimers at high protein concentrations. The Veatch and Stryer model prediction of
oligomeric size depends on the concentration level giving a bigger oligomeric size for higher
concentration.
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Also, for the constitutive oligomer of the Ep value equal to 0.30, simulation results were
fitted with the models based on kinetic theory formalism. The results of the fits were consistently
correct for the dimers or tetramers at all the concentration values.
According to the study by King et al, the kinetic theory of FRET proposed by Raicu is in
full agreement with numerical simulations. As we have described above, it is also in agreement
with experiment (see section 4.2.3).
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Chapter 5: Oligomerization of sigma-1 receptor in living cells
As discussed in Chapter 1, the Sigma-1 receptor (S1R) is a molecular chaperone located in the
plasma membrane of some mammalian cells, which regulates ion channels and interacts with
several other proteins including GPCRs [1]. S1R seems to be implicated in substance abuse [2-5]
and many other diseases [6-13]. S1R had been reported to interact with many exogenous ligands
such as cocaine [4, 14, 15], haloperidol [2, 16-18] and pentazocine [10, 18]. It also interacts with
endogenous molecules such as dimethyltryptamine [19, 20]. Understanding the quaternary
structure of S1R (i.e., S1R oligomerization) may help using S1R as a drug target to cure certain
diseases and addictions.
Effects of ligands on S1R dimerization and oligomerization have been investigated
previously [21, 22], but never directly proven. We investigated the quaternary structure of S1R
alone, as well as S1R in the presence of haloperidol or pentazocine plus, using spectral FRET and
two-photon micro-spectroscopy in Cos-7 cells, using GFP2 and YFP as a donor-tag and an
acceptor-tag attached to S1R.

5.1 Materials and methods
5.1.1 Genetic constructs
The human S1R cDNA (NM_005866, Origene Technology) was PCR amplified using Pfx
polymerase (Invitrogen, ThermoFisher Scientific, MA) replacing the stop codon with a MluI
restriction enzyme recognition sequence (ACGCGT) and fused to the GFP2 or YFP fluorophore’s
cDNA where the start ATG of the fluorophore was deleted to assure no expression of the
fluorophore alone. The constructs were both C-terminal S1R fluorophore fusions. The reporter
fluorophores were as described earlier [23, 24] and consisted of a modified GFP sequence
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containing the point mutations F64L, A206K for GFP2 and S65G, S72A, T203Y for the YFP. The
C-fusion S1R donor and acceptor constructs were subcloned into a pCI (Promega, Inc., WI)
eukaryotic expression vector and expressed by transient transfection using Lipofectamine 2000
(ThermoFisher Scientific, MA).

5.1.2 Source and use of drugs
(+)-Pentazocine was obtained from Sigma–Aldrich and haloperidol hydrochloride was obtained
from Tocris Biosciences. (+)-Pentazocine was titrated with HCl in aqueous solution to a stock
concentration of 10 mM. The aqueous stock of haloperidol HCl was also 10 mM. Cells were
incubated with final concentrations of 100 μM for both the compounds in OptiMEM for
approximately one hour prior to imaging.

5.1.3 Fluorescent tags
GFP2 [25] and YFP [26, 27] were fused to two-sub-populations of the sigma 1 receptor. Between
these two, GFP2 acts as a donor and YFP as an acceptor of energy. GFP2 has a large Stokes shift,
and its emission spectrum overlaps well with the excitation spectrum of YFP. These two qualities
make the GFP2 and YFP an ideal FRET pair. Also, the two-photon excitation spectrum of GFP2
and YFP fits well with the emission wavelengths of the Mai Tai™ (Spectra Physics, Santa Clara,
CA) laser used. Both florescent proteins had the A206K mutation to prevent the specific tendency
of GFP to form non-specific oligomers [28]

5.1.4 Culturing Cos-7 cells
Cos-7 cells were cultured in T25 flask Dulbecco’s Modified Eagle Medium (DMEM, Life
Technologies) with 10% FBS, 2 mM L-glutamine, 100 units/ml penicillin and 100 μg/ml
streptomycin. The flasks were incubated at 37 °C and in the presence of 5% CO2 for about 48 hours
or until the flasks got about 80-90 % confluent. After a few passages, portions of these cells were
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seeded in 0.17 mm thick (clear) Delta T® Culture Dishes (Bioptechs) in 2ml of above-mentioned
cell-media. The dishes were incubated for ~24 hours at 37 °C and in an atmosphere containing 5%
CO2.

5.1.5 Plasmid transfection
After the dishes were taken out of the incubator, the Cos-7 cells were washed twice with
Phosphate-buffered saline (PBS), and 2 ml of Opti-MEM® (Life Technologies, Carlsbad, CA)),
Reduced Serum Medium (ThermoFisher Scientific, MA) was added to each dish.
Two μg each of sigma-1-mGFP2 (i.e., sigma-1 fused with monomeric green fluorescent
protein) and sigma-1-mYFP (sigma-1 fused with monomeric yellow fluorescent protein) were
diluted into 5 μl of Opti-MEM. 5 μl of Lipofectamine 2000 was also diluted with 5 μl of OptiMEM. After 5 minutes, the Lipofectamine dilutions were added to the plasmid dilutions. 20
minutes after that, the mixture of plasmids and Lipofectamine in Opti-MEM was added to the
dishes. Cells were incubated again at the above-mentioned conditions, for about 24 hours, before
they were taken out for imaging. The cells were washed again with PBS and 2 ml of Opti-MEM
was added to each dish before imaging.

5.1.6 Imaging samples
The samples which had only Sigma-1 mGFP2 or Sigma-1 mYFP were excited at 800 and 960 nm
respectively, to generate the elementary spectra of the donors and acceptors respectively. These
wavelengths are almost equal to the respective peak excitation wavelengths of GFP2 and YFP.
Each sample was excited using a line-excitation mode [29]. The dwell time for each line
(which also translates, for each pixel) was 35 ms. The excitation power used was 250 mW for the
entire line or ~ 0.5 mW per pixel, while the spectral resolution was set to ~ 1nm.
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5.1.7 Spectral analysis of protein standards
The GFP2 protein solution was obtained from Lucigen Corporation, WI, which had a stock
concentration of 167 µM. The stock solution was then subdivided into 50 µl aliquots, under orange
light to prevent photobleaching, and stored at -70 °C. Before measurements, the protein solutions
were diluted with PBS to get the following concentrations: 2.5, 5, 10 and 20 µM. These dilutions
were imaged under same imaging conditions which were used to image the S1R samples with
either GFP2 or YFP fluorophores. The emission intensities were plotted against the molar
concentrations of the protein solution dilutions. The slope of this graph gave the emission intensity
per unit concentration of the fluorescent protein. This information was used to extract the donor
concentration from the total donor emission intensity (FD) for the FRET samples.

5.2 Analysis methods
5.2.1 Spectral unmixing and Eapp histograms
Cos-7 cells expressing Sigma-1-mGFP2 or Sigma-1-mYFP samples were used to obtained pixellevel emission spectra averaged over a large number of pixels), to obtain good representative
elementary spectra for the donor and acceptor, respectively. These spectra were used for unmixing
the composite emission spectrum of the donor and acceptor obtained from the FRET samples (i.e.,
Cos-7 cells co-expressing both fusion proteins), using our in-house developed MATLAB routine
for spectral unmixing which is based on the least square algorithm [30]. The composite spectrum
(S) can be written in terms of the donor emission in the presence of acceptor (k DA ), acceptor
emission in the presence of donor (k AD ), and the spectral integrals of the elementary spectra of
donor (w D ) and acceptor (w A ), as following
𝑆 = 𝑘 𝐷𝐴 𝑤 𝐷 + 𝑘 𝐴𝐷 𝑤 𝐴.
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(5.1)

𝑘 𝐷𝐴 and 𝑘 𝐴𝐷 obtained from equation (5.1), by pixel-level unmixing, were used to get the FRET
efficiency (Eapp) of each pixel of the spectral images using the equation (3.11).
A signal-to-noise ratio threshold of 1 was applied on each pixel of the Eapp images. By
binning the Eapp pixels in intervals of 0.01 (or 1%) of FRET efficiency, Eapp histograms were
created for each cell imaged.

5.2.2 Constructing Eapp meta-histograms
Different configurations of donors and acceptors within a given quaternary structure is
characterized by different Eapp values, each of which can be expressed in terms of the FRET
efficiency of a chosen single donor-acceptor pair in the oligomer chosen as a reference; this
reference value is called pairwise FRET efficiency (Ep). When many different configurations are
present in the pixels of a selected image region, and an Eapp histogram is built, those configurations
that dominate in most of the pixels will constitute the dominant peak of the histogram [23]. With
a few exceptions [24] it is rather uncommon to have all the peaks corresponding to all possible DA configurations in a single histogram. To capture the Eapp values corresponding to all the possible
configurations of donor and acceptor molecules in a multimeric complex, we collected the peak
positions of all the Eapp histograms, and binned them again in a bin interval of 0.025 (or 2.5% )of
FRET efficiency, to create a histogram of histograms, called meta-histogram, as described
previously [23, 26, 31]. Therefore, the metahistogram should show Eapp peaks corresponding to all
the FRET configurations of the quaternary structure.
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Figure 5. 1 Metahistogram for 887 Coss7 cells expressing S1R alone. Eapp histograms peaks were binned
in the bin size of 2% of FRET efficiency to generate the meta-histogram.

Figure 5. 2 Metahistogram for 553 Coss7 cells expressing S1R in the presence of haloperidol. Eapp
histograms peaks were binned in the bin size of 2% of FRET efficiency to generate the meta-histogram.
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Figure 5. 3 Metahistogram for 390 Coss7 cells expressing S1R in the presence of (+)-pentazocine. Eapp
histograms peaks were binned in the bin size of 2% of FRET efficiency to generate the meta-histogram.

All three metahistograms shown above were fitted with models of Eapp, as discussed in the
next section, to find the quaternary structure for each case which would correspond to the best fit
model.

5.2.3 Fitting FRET models to the meta-histogram
FRET models corresponding to several possible quaternary structures, as described in the Kinetic
Theory of FRET in Chapter 2, were fitted to the meta-histogram. Two of the models tested
consisted of a parallelogram tetramer and a mixture of dimers and monomers. The parallelogram
tetramer model is described in Chapter 2, and the dimers and monomers model is explained in the
next section.

5.2.4 Dimers and monomers model
When there is a mixture of dimers and monomers present in the image pixels, the Eapp value of
each pixel depends on the total number of donors in that pixel is given as below
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𝐸𝑎𝑝𝑝 =

𝑙
𝐸 ,
𝑛

(5.1)

where Ed is the pairwise FRET efficiency of the dimer, and n is the number of donors in each pixel
and 𝑙 can have any positive integer value, ranging between 0 and 𝑛. The Eapp value for each such
configuration Eapp (𝑙) corresponds to the ensemble of n donors which form 𝑙 FRET dimers.
For a given number (𝑛) of donors, there are n possible combinations of dimers and monomers (see
figure 5.1).

The Eapp model for the mixture of dimers and monomers is the sum of Gaussians with their
peak positions defined by the above equation, and each Gaussian having its independent amplitude
and standard deviation. Ed, 𝑛, amplitudes and standard deviations of the Gaussian are the fitting
parameters, of this model, as given by the following equation:
𝑙

f(𝐸𝑎𝑝𝑝 ) = ∑𝑛𝑙=1 G (𝑛 𝐸𝑑 ).

(5.2)

The fitting residual which was minimized to find the best fit of a model to the data is given by the
following equation:
Fitting residual =

∑i|Experimentali − Simulatedi |
,
Degree of freedom

(5.3)

where Experimentali is the 𝑖th data point corresponding to experimental results and Simulatedi
is the simulated value given by the FRET model at the 𝑖th value of the independent variable in the
data.
All possible FRET configurations for the dimers and monomers model in the case of nine
donors in each pixel is given in figure 5.3. Number 9 was the value of the number of donors per
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pixel as a best- fit parameter for the dimers and monomers model which best fitted the metahistogram, as shown in the results section.

Figure 5.4 Geometrical configurations and the corresponding mathematical expressions for apparent
FRET efficiencies (Eapp) of mixtures of dimers and donors, for the case where each pixel contains
on average 9 donors. For larger numbers of donors, the number of predicted peaks increases
proportionally. Free acceptors, as well as dimers containing only acceptors, were ignored as they are not
excited directly by light and do not contribute to the measured signal. This figure is taken with permission
from [17].

Even though this model accepts only a fixed number of donors as one of the fitting
parameters, even though the expression level of the proteins per voxel of the sample (or per image
pixel) cannot be a fixed number. Instead, there would be several such series of Eapp, as given by
the equation 5.2, each for a fixed number of donors. This situation will result into a superposition
of such functions of Eapp. The function which corresponds to the maximum number of the pixels
in a region of interest would dominate the metahistogram features. The remaining function for all
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other values of 𝑛, forms a uniform smooth curve, and the dominant population shapes the metahistogram peaks.

5.2.5 Plotting Eapp vs. donor concentration (ND)
Average Eapp was computed for each cell, by simply averaging the Eapp value of each pixel. Also,
the average donor concentration was computed for each cell, by comparing the average of the total
donor emission intensity and comparing it to the emission intensity of the donor in a solution of
known donor-concentration.
The averaged total donor intensity was computed by averaging the donor intensity over all
the pixels of a cell or region of interest. The total donor emission intensity (FD) for each pixel was
computed using the equation 4.1 (Chapter 4).
The graph of Eapp vs. ND was plotted for ND (horizontal) axis shown in log-10, to expand the scatter
along the horizontal direction for visualization purpose.

5.3 Results
The results of spectral unmixing, the process which is described in the theoretical section of this
chapter, for three representative cells are shown in figure 5.2. Eapp histograms were created for the
entire cell selections. The varying position of the peaks in the Eapp histograms for the three cells
shows that the dominant configuration of donor and acceptor for the quaternary structure varies
cell to cell.
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Figure 5. 5 The spectral unmixing of GFP2 and YFP, attached to the sigma-1 receptor,
expressed in Cos-7 cells. The spectral maps, for donor in the presence of acceptor (k DA ), acceptor
in the presence of donor (k AD ), and the pixel level FRET efficiency (Eapp ) map. Histograms were
plotted using the Eapp pixels falling into the complete cell selections and binning them into the bin
of 0.01 or 1% FRET efficiency. This figure is reproduced, with permission, from [17]
Eapp was calculated at pixel level by using the values of KDA and KAD for each pixel,
applying equation 4.14. A threshold of the signal to noise ratio equal to one was applied to the KDA
and KAD, while calculating Eapp values, to eliminate false Eapp values which may occur due to noise
only, in the low signal area. Eapp map gives the distribution of FRET efficiencies over the entire
image. Eapp histograms were created by circling each cell and binning the pixels into the bin
interval of 0.01 or 1% of FRET efficiency. Eapp histogram peaks should give the Eapp values
corresponding to the dominant permutation of donors and acceptors in a multimeric complex, in
each cell.
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5.3.1 Results of the meta-histograms
Meta-histograms for the three cases, sigma-1 alone, in the presence of haloperidol and in the
presence of pentazocine plus are shown, in figures 5.5 (a), 5.6 (a) and 5.7 (a) respectively.

Figure 5. 6 Metahistogram for 887 Coss7 cells expressing S1R alone, fitted with a mixture of dimers
and monomers model. Eapp histograms peaks were binned in the bin size of 2% of FRET efficiency to
generate the meta-histogram. The best-fit value for Ed is 0.433 and the most probable value of the number
of donors per pixel (𝒏) is 9. Reduced fitting residual for the fitting is 4.42. Fittings for n equal to 8 and 10
are shown in Appendix B.
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Figure 5. 7 Metahistogram for 553 Coss7 cells expressing S1R in the presence of haloperidol, fitted
with a mixture of dimers and monomers model. Eapp histograms peaks were binned in the bin size of 2%
of FRET efficiency to generate the meta-histogram. The best-fit value for Ed is 0.435 and the most probable
value of the number of donors per pixel (𝑛) is 9. Reduced fitting residual for the fitting is 6.70. Fittings for
n equal to 8 and 10 are shown in Appendix B.

Figure 5. 8 Metahistogram for 390 Coss7 cells expressing S1R in the presence of (+)-pentazocine,
fitted with a mixture of dimers and monomers model. Eapp histograms peaks were binned in the bin size
of 2% of FRET efficiency to generate the meta-histogram. The best-fit value for Ed is 0.435 and the most
probable value of the number of donors per pixel (𝑛) is 10. Reduced fitting residual for the fitting is 1.83.
Fittings for n equal to 9 and 11 are shown in Appendix B.

111

S1R histograms in the absence or presence of the haloperidol or (+)-pentazocine were fitted best
by a model consisting of a mixture of dimers and monomers. Also, the two main fitting
parameters came out very similarly for the three cases, i.e., in the absence or presence of the
above mentioned ligands.

5.3.2 Results of the cellular average of Eapp vs. number of donors (ND)
Eapp vs. ND for the three cases, sigma-1 alone, in the presence of haloperidol and in the presence
of pentazocine plus are shown, in figures 5.8, 5.9 and 5.10 respectively.

Figure 5. 9 Average FRET efficiency (Eapp) vs. average donor expression (ND) graph for sigma-1
receptor alone. The donor expressed is given in the logarithmic scale of base 10. The dashed red

line shows the Eapp value for the dimers and monomers model, obtained by fitting the model to
the Eapp meta-histogram.
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Figure 5. 10 Average FRET efficiency (Eapp) vs. average donor expression (ND) graph for the sigma1 receptor in the presence of haloperidol. The donor expressed is given in the logarithmic scale of base
10. The dashed red line shows the Eapp value for the dimers and model, obtained by fitting the model to the
Eapp meta-histogram.

Figure 5. 11 Average FRET efficiency (Eapp) vs. average donor expression (ND) graph for the
sigma-1 receptor in the presence of (+)-pentazocine. The donor expressed is given in the logarithmic
scale of base 10. The dashed red line shows the Eapp value for the dimers and monomers model,
obtained by fitting the model to the Eapp meta-histogram.
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5.4 Discussion
The mixture of dimers and monomers was the best-fitting model into the Eapp metahistograms for
all three cases: S1R alone, in the presence of haloperidol or (+)-pentazocine. Also, the two main
fitting parameters, the pairwise FRET efficiency of the dimer (Ed) and the number of donors per
pixel (𝑛), for each of the three cases were similar. This confirms they had same dominant
population present which metahistograms preferentially show.
Results of the other analysis method that fits models into Eapp vs. ND graphs show that for
the extremely low concentration, i.e., the far-left side of the Eapp vs. ND graphs, all three graphs
approach about the same value of the same FRET efficiency which is about 0.45.
Eapp vs. ND graphs can show the results of low expression and high expression. The right
side of the graphs shows that at higher donor concentration, they receptor tend to form a broader
distributing of FRET efficiencies, which indicate the presence of higher order oligomers at high
expression levels.
S1R in the presence of haloperidol helps the spread more than the no ligand case.
Pentazocine, however, seems to stabilize the spread of oligomeric forms, to dimers.
Although care was taken to not have any endogenous receptors, the presence of the sigma1 receptor produced constitutively by the Cos-7 cells cannot be completely ruled out; its presence
could cause the quaternary structure to be perceived smaller than the structure the receptors
actually presented, when the detection methods are based on fluorescent protein tagging.
Also, photobleaching can cause the similar effect as the endogenous S1R receptors.
However, since we used line scanning method, it is much less likely to photobleach the fluorescent
proteins, in a single scan. Especially if compared to point scanning, the line scanning will have
very small chance and rate of photobleaching [29].
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5.5 Comparison to the literature
Using the spectral FRET approach [24, 32], we found that S1R receptor resides in the forms of
monomers and dimers at lower expression levels, and may form higher-order oligomers at higher
expression levels when transiently expressed in Cos-7 cells.
S1R agonist haloperidol caused further spreading of FRET efficiencies when compared to
the case of S1R alone. While the S1R agonist pentazocine plus diminished the FRET efficiency
spread for the higher Eapp values, which indicate that at higher concentration the functional form
of the receptor is likely not as higher order oligomer, as in the cases of S1R alone and in the
presence of the receptor antagonist. In other words, pentazocine favored the dimeric form of the
receptor.
S1R oligomerization in relation to ligand-binding is reported in the literature For example,
in vitro analyses of highly purified MBP S1R fusion protein (MBP–4Ala–S1R) in
dodecylmaltoside (DDM) showed oligomeric forms, including tetramers and hexamers/octamers
that specifically bound -(+)-pentazocine [22].
The oligomeric forms were stabilized by both S1R agonists and antagonists. The
monomeric form of the S1R did not bind -(+)-pentazocine [22]. High affinity radioiodinated S1R
photoaffinity probes identified oligomeric forms of S1R in rat liver membranes [33]. The GXXXG
sequence that occurs in putative TM2 of S1R is an important motif that, in part, determines the
ability of the MBP–4Ala–S1R to oligomerize [22]. Additional residues of the S1R have also been
implicated in S1R dimerization/oligomerization [34].
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Chapter 6: Oligomerization of rhodopsin in living cells
Rhodopsin, a prototypical GPCR located in the cone and rod cells of the retina of the eye, is a light
receptor involved in the sense of vision. As mentioned in chapter 1, AFM images suggested that
rhodopsin molecules form arrays of dimers. However, other studies have shown that the functional
form of rhodopsin is monomeric [1] or that it forms dimers [2]. Therefore, there have been
suggestions in the literature that the rhodopsin oligomerization seen in room temperature AFM
studies may be artifacts of phase separation between the cell membrane lipids and rhodopsin due
to low temperatures [3]. To help solve this dilemma, we used spectral FRET and two-photon
micro-spectroscopy, as described in chapter 4, to investigate rhodopsin oligomerization at body
temperature. We show that rhodopsin forms a mixture of dimers and tetramers at body temperature
at relatively lower concentrations and may form higher order oligomers at higher concentration
levels [4].

6.1 Experimental methods
6.1.1 Preparation of plasmids and fluorescent protein solutions
Genetic constructs and purified fluorescent proteins were prepared by our collaborators, Megan
Gregg and Prof. Paul Park, in the Department of Ophthalmology and Visual Sciences, at the Case
Western Reserve University, Cleveland, OH.
The fluorescent proteins of our choice were mTurquoise (mTq) and SYFP2, which are
brighter and more photostable variants of the widely used yellow fluorescent protein (YFP) and
cyan fluorescent protein respectively [5, 6].
To prepare the DNA constructs used to express the fusion proteins formed by rhodopsin
and the fluorescent proteins, the vectors pmRho-SYFP2-1D4 and pmRho-mTq-1D4 were
generated as described previously [7, 8]. The full CMV Q1 promoter in these vectors was replaced
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by a truncated CMV promoter to decrease the expression level of rhodopsin. The truncated CMV
promoter,

CMVd3,

was

generated

by

PCR

using

the

primers

5′-

ACGATGATTATATGGGCGGTAGGCGTGTACG and 5′-GGTAGCGCTAGCGGATCTGA
and included an AseI restriction site at the 5′-end and a NheI restriction site at the 3′-end. The
amplified CMVd3 replaced the endogenous full CMV promoter in pmRho-SYFP2-1D4 and
pmRho-mTQ-1D4 at the AseI and NheI restriction sites to generate the vectors pCMVd3-mRhoSYFP2-1D4 and pCMVd3-mRho-mTQ-1D4.
To prepare the purified fluorescent proteins, two vectors, pRSET-SYFP2, and pRSETmTq, were generated [9, 10]. BL21 (DE3) competent cells (purchased from NEB, Ipswich, MA)
were transformed with pRSET-SYFP2 or pRSET-mTq and plated on Luria broth (LB) agar with
50 mg/ml ampicillin and incubated overnight at 37°C. Five tubes of 6 ml of LB broth with 50
mg/ml ampicillin were inoculated with bacteria picked from individual colonies and incubated
overnight at 37°C with orbital shaking. Fluorescent protein expression was induced by adding 40
µl of IPTG (100 mM stock) and incubating further for 4 hours at 37°C with orbital shaking. The
cultures were spun down at 4500×g for 10 min and placed at −80°C for 1 hour. Cells were lysed
using the CelLytic B-Plus kit (Sigma-Aldrich, St. Louis, MO). Cell pellets were pooled from the
five tubes, resuspended in 2 ml of CelLytic B-Plus working solution, and incubated at room
temperature for 10 min with shaking. The cell lysate was centrifuged at 1900×g for 10 min. The
supernatant containing the fluorescent protein was collected and loaded by gravity flow on a 1 ml
HisPur Ni-NTA spin column (Thermo Fisher Scientific, Waltham, MA), which was equilibrated
with 2 ml of 10 mM imidazole in phosphate-buffered saline (PBS), and incubated for 30 min at
room temperature. The column was centrifuged at 700×g for 2 min. The column was washed three
times by the addition of 2 ml of 25 mM imidizole in PBS and centrifuged at 700×g for 2 min. The

120

bound fluorescent protein was eluted with 1 ml of 250 mM imidazole in PBS and centrifuged at
700×g for 2 min. Imidazole was removed using a 2 ml ZebaSpin desalting spin column (Thermo
Fisher Scientific, Waltham, MA). Eluant (700 µl) was loaded on the desalting column equilibrated
with PBS. Purified fluorescent protein was collected by centrifugation at 1000×g for 2 min. The
concentration of purified fluorescent protein was determined by UV/Vis absorbance spectroscopy
on a Nanodrop2000c (Thermo Fisher Scientific, Waltham, MA). The λmax and extinction
coefficient for SYFP2 were 515 nm and 101 × 103 M−1 cm−1, respectively, and those for mTq
were 434 nm and 30 × 103 M−1 cm−1, respectively.

6.1.2 Cell culture
Chinese Hamster Ovary (CHO) cells were maintained in T-25 flasks in 5 ml of Dulbecco’s
Modified Eagle Medium (DMEM), Thermo Fisher Scientific, Waltham, MA) containing 10% fetal
bovine serum and 1% non-essential amino acids. The flasks were incubated at 37 °C and 5% CO2
and subcultured when they were about 80-90% confluent. Cells were seeded at about 40%
confluency in Delta-T temperature controlled dishes (Bioptechs, Inc., Butler, PA), in the abovementioned cells media. The dishes were incubated for about 24 hours at 37 °C and 5% CO2 before
they were taken out for transfection.

6.1.3 Plasmids transfection
Two plasmid vectors used for the transfection were: pCMVd3-mRho-SYFP2-1D4 and pCMVd3mRho-mTQ-1D4.
Six types of samples were used for each experiment, out of which five samples were
transfected, each with 4 µg of plasmids; one sample, which did not contain any plasmids, was used
as a negative control. Out of five transfected samples, two were used with either donor-tagged or
acceptor-tagged plasmid. These two samples were used to acquire the elementary spectrum of the
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donor and acceptor proteins. The other three transfected samples, which were transfected with
donor and acceptor-tagged plasmids in the donor-to-acceptor ratio of 3:1, 1:1, and 1:3, were used
to determine FRET. Different ratios were intentionally selected so that as broad a range of donorto-acceptor protein ratio as possible is achieved. As discussed below, this leads to broad metahistograms of Eapp, which are very helpful in analyzing the data.
For each sample type, total 4 µg of plasmids and 5 µl of Lipofectamine® (Invitrogen,
Carlsbad, CA) were separately diluted with 250 µl of Opti-MEM® (2 ml; Life Technologies,
Carlsbad, CA), and after five minutes the two types of dilution were combined separately for each
sample type. After twenty minutes, the combined solutions were added to each sample dish, and
the dishes were incubated for ~24 hours in the above-mentioned conditions before they were taken
out for imaging.

6.1.4 Fluorescence microscopy
A portable incubator (Darwin Chambers Company, St. Louis, MO) was used to transport the
samples, at 37°C, from the tissue culture facility to the imaging facility. The microscope was
equipped with a temperature-controlled microscope stage, Delta-T temperature-control system
(Bioptechs, Inc., Butler, PA), to maintain the temperature of cells at ~37°C throughout the image
acquisition process.
Samples were excited by a tunable femtosecond laser (Mai Tai™, Spectra Physics, Santa
Clara, CA) and imaged using a two-photon optical microspectroscope, OptiMiS™ TruLine
(Aurora Spectral Technologies, Milwaukee, WI), coupled to an inverted microscope (Nikon
Eclipse Ti™, Nikon Instruments, Inc., Melville, NY) equipped with a 100× oil-immersion
objective (NA=1.45 ). Each sample was line-scanned [11], applying an average power of 350 mW
of laser light per line (0.23 mW per excitation voxel), successively at two wavelengths 815 and
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960 nm. The image integration time was set to 30 ms per line and a spectral resolution of ∼1 nm
was used to collect the fluorescence emission.

6.1.5 Measurement of fluorescent protein solutions
For fluorescent protein solution measurements, the same type of dishes as described above were
coated with 1% bovine serum albumin in PBS (1-hour incubation at 37°C) to prevent binding of
the protein molecules to the dish bottom. Fluorescent protein standard solutions of mTq and
SYFP2 (stored at −70°C), prepared as mentioned above, were diluted with deionized water, to
bring the final concentrations to 5, 10, 20, or 40 mM. These samples were then imaged under the
same imaging conditions, as the rhodopsin samples were imaged.

6.2 Analysis methods
6.2.1 Spectral tags and unmixing
Images from singly expressing samples were used to obtain the elementary spectra of mTQ and
sYFP2 as donor and acceptor of energy, respectively, which were used in spectral unmixing as
described below.
Pixel-level spectral unmixing of the composite signal was performed using the elementary
spectra, quantum yields, and spectral integrals of the donor and acceptor [12] This was performed
with the help of a MATLAB routine for unmixing, produced in-house, which is based on the leastsquares minimization method, to generate the images of donor emission in presence of the acceptor
(kDA) and acceptor emission in the presence of donor (kAD) ([11, 13] FRET efficiency (Eapp) images
were generated by computing the pixel-level FRET from the kDA and kAD images using equation
(4.14). Three representative cells are shown in figure 6.1, one cell per row, to illustrate the
unmixing process.
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Figure 6. 1 Spectral Images, FRET efficiency (Eapp) map and Eapp-histograms for three
Representative Cell. CHO cells coexpressing m-Turquoise-WT-opsin and m-SYFP2-WT-opsin. The
three columns are the result of the spectral unmixing of the combined signal from donor and acceptor,
giving donor in presence of acceptor (kDA), acceptor in presence of donor (kAD), and the Eapp distribution
computed from the corresponding pixels in kDA and kAD micro-spectrographs, while applying a threshold
on the signal-to-noise ratio of 3. The Eapp pixels for the selected membrane regions as shown in the Eapp
images were binned in the bin interval of 1% of the FRET efficiency, to create Eapp histograms. This figure
is reproduced with permission from [4].

Regions of interests (ROIs) are shown in the Eapp maps. The Eapp histograms in the rightmost column were computed from ROI’s for each cell.

6.2.2 Eapp meta-histogram
For each membrane region selected, a histogram of bin size of 0.01, or 1% of Eapp, was created by
binning the pixels of Eapp image, which fell into the selected region of interest. The tallest peak
positions of these histograms were binned in bin size of 0.02, to get the meta-histogram [4, 12-18],
as shown in figure 6.2.
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Figure 6. 2 Meta-histogram of peak positions corresponding to regions of interests obtained from 398
cells. Peak positions of Eapp histograms were binned in intervals of 2% of Eapp to generate the metahistogram, shown by the open circles. The line The line through the circles is for visualization purpose only.

In order to represent all possible configurations of the donors and acceptors within a
multimeric complex, a range of donor to acceptor ratio is required to be present in the samples. To
achieve that, we used several samples with different transfection ratios as discussed earlier in this
chapter. Effect of the donor to acceptor transfection ratio on meta-histogram is shown in appendix
C.

6.2.3 Meta-histogram fitted with the theoretical models of Eapp
Several theoretical Eapp models for different stoichiometry and geometry were fitted into the metahistogram. Among other models, the model consisting of a mixture of dimers and monomers,
which was described and used in the analysis presented in chapter 5, and was the best fitting model
for sigma-1 receptors, was also tested. The data fitting to that model is shown in Appendix C.
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Dimers-only is a special case of the dimers and monomers model, when the alternating peaks of
the model have zero amplitudes. Based on the fitting of the dimers and monomers model, the
possibility of dimers-only was ruled out.
The best fitting model consisted of a parallelogram tetramer, as shown in figure 6.3. This
model is discussed in Appendix A. In short, the meta-histogram was fitted with a set of seven
correlated Gaussians prescribed by the parallelogram model. The peak positions of the Gaussian
were determined by three independent fitting parameters, namely, pair-wise FRET efficiency (Ep),
the ratio of the sides of the parallelogram (𝑟1⁄𝑟2 ) and the angle between the two sides (𝛼). The
amplitudes and standard deviations of the Gaussians were also independent fitting parameters
Also, fittings using a different model, that of a mixture of dimers and monomers, are
presented in appendix A.
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Figure 6. 3 Metahistogram for regions of interest of the membrane areas of CHO cells expressing
rhodopsin, fitted with a parallelogram model. The values of the FRET efficiency (Ep), along with the
horizontal side of the tetramer, ratio of the sides (r1/r2), and the angle between the two sides (α) as the
geometrical fitting parameters are 0.380, 0.934, and 62.170 respectively. The other fitting parameters are
the amplitudes and standard deviations for the Gaussians. The reduced fitting residual for this model is
6.40. The bottom panel of the figure shows the parallelogram configurations, each of which represents a
Gaussian in the figure, expect for the peaks five and six, which coincide numerically for the best-fit
parameters, thus fitted with a single Gaussian (dark green).

For the best-fit parameters, 6th and 7th peaks numerically coincided, so only one of them is
shown in figure 6.3. The reduced fitting residual for the parallelogram model was the lowest among
all the models tested, making the parallelogram tetramer the best choice. However, the right-handside feature of the meta-histogram could not be fitted with this model. We suggested that the farright feature of the meta-histogram comes from the presence of higher order oligomer, which is
discussed later in this chapter.

6.2.4. Reduced fitting residual as a measure of the goodness of fits
Throughout the analysis, we used reduced fitting residuals, e.g., when calculating the fitting
residuals for the meta-histogram fittings. The reduced fitting residual is given by:
𝑅𝑒𝑑𝑢𝑐𝑒𝑑 𝑓𝑖𝑡𝑡𝑖𝑛𝑔 𝑟𝑒𝑠𝑖𝑑𝑢𝑙 =

𝑓𝑖𝑡𝑡𝑖𝑛𝑔 𝑟𝑒𝑠𝑖𝑑𝑢𝑎𝑙
,
𝑑𝑒𝑔𝑟𝑒𝑒𝑠 𝑜𝑓 𝑓𝑟𝑒𝑒𝑑𝑜𝑚

(6.9)

where the degree of freedom was calculated as
𝑑𝑒𝑔𝑟𝑒𝑒𝑠 𝑜𝑓 𝑓𝑟𝑒𝑒𝑑𝑜𝑚
(6.10)
= 𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑣𝑎𝑟𝑖𝑎𝑏𝑙𝑒𝑠 − 𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑓𝑖𝑡𝑡𝑖𝑛𝑔 𝑝𝑎𝑟𝑎𝑚𝑒𝑡𝑒𝑟𝑠.
The number of fitting parameters is given by the total number of amplitudes and standard
deviations for all the Gaussians and other fitting parameters, such as pairwise FRET efficiency (Ep
or Ed) and the number of donors per pixel n.
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6.2.5 Estimating rhodopsin concentrations
The average fluorescence intensity of several dilutions of the protein solutions was plotted against
the protein solution concentration for each of the two, donor and acceptor, fluorescent proteins.
Each such graph was best fitted with a straight line. The slope of these lines gave the fluorescence
counts per μM of the protein concentration. The slopes for the donor and acceptor protein solutions
were used to estimate the concentration of the rhodopsin molecules attached with either type of
fluorescent markers in the CHO cell membranes.

6.2.6 Average Eapp vs. XA
Although the parallelogram tetramers model best fitted the meta-histogram, the simultaneous
presence of dimers and tetramers could not be ruled out. To test whether both dimers and tetramers
were present, we used another method of analysis, a statistical ensemble approach based on the
average FRET efficiency (Eapp) vs. acceptor molar concentration (XA). The procedure of this
analysis is described below.
For each membrane ROI selected, average Eapp was computed from the average KDA and
KAD values. The average values for KDA and KAD were obtained by averaging them over the pixels
which fell into each ROI. Average Eapp values were corrected for direction excitation of acceptors
using the images acquired at two wavelengths. Also, average acceptor molar fraction for each ROI
was estimated using the following equation
𝑋𝐴 =

[𝐴]
,
[𝐷] + [𝐴]

(6.11)

where [D] and [A] are the donor and acceptor molar concentrations.

6.2.7 Eapp vs. XA fitted with the theoretical models of Eapp
Each point of the Eapp vs. XA graph was compared with the theoretical value of average Eapp. These
theatrical values of Eapp were calculated by using the experimental XA and taking the weighted
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average of the Eapp values of the dimers and tetramers of different donor-acceptor configurations,
where the weights are the probabilities of each donor-acceptor configuration, which can be
determined from the average XA value of each ROI.
The Eapp vs. XA graph is fitted with a theoretical model of the mixture of dimers and
parallelogram shape tetramer. The geometry of the tetramer, which was extracted from the
metahistogram fits, was fixed for the Eapp vs. XA fittings. And the intermolecular distance of the
dimers was also fixed and set equal to the length of a side of the tetramer.
The fitting of the Eapp vs. XA graph by the dimers-only model are shown in figure 6.4.

Figure 6. 4 Average apparent FRET efficiency (Eapp) versus acceptor mole fraction (XA) fitted by
Dimer model. The average Eapp and XA were computed from pixel-level FRET efficiencies for plasma
membranes of individual CHO cells. Data were fitted with models assuming the presence of only dimers
(blue dashed line). The best-fit value of the FRET efficiency for a model consisting of only dimers was
0.550 and the corresponding fitting residual was 2.212.
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Also, the Eapp vs. XA graph was fitted with a mixture of the dimers and tetramers, for which
the fittings are shown in figure 6.5.

Figure 6. 5 Average apparent FRET efficiency (Eapp) versus acceptor mole fraction (XA) fitted by a
mixture of tetramer and dimer model. The average Eapp and XA were computed from pixel-level

FRET efficiencies for plasma membranes of individual CHO cells. Data were fitted with models
assuming the presence of only dimers (solid black line) or a mixture of dimers and parallelogram
tetramers (solid red line). The best-fit value of the FRET efficiency for a model consisting of only
dimers was 0.550 and the corresponding fitting residual was 2.212. When incorporating tetramers
to the fitting model, the values of Ep, the main parallelogram angle (α), and the ratio between the
lengths of the sides were fixed to the values obtained from the meta-histogram analysis displayed
in figure 6.3. The best-fit value for the tetramer-to-dimer ratio (ρ) was 1.47 and the corresponding
fitting residual was 2.127.

6.2.8 Eapp vs. XA for receptor concentration ranges, fitted with the theoretical
models of the mixture of dimers and tetramers
Since Eapp vs. XA for all the cells (ROIs) fittings showed the presence of both dimers and tetramers,
there would be a dynamic equilibrium of the two species and the ratio of the two population is
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governed by the Law of Mass Action. Thus, the tetramer to dimer dissociation constant (K t⇌d)
depends on the total receptor concentration, [A] + [D].
The sum of the differences of the calculated and experimental Eapp value for each
experimental XA value is the fitting residual, which was minimized for the single fitting
parameter- tetramer to dimer ratio (𝜌), where 𝜌 is given by the following equation
𝜌 = [𝑡]/[𝑑],

(6.12)

where [t] and [d] are the tetramer and dimer concentrations respectively.
Molecular concentration is a driving force for change in the relative presence of different
species in a biochemical reaction. Therefore, in order to perform a study of concentration
dependence, we divided the cells into three, four or five concentration ranges, each having about
the same number of cells. For each such concentration sub-range, we plotted the Eapp vs. XA graph
again and fitted them by a mixture of the dimers and parallelogram tetramers. The fittings for the
case of four ranges are shown in figure 6.6.
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Figure 6. 6 Average apparent FRET efficiency (Eapp) versus acceptor molar fraction (XA)
determined from cells expressing different concentrations of opsin. Data in Figure 6.5 were split into
four subsets according to the concentration of opsin in the plasma membrane of the cell. The ranges of
concentrations of opsin represented in each subset are as follows: (a) <402 molecules/μm2 (average, 227
molecules/μm2), (b) 402–804 molecules/μm2 (average, 591 molecules/μm2), (c) 804–1607 molecules/μm2
(average, 1147 molecules/μm2), and (d) >1607 molecules/μm2 (average, 3400 molecules/μm2). The data
were fit with a model assuming a mixture of parallelogram-shaped tetramers and dimers (red solid line).
The values of Ep, the main parallelogram angle (α), and the ratio between the lengths of the sides were fixed
to the values obtained from the meta-histogram analysis displayed in Figure 6.3. The best-fit values for the
tetramer-to-dimer ratios (ρ) were: (a) 0.401, (b) 1.08, (c) 1.79, and (d) 484. The corresponding fitting
residuals were: (a) 1.165, (b) 1.049, (c) 0.937, and (d) 0.903. The individual lines corresponding to the
dimer component (dotted blue line) and the tetramer component (dashed green line) are also indicated for
each concentration range. The first three values of the 𝜌 and their respective error estimates (standard
deviations), using bootstrapping method, are 0.40 ± 0.14, 1.20 ± 0.52 and 1.74 ± 0.17.

The only fitting parameters were tetramer to dimer ratio (ρ). Using the first two, three or
four concentration ranges for the cases of the three, four and five ranges and their respective values
of ρ, we estimated the value of the dissociation constant, which is discussed in the next section.
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6.2.9 Estimating the value of the tetramer to dimer dissociation constant
To recap the Eapp vs. XA analysis done so far, we used α, r1/r2 and Ep from the meta-histogram fits
to constrain the fit of the Eapp vs. XA. In order to estimate the change in 𝜌 as a function of
concentration, we also separated the average Eapp vs. XA plots, as shown in Figure 6.6, and repeated
the analysis described above.
We plotted the 𝜌 ratios as a function of the total expression level and we simulated that
using the equation below
4𝜌2 + 2𝜌 −

[𝐴] + [𝐷]
= 0,
𝐾𝑡→𝑑

(6.3)

where, the dissociation constant, 𝐾𝑡→𝑑 is defined as
𝐾𝑡→𝑑

𝑑2
=
𝑡

(6.4)

Tetramer to dimer ratio was plotted against the average concentration of each range for the
three, four or five ranges, and a theoretical model built on equation 6.3, was fitted into the first
two, three, or four data points, leaving the highest data point out. The highest data point (𝜌 value)
value for each case was way too high which could not be fitted by the same curve which fitted
decently the lower concentration 𝜌 values. The fitting for the case of the four ranges, are shown in
Figure 6.7.
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Figure 6. 7 Tetramer to dimer ratio (𝝆) vs. average rhodopsin concentration. The value of 𝝆, extracted
from the experiments (open circles), is fitted with a theoretical model for 𝝆. The theoretical model is based
on the Law of Mass Action.

To determine which concentration ranges are the best choice, we calculated the error
(standard deviation) in estimating the 𝜌 value for each range, by applying bootstrapping method
that is randomly resampling the data points with replacement. The bootstrapping method used in
this analysis is given, in more details, in Appendix C.
By using errors calculated by the bootstrapping method, we calculated the total reduced
Chi-square value for the three, four or five ranges. The lowest value of the reduced Chi-square was
0.45 which came out from the five-ranges of concentration. The value of the dissociation constant
for the five ranges was46.50 ± 27.24, which is the most acceptable value of the dissociation
constant as extracted from our data by the analysis methods mentioned above.
Values of the reduced Chi-square and the dissociation constant for the other two ranges are
given in Appendix C.
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6.2.10 Meta-histogram for the concentration ranges fitted by the parallelogram
tetramer
Now, I return to the possible presence of higher order rhodopsin oligomers, which are bigger than
tetramer. Since we performed the Eapp vs. XA analysis, we decided to do the same for the metahistogram as well. Therefore, we created meta-histograms for each concentration range, same
ranges as used for the Eapp vs. XA analysis in the previous section, and fitted them with the
parallelogram tetramer model with the same geometrical parameters which were extracted from
the fittings of the meta-histogram of all the cells. These fitting are shown in Figure 6.8. To further
explain these fittings; we only fitted the amplitudes and standard deviations of the Gaussians, into
the meta-histograms for the cells divided by the four concentration ranges, while their peak
positions were fixed by the above-mentioned predetermined geometry of the tetramer structure.
As shown in the figure, the right-side features which we hypothesized earlier, evolves as
the concentration rises. The features only start showing up from the second highest concentration
range, and then it grows bigger for third and the biggest for the fourth and highest concentration
level. This trend strongly suggests the presence of bigger than tetrameric quaternary structure at
increased concertation levels.

135

Figure 6. 8 Meta-histograms for different concentrations of opsin. Data in Figure 6.3 were split into
four subsets according to the concentration of opsin in the plasma membrane of the cell. The range of
concentrations of opsin represented in each subset are as follows: (a) less than 400 molecules/μm2 (average,
~225 molecules/μm2), (b) 400 - 800 molecules/μm2 (average, ~600 molecules/μm2), (c) 800 – 1600
molecules/μm2 (average, ~1150 molecules/μm2), and (d) greater than 1650 molecules/μm2 (average, ~3400
molecules/μm2). The fitting parameters, Ep = 0.380, 𝜶 = 𝟔𝟐. 𝟐° , and 𝒓𝟏 ⁄𝒓𝟐 = 𝟎. 𝟗𝟑, are the same as those
derived from the meta-histogram fit to data from all cells.

And the disproportionally high tetramer to dimer ratio (484 compared to the theoretical
prediction of 3.4) for the most concentrated range is likely due to the higher average Eapp
contribution from these larger quaternary structures. Bigger quaternary structures provide on
average, more possibilities (resonance energy transfer pathways) for donors to lose energy via
FRET, compared to the smaller quaternary structures, giving a higher value for Eapp for those
quaternary structures. In other words, for bigger quaternary structures, a fraction of molecules

136

being inside, to being on the outer sides of the geometry of the quaternary structure is higher, hence
donors are likely to see more acceptors nearby.
We explored such bigger structures, and the first such natural choice was hexamer, which
can be formed due to the association of a dimer and a tetramer, or three dimers. We systematically
drew all the possible configuration of such hexamers, with their mathematical FRET efficiency
(Eapp) expressions. These hexamers were created using the same parallelogram geometry as
reported earlier in this chapter, and growing it to hexamer, along with the longer side of the
tetramer. These expressions are shown in Appendix A
We also calculated the numerical values for the structures bigger than hexamer such as two
hexamers vertically stacked to each other, or 12-mer. Some of these numerical values for Eapp,
which are higher than 0.70 or 70%, are shown in Figure 6.9.

Figure 6. 9 Schematic of a parallelogram-shaped 12-mer. Green and yellow filled circles represent
donors and acceptors respectively.

Therefore, those higher Eapp peaks (right-hand-side features) in the meta-histograms can
be explained with higher order structures which are founded on the parallelogram structure
obtained from the meta-histogram fit.
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6.3 Conclusion and comparing our results with the literature
We conclude based on our spectral FRET study of the rhodopsin oligomerization, that rhodopsin
exists as a combination of dimer and tetramer at an average total concentration of 227
molecules/μm2 and at average concentration of 591 molecules/μm2, there is a little fraction of
molecules start forming higher structures. For concentrations, higher than 804 molecules/μm2 it
may predominately from higher order oligomers, like hexamers, and if two hexamer stack
vertically, it may from a 12-mer. We showed the configurations of 12-mer, which can generate
higher order FRET efficiencies to support our hypothesis. We show that rhodopsin forms dimers
and tetramer at lower concentrations, which is in contrast to some previous studies showing that
dimers are stable oligomers or rhodopsin resides only in dimeric form or reporting only monomerdimer equilibrium.
We also extracted the value of dissociation constant from our concentration dependent
study, which was equal to 87 molecules/μm2. Other studies have also estimated the value of
dissociation constant. One study conducted using fluorescent cross-correlation spectroscopy
(FCS), in Cos-7 cells, reported the equilibrium dissociation constant of 1010 molecules/μm2, any
other study was done on the GPCR N-formyl peptide estimated the value of equilibrium for 3.6
molecules/μm2. Both of these studies reported monomer-dimer equilibrium of rhodopsin
molecules. In the FCS study, the estimate was indirectly inferred, leaving room for errors. The
difference of CHO vs Cos-7 as host cells also may contribute partly to the difference in their
estimation from our value of the dissociation constant. In the case of N-formyl peptide, their
estimate is consistent with our value when the monomer-dimer equilibrium dissociation constant
is projected for that of the dimer-tetramer system.
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Rhodopsin forms dimers and tetramers at lower concentrations and may form bigger
structures, such as hexamer, 12-mer at higher concentrations. The array of dimers shown by a
previous study had used AFM for the disc patches of rod cells, which have much higher receptor
(rhodopsin) concentration than what we have reported. Therefore, the AFM study showing larger
structure is not inconsistent with our findings, and the concerns regarding experimental artefacts
to which the AFM study could have been subjected are unfounded.
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Chapter 7: Conclusion and Directions for Future Research
The purpose of this thesis work was to investigate the quaternary structure of membrane receptors
in living cells. Membrane receptors transfer information from the environment to the cell's interior
[1-3]. Quaternary structure of the membrane receptors is highly researched yet rather controversial
[4-8]. I addressed this issue using fluorescent tags and FRET spectrometry for two such receptors:
(i) Sigma-1 receptors and (ii) Rhodopsin.
In the Sigma-1 receptor (S1R) project, we used S1R-GFP2 and S1R-YFP plasmids, and
expressed them in Cos-7 cells. We conducted FRET spectroscopy measurements on these cells, in
the presence and absence of haloperidol and pentazocine plus.
We used two different approaches to analyze the FRET data, one involving metahistograms of apparent FRET efficiencies (Eapp) and the other used plots of average Eapp vs. donor
concentration (ND). For the metahistogram approach, we found two different models giving good
visual fittings, which were a parallelogram tetramer and a mixture of dimers and monomers.
However, the dimers and monomers model gave about 50% lower fitting residual, making it a
better choice. We extracted a value for the most-probable number of donors per pixel (𝑛) from the
metahistogram fittings, which was equal to 8 donors/pixel. Using the Eapp vs. ND analysis method,
we confirmed that S1R forms a mixture of dimers and monomers at low donor expressions for
each case, i.e., in the absence and presence of the drugs. However, at higher donor expression
levels, S1R alone and those in the presence of haloperidol, showed at wide spread of E app values,
indicating the presence of higher order oligomers, which actually increased in proportion in the
presence of haloperidol. In contrast, S1R in the presence of pentazocine-plus mostly appeared to
stabilize the quaternary structure in the dimers-monomers form.
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All experiments involving S1Rs relied on a single excitation wavelength, which excited
the donors only. In the future, experiments could be conducted where S1R can be imaged following
two different excitation wavelengths. That will enable one to calculate both donor and acceptor
concentrations, from which the total receptor concentrations could be obtained. With that
information, analysis of Eapp vs. the molar acceptor fraction (XA) can be performed, similar to what
we did as part of the rhodopsin project, summarized below. By dividing the total concatenation
range into sub-ranges, we may be able to determine at what receptor concentration higher
oligomers start to form, both in the absence or presence of ligands.
For the rhodopsin project, we expressed the wild-type rhodopsin at body temperature, in
Chinese Hamster Ovary (CHO) cells which are a very competent medium for expression of wild
type rhodopsin, and used the method of FRET spectrometry[9-19], to determine the quaternary
structure of wild type rhodopsin at room temperature. In contrast to the model proposed by Fotiadis
et al.[20], we observed that the wild type rhodopsin forms a mixture or dimers and tetramers in
CHO cells at body temperature and that the oligomeric state of wild type rhodopsin is dynamic.
We performed the concentration dependent study and extracted tetramer to dimer dissociation
constant. We compared our value of the constant to those available in the literature.
Besides, we detected the presence of the higher order oligomers at higher rhodopsin
concentrations. We used two methods for detecting the higher order oligomers; one method is
based on the Eapp histogram peaks, and other involves average cellular Eapp dependence on acceptor
molar concentration XA. Our findings were consistent for both analysis methods.
More work needs to be done in the future. For instance, one could assess whether rhodopsin
with G188R mutation forms oligomers in living cells. If the quaternary structure of the mutants is
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found different than the wild-type, then this will allow one to find correlations between the protein
misfolding and its quaternary structure [21, 22].
Our purpose of maintaining the body temperature for wild-type rhodopsin experiments was
to avoid the possibility that phase separation can drive oligomerization [4, 23, 24]. However, it
would be also interesting to investigate the effect of temperature on oligomerization. By
performing a temperature-dependence study using the same experiential design and analysis
methods, it can be further demonstrated that the temperature does not have any effect on the
wildtype rhodopsin oligomerization.
In summary, the primary contributions of my doctoral research to this field are in the area
of theoretical modeling and experimental method development. Specifically,
1. I extended the FRET tetramer model to include arbitrary side lengths and angles
between sides, and
2. Developed a methodology for concentration-dependent study of macromolecules
oligomerization states, relying on two wavelength excitations.
Using these advances, I was able to discover that:
3. The quaternary structure of the sigma-1 receptors is affected by binding of agonist
and antagonist ligands;
4. The prototypical GPCR rhodopsin forms dimers, which upon increasing the
concentration may associate to form tetramers as well as higher order oligomers.
5. This allowed me to estimate the numerical value for tetramer-to-dimer dissociation
constant of rhodopsin in living cells.
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Appendix A
A-1 Theoretical FRET efficiency models for a parallelogram hexamer
Extending the parallelogram tetramer structure to a parallelogram hexamer, we get 64 different
configurations. However, almost half of them have mirror images of the others. Thus leaving 32
Eapp expresssions, which are tabulated in table 2.2. Also, two simplyfy these eqautions, we left
out the insignificant terms out the insignificant terms of the Eapp expressions in table 2.2, which
gives as another Table 2.3, shown right ater Table 2.2.

148

Table A-1. Parallelogram hexamer configurations, and their FRET efficiencies.
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) ] 1 − 𝐸1 + 𝐸1 [( 1 ) ] 1 − 𝐸1 + 𝐸1 [(1) ]
𝑟𝑑1
𝑟𝑑3
2
𝑟 6
𝐸1 ( 1 )
𝑟2

7.

𝑟 6
1 − 𝐸1 + 𝐸1 [( 1 ) ]
𝑟2
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6

𝑟1 6
𝑟
) + ( 1) ]
𝑟𝑑1
𝑟2

1 6
𝐸1 [1 + ( ) ]
2
,
6 ,
1 6
𝑟1 6
𝑟1
1 − 𝐸1 + 𝐸1 [( ) + ( ) ] 1 + 𝐸1 (2)
𝑟𝑑1
𝑟2
𝐸1 [(

8.

6

𝑟1 6
𝑟
) + ( 1) ]
𝑟𝑑1
𝑟2

1 6
𝐸1 [1 + ( ) ]
2
6 ,
6
1 6
𝑟
𝑟
1 − 𝐸1 + 𝐸1 [( 1 ) + ( 1 ) ] 1 + 𝐸1 (2)
𝑟𝑑1
𝑟2
𝐸1 [(

6

𝑟 6
𝑟
1 6
𝐸1 [( 1 ) + ( 1 ) ]
𝐸1 [( ) + 1]
𝑟2
𝑟𝑑2
2
,
6 ,
1 6
𝑟 6
𝑟
1 + 𝐸1 ( ) 1 − 𝐸1 + 𝐸1 [( 1 ) + ( 1 ) ]
2
𝑟2
𝑟𝑑2

9.

6

𝑟 6
𝑟
1 6
𝐸1 [( 1 ) + ( 1 ) ]
𝐸1 [( ) + 1]
𝑟
𝑟𝑑2
2
2
,
6
1 6
𝑟 6
𝑟
1 + 𝐸1 ( ) 1 − 𝐸1 + 𝐸1 [( 1 ) + ( 1 ) ]
2
𝑟2
𝑟𝑑2

10.

𝑟1 6
𝑟 6
𝑟 6
𝑟 6
) +( 1) ]
𝐸1 [( 1 ) + 1] 𝐸1 [1 + ( 1 ) ]
𝑟𝑑3
𝑟𝑑1
𝑟𝑑1
𝑟𝑑2
,
,
,
𝑟1 6
𝑟1 6
𝑟1 6
𝑟 6
1 − 𝐸1 + 𝐸1 [( ) + ( ) ] 1 + 𝐸1 ( )
1 + 𝐸1 ( 1 )
𝑟𝑑3
𝑟𝑑1
𝑟𝑑1
𝑟𝑑2

11.

1 6
𝑟 6
𝐸1 [( ) + ( 1 ) ]
2
𝑟2
1 6
𝑟 6
1 − 𝐸1 + 𝐸1 [( ) + ( 1 ) ]
2
𝑟2

12.

𝑟 6
𝑟 6
𝑟 6
𝐸1 [( 1 ) + ( 1 ) ]
𝐸1 [1 + ( 1 ) ]
𝑟2
𝑟𝑑3
𝑟2
,
,
𝑟1 6
𝑟1 6
𝑟 6
1 − 𝐸1 + 𝐸1 [( ) + ( ) ] 1 − 𝐸1 + 𝐸1 ( 1 )
𝑟2
𝑟𝑑3
𝑟2

𝐸1 [(

6

13.

𝑟 6
1
𝑟 6
𝐸1 [( 1 ) + ( ) ]
𝐸1 [1 + ( 1 ) ]
𝑟𝑑2
2
𝑟2
,
6
6
𝑟1 6
1 + 𝐸1 ( ) 1 − 𝐸1 + 𝐸1 [( 𝑟1 ) + (1) ]
𝑟2
𝑟𝑑2
2
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14.

1 6
𝑟 6
𝑟 6
𝐸1 [( ) + ( 1 ) ]
𝐸1 [( 1 ) + 1]
2
𝑟𝑑2
𝑟2
,
,
1 6
𝑟1 6 1 + 𝐸 (𝑟1 )6
1 − 𝐸1 + 𝐸1 [( ) + ( ) ]
1 𝑟
2
𝑟𝑑2
2

15.

𝑟 6
𝑟 6
𝑟 6
𝐸1 [( 1 ) + 1]
𝐸1 [( 1 ) + ( 1 ) ]
𝑟2
𝑟𝑑4
𝑟2
,
𝑟 6
𝑟 6
𝑟 6
1 + 𝐸1 ( 1 ) 1 − 𝐸1 + 𝐸1 [( 1 ) + ( 1 ) ]
𝑟2
𝑟𝑑4
𝑟2

16.

𝑟1 6
𝑟 6
𝑟 6
𝑟 6
) + 1] 𝐸1 [1 + ( 1 ) ]
𝐸1 [( 1 ) + ( 1 ) ]
𝑟𝑑1
𝑟𝑑2
𝑟𝑑2
𝑟𝑑4
,
,
,
𝑟 6
𝑟 6
𝑟 6
𝑟 6
1 + 𝐸1 ( 1 )
1 + 𝐸1 ( 1 ) 1 − 𝐸1 + 𝐸1 [( 1 ) + ( 1 ) ]
𝑟𝑑2
𝑟𝑑2
𝑟𝑑2
𝑟𝑑4

𝐸1 [(

𝑟 6
1 6
𝐸1 [( 1 ) + ( ) ]
𝑟2
2
,
𝑟1 6
1 6
1 − 𝐸1 + 𝐸1 [( ) + ( ) ]
𝑟2
2

17.

18.

𝑟1 6
𝑟 6
𝑟 6
) + 1]
𝐸1 [( 1 ) + ( 1 ) ]
𝑟𝑑4
𝑟𝑑1
𝑟𝑑2
,
,
𝑟 6
𝑟 6
𝑟 6
1 + 𝐸1 ( 1 ) 1 − 𝐸1 + 𝐸1 [( 1 ) + ( 1 ) ]
𝑟𝑑4
𝑟𝑑1
𝑟𝑑2

19.

𝐸1 [1 + (

𝐸1 [(

𝑟1 6
𝑟 6
𝑟 6
) ]
𝐸1 [( 1 ) + ( 1 ) ]
𝑟𝑑3
𝑟2
𝑟2
,
𝑟 6
𝑟 6
𝑟 6
1 + 𝐸1 ( 1 ) 1 − 𝐸1 + 𝐸1 [( 1 ) + ( 1 ) ]
𝑟𝑑3
𝑟2
𝑟2

20.

1 6
𝑟 6
𝑟 6
𝑟 6
𝐸1 [( ) + ( 1 ) ]
𝐸1 [( 1 ) + ( 1 ) ]
2
𝑟𝑑3
𝑟2
𝑟𝑑1
,
,
𝑟1 6
𝑟1 6
1 6
𝑟 6
1 − 𝐸1 + 𝐸1 [( ) + ( 1 ) ] 1 − 𝐸1 + 𝐸1 [(𝑟 ) + (𝑟 ) ]
2
𝑟𝑑3
2
𝑑1

21.

𝑟1 6
𝑟 6
𝑟 6
1 6
) + ( 1) ]
𝐸1 [( 1 ) + ( ) ]
𝑟𝑑2
𝑟2
𝑟𝑑4
2
,
6
6
𝑟1 6
𝑟1 6
𝑟
1 − 𝐸1 + 𝐸1 [( ) + ( ) ] 1 − 𝐸1 + 𝐸1 [( 1 ) + (1) ]
𝑟𝑑2
𝑟2
𝑟𝑑4
2
𝐸1 [(
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22.
6

𝑟 6
𝑟
𝑟 6
𝑟 6
𝐸1 [( 1 ) + ( 1 ) ]
𝐸1 [( 1 ) + ( 1 ) ]
𝑟
𝑟
𝑑2
2
𝑟2
𝑟𝑑1
,
6
6
6 ,
6
𝑟
𝑟
1 − 𝐸1 + 𝐸1 [( 1 ) + ( 1 ) ] 1 − 𝐸1 + 𝐸1 [( 𝑟1 ) + (𝑟1 ) ]
𝑟2
𝑟𝑑1
𝑟𝑑2
𝑟2
𝑟1 6
𝑟 6
𝑟 6
𝑟 6
) + ( 1) ]
𝐸1 [( 1 ) + ( 1 ) ]
𝑟𝑑1
𝑟2
𝑟𝑑2
𝑟2
,
𝑟 6
𝑟 6
𝑟 6
𝑟 6
1 − 𝐸1 + 𝐸1 [( 1 ) + ( 1 ) ] 1 − 𝐸1 + 𝐸1 [( 1 ) + ( 1 ) ]
𝑟𝑑1
𝑟2
𝑟𝑑2
𝑟2
𝐸1 [(

23.
𝑟1 6
𝑟 6
𝑟 6
1 6
1 6
𝑟 6
) + 1 + ( 1 ) ] 𝐸1 [1 + ( 1 ) + ( ) ] 𝐸1 [1 + ( ) + ( 1 ) ]
𝑟𝑑1
𝑟2
𝑟𝑑2
2
2
𝑟2
,
6 ,
6
6
6
𝑟1 6
𝑟1 6
𝑟
1
1
1 + 𝐸1 [( ) + ( ) ] 1 + 𝐸1 [( 1 ) + ( ) ] 1 + 𝐸1 [( ) + (𝑟1 ) ]
𝑟𝑑1
𝑟2
𝑟𝑑2
2
2
𝑟2
𝐸1 [(

24.

25.
𝑟1 6
𝑟 6
𝑟 6
𝑟 6
𝑟 6
𝑟 6
) + ( 1 ) + 1] 𝐸1 [( 1 ) + 1 + ( 1 ) ] 𝐸1 [1 + ( 1 ) + ( 1 ) ]
𝑟𝑑3
𝑟𝑑1
𝑟𝑑1
𝑟𝑑2
𝑟𝑑2
𝑟𝑑4
,
,
𝑟 6
𝑟 6
𝑟 6
𝑟 6
𝑟 6
𝑟 6
1 + 𝐸1 [( 1 ) + ( 1 ) ] 1 + 𝐸1 [( 1 ) + ( 1 ) ] 1 + 𝐸1 [( 1 ) + ( 1 ) ]
𝑟𝑑3
𝑟𝑑1
𝑟𝑑1
𝑟𝑑2
𝑟𝑑2
𝑟𝑑4
𝐸1 [(

26.

27.
6

1 6
𝑟1
𝑟1 6
𝑟 6
𝑟 6
1 6
) + 1 + ( 1 ) ] 𝐸1 [1 + ( 1 ) + ( ) ] 𝐸1 [1 + (2) + (𝑟2 ) ]
𝑟𝑑1
𝑟2
𝑟𝑑2
2
,
6 ,
6
6
6
𝑟1 6
𝑟1 6
𝑟
1 + 𝐸1 [( ) + ( ) ] 1 + 𝐸1 [( 1 ) + (1) ] 1 + 𝐸 [(1) + (𝑟1 ) ]
𝑟𝑑1
𝑟2
1
𝑟𝑑2
2
2
𝑟
𝐸1 [(

28.

2

29.
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30.

6

1 6
𝑟
𝑟 6
𝐸1 [( ) + ( 1 ) + ( 1 ) ]
2
𝑟𝑑3
𝑟𝑑1

𝑟 6
𝑟 6
𝐸1 [( 1 ) + ( 1 ) + 1]
𝑟2
𝑟𝑑1
,
6
6
6 ,
1 6
𝑟1
𝑟1 6 1 + 𝐸1 [(𝑟1 ) + ( 𝑟1 ) ]
1 − 𝐸1 + 𝐸1 [( ) + ( ) + ( ) ]
𝑟2
𝑟𝑑1
2
𝑟
𝑟
𝑑3

𝑑1

6

𝐸1 [(

𝑟1 6
1 6
𝑟
) + ( ) + ( 1) ]
𝑟𝑑4
2
𝑟2
6

1 − 𝐸1 + 𝐸1 [(

𝑟1 6
1 6
𝑟
) + ( ) + ( 1) ]
𝑟𝑑4
2
𝑟2

31.

𝑟1 6
𝑟 6
𝑟 6
𝑟 6
1 6
) + ( 1 ) + ( 1) ]
𝐸1 [1 + ( 1 ) + ( ) ]
𝑟𝑑1
𝑟𝑑2
𝑟2
𝑟𝑑3
2
,
6 ,
6
𝑟1 6
𝑟1 6
𝑟1 6
𝑟
1 − 𝐸1 + 𝐸1 [( ) + ( ) + ( ) ] 1 + 𝐸1 [( 1 ) + (1) ]
𝑟𝑑1
𝑟𝑑2
𝑟2
𝑟𝑑3
2

32.

𝑟 6
𝑟 6
𝑟 6
𝐸1 [( 1 ) + ( 1 ) + ( 1 ) ]
𝑟2
𝑟𝑑1
𝑟2
𝑟 6
𝑟 6
𝑟 6
1 − 𝐸1 + 𝐸1 [( 1 ) + ( 1 ) + ( 1 ) ]
𝑟2
𝑟𝑑1
𝑟2

𝐸1 [(

33.

34.

𝑟 6
𝑟 6
𝑟 6
𝑟 6
𝑟 6
𝑟 6
𝐸1 [( 1 ) + ( 1 ) 1] 𝐸1 [1 + ( 1 ) + ( 1 ) ] 𝐸1 [( 1 ) + 1 + ( 1 ) ]
𝑟2
𝑟𝑑3
𝑟𝑑3
𝑟2
𝑟2
𝑟2
,
,
𝑟1 6
𝑟1 6
𝑟1 6
𝑟1 6
𝑟1 6
𝑟 6
1 + 𝐸1 [( ) + ( ) ] 1 + 𝐸1 [( ) + ( ) ] 1 + 𝐸1 [( ) + 1 + ( 1 ) ]
𝑟2
𝑟𝑑3
𝑟𝑑3
𝑟2
𝑟2
𝑟2

35.

1 6
𝑟 6
𝑟 6
𝑟 6
𝑟 6
𝐸1 [( ) + ( 1 ) + 1]
𝐸1 [( 1 ) + ( 1 ) + ( 1 ) ]
2
𝑟𝑑3
𝑟2
𝑟𝑑1
𝑟𝑑2
,
,
1 6
𝑟1 6 1 − 𝐸 + 𝐸 [ (𝑟1 )6 + ( 𝑟1 )6 + ( 𝑟1 )6 ]
1 + 𝐸1 [( ) + ( ) ]
1
1
𝑟2
𝑟𝑑1
𝑟𝑑2
2
𝑟𝑑3

36.

𝑟 6
𝑟
𝑟 6
𝐸1 [( 1 ) + ( 1 ) + ( 1 ) ]
𝑟2
𝑟𝑑2
𝑟2

6

6

𝑟 6
𝑟
𝑟 6
1 − 𝐸1 + 𝐸1 [( 1 ) + ( 1 ) + ( 1 ) ]
𝑟2
𝑟𝑑2
𝑟2

37.

𝑟 6
1 6
𝑟 6
𝑟 6
𝑟 6
𝐸1 [( 1 ) + ( ) + ( 1 ) ]
𝐸1 [1 + ( 1 ) + ( 1 ) ]
𝑟2
2
𝑟𝑑3
𝑟𝑑2
𝑟2
,
,
𝑟1 6
1 6
𝑟1 6 1 + 𝐸 [( 𝑟1 )6 + (𝑟1 )6 ]
1 − 𝐸1 + 𝐸1 [( ) + ( ) + ( ) ]
1
𝑟𝑑2
𝑟2
𝑟2
2
𝑟𝑑3

38.

𝑟1 6
𝑟 6
1 6
) +( 1 ) +( ) ]
𝑟𝑑1
𝑟𝑑3
2
𝑟1 6
𝑟1 6
1 6
1 − 𝐸1 + 𝐸1 [( ) + ( ) + ( ) ]
𝑟𝑑1
𝑟𝑑3
2
𝐸1 [(

154

39.

40.

1 6
𝑟 6
𝑟 6
𝑟 6
𝑟 6
𝐸1 [( ) + ( 1 ) + 1]
𝐸1 [( 1 ) + ( 1 ) + ( 1 ) ]
2
𝑟𝑑3
𝑟2
𝑟𝑑1
𝑟𝑑2
,
,
1 6
𝑟1 6 1 − 𝐸 + 𝐸 [(𝑟1 )6 + ( 𝑟1 )6 + ( 𝑟1 )6 ]
1 + 𝐸1 [( ) + ( ) ]
1
1
𝑟2
𝑟𝑑1
𝑟𝑑2
2
𝑟𝑑3
6

𝑟 6
𝑟
𝑟 6
𝐸1 [( 1 ) + ( 1 ) + ( 1 ) ]
𝑟2
𝑟𝑑2
𝑟2
6

𝑟 6
𝑟
𝑟 6
1 − 𝐸1 + 𝐸1 [( 1 ) + ( 1 ) + ( 1 ) ]
𝑟2
𝑟𝑑2
𝑟2

41.

42.

𝑟 6
𝑟 6
𝑟 6
𝑟 6
𝑟 6
𝐸1 [( 1 ) + ( 1 ) + 1]
𝐸1 [( 1 ) + ( 1 ) + ( 1 ) ]
𝑟2
𝑟𝑑1
𝑟𝑑2
𝑟𝑑4
𝑟2
,
,
𝑟 6
𝑟 6
𝑟 6
𝑟 6
𝑟 6
1 + 𝐸1 [( 1 ) + ( 1 ) ] 1 − 𝐸1 + 𝐸1 [( 1 ) + ( 1 ) + ( 1 ) ]
𝑟2
𝑟𝑑1
𝑟𝑑2
𝑟𝑑4
𝑟2
𝑟 6
1 6
𝑟 6
𝐸1 [( 1 ) + ( ) + ( 1 ) ]
𝑟2
2
𝑟𝑑1
𝑟1 6
1 6
𝑟 6
1 − 𝐸1 + 𝐸1 [( ) + ( ) + ( 1 ) ]
𝑟2
2
𝑟𝑑1

43.
𝑟1 6
𝑟 6
𝑟 6
𝑟 6
𝑟 6
1 6
) + 1 + ( 1 ) + ( 1 ) ] 𝐸1 [1 + ( 1 ) + ( 1 ) + ( ) ]
𝑟𝑑1
𝑟𝑑2
𝑟2
𝑟𝑑2
𝑟𝑑4
2
,
6
6
6
6
6
6
𝑟
𝑟
𝑟
1 + 𝐸1 [( 1 ) + ( 1 ) + ( 1 ) ] 1 + 𝐸1 [( 𝑟1 ) + ( 𝑟1 ) + (1) ]
𝑟𝑑1
𝑟𝑑2
𝑟2
𝑟𝑑2
𝑟𝑑4
2
𝐸1 [(

44.

45.

6

𝑟 6
𝑟 6
1 6
𝑟
𝐸1 [( 1 ) + ( 1 ) + ( ) + ( 1 ) ]
𝑟𝑑2
𝑟𝑑4
2
𝑟2
6

𝑟 6
𝑟 6
1 6
𝑟
1 − 𝐸1 + 𝐸1 [( 1 ) + ( 1 ) + ( ) + ( 1 ) ]
𝑟𝑑2
𝑟𝑑4
2
𝑟2

46.

,

6

𝑟 6
1 6
𝑟
𝑟 6
𝐸1 [( 1 ) + ( ) + ( 1 ) + ( 1 ) ]
𝑟2
2
𝑟𝑑3
𝑟𝑑1
6

𝑟 6
1 6
𝑟
𝑟 6
1 − 𝐸1 + 𝐸1 [( 1 ) + ( ) + ( 1 ) + ( 1 ) ]
𝑟2
2
𝑟𝑑3
𝑟𝑑1
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47.

1 6
𝑟 6
𝑟 6
𝑟 6
𝑟 6
𝑟 6
𝐸1 [( ) + ( 1 ) + ( 1 ) + 1] 𝐸1 [( 1 ) + ( 1 ) + 1 + ( 1 ) ]
2
𝑟𝑑3
𝑟𝑑1
𝑟2
𝑟𝑑1
𝑟𝑑2
,
1 6
𝑟1 6
𝑟1 6 1 + 𝐸 [(𝑟1 )6 + ( 𝑟1 )6 + ( 𝑟1 )6 ]
1 + 𝐸1 [( ) + ( ) + ( ) ]
1
𝑟2
𝑟𝑑1
𝑟𝑑2
2
𝑟𝑑3
𝑟𝑑1

48.

49.

50.

𝑟 6
𝑟 6
𝑟 6
𝑟 6
𝑟 6
𝑟 6
𝐸1 [( 1 ) + ( 1 ) + ( 1 ) + 1] 𝐸1 [1 + ( 1 ) + ( 1 ) + ( 1 ) ]
𝑟2
𝑟𝑑3
𝑟𝑑1
𝑟𝑑2
𝑟𝑑4
𝑟2
,
𝑟1 6
𝑟1 6
𝑟1 6
𝑟1 6
𝑟1 6
𝑟 6
1 + 𝐸1 [( ) + ( ) + ( ) ] 1 + 𝐸1 [ ( ) + ( ) + ( 1 ) ]
𝑟2
𝑟𝑑3
𝑟𝑑1
𝑟𝑑2
𝑟𝑑4
𝑟2

51.

52.

𝑟 6
𝑟 6
𝑟 6
𝑟 6
1 6
𝑟 6
𝐸1 [( 1 ) + 1 + ( 1 ) + ( 1 ) ] 𝐸1 [ ( 1 ) + ( ) + ( 1 ) + 1]
𝑟2
𝑟𝑑2
𝑟2
𝑟2
2
𝑟𝑑3
,
6
6
6
𝑟1 6
𝑟1 6
𝑟1 6
𝑟
1
1 + 𝐸1 [( ) + ( ) + ( ) ] 1 + 𝐸1 [ ( 1 ) + ( ) + ( 𝑟1 ) ]
𝑟2
𝑟𝑑2
𝑟2
𝑟2
2
𝑟𝑑3

53.
𝑟1 6
1 6
𝑟 6
𝑟 6
𝑟 6
𝑟 6
) + ( ) + ( 1 ) ] 𝐸1 [ ( 1 ) + ( 1 ) + 1 + ( 1 ) ]
𝑟𝑑3
2
𝑟2
𝑟2
𝑟𝑑1
𝑟2
,
𝑟1 6
1 6
𝑟1 6 1 + 𝐸 [ (𝑟1 )6 + ( 𝑟1 )6 + (𝑟1 )6 ]
1 + 𝐸1 [ ( ) + ( ) + ( ) ]
1
𝑟2
𝑟𝑑1
𝑟2
𝑟𝑑3
2
𝑟2
𝐸1 [ 1 + (

54.

𝑟1 6
1 6
𝑟 6
𝑟 6
1 6
𝑟 6
) + ( ) + ( 1 ) ] 𝐸1 [ 1 + ( 1 ) + ( ) + ( 1 ) ]
𝑟𝑑2
2
𝑟2
𝑟𝑑2
2
𝑟2
,
𝑟1 6
1 6
𝑟1 6
𝑟1 6
1 6
𝑟1 6
1 + 𝐸1 [( ) + ( ) + ( ) ] 1 + 𝐸1 [( ) + ( ) + ( ) ]
𝑟𝑑2
2
𝑟2
𝑟𝑑2
2
𝑟2

55.

𝐸1 [ 1 + (

56.

𝑟 6
1 6
𝑟 6
𝑟 6
1 6
𝑟 6
𝐸1 [( 1 ) + ( ) + ( 1 ) + 1 ] 𝐸1 [( 1 ) + ( ) + ( 1 ) + 1 ]
𝑟2
2
𝑟𝑑1
𝑟2
2
𝑟𝑑1
,
𝑟 6
1 6
𝑟 6
𝑟 6
1 6
𝑟 6
1 + 𝐸1 [( 1 ) + ( ) + ( 1 ) ] 1 + 𝐸1 [( 1 ) + ( ) + ( 1 ) ]
𝑟2
2
𝑟𝑑1
𝑟2
2
𝑟1
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𝑟 6
𝑟 6
𝑟 6
𝑟 6
𝐸1 [( 1 ) + ( 1 ) + ( 1 ) + ( 1 ) ]
𝑟2
𝑟𝑑1
𝑟𝑑2
𝑟2
,
𝑟1 6
𝑟1 6
𝑟1 6
𝑟 6
1 − 𝐸1 + 𝐸1 [( ) + ( ) + ( ) + ( 1 ) ]
𝑟2
𝑟𝑑1
𝑟𝑑2
𝑟2

57.

𝑟 6
𝑟 6
𝑟 6
𝑟 6
𝐸1 [( 1 ) + ( 1 ) + ( 1 ) + ( 1 ) ]
𝑟2
𝑟𝑑1
𝑟𝑑2
𝑟2
𝑟1 6
𝑟1 6
𝑟1 6
𝑟 6
1 − 𝐸1 + 𝐸1 [( ) + ( ) + ( ) + ( 1 ) ]
𝑟2
𝑟𝑑1
𝑟𝑑2
𝑟2

58.
𝑟 6
1 6
𝑟 6
𝑟 6
𝐸1 [( 1 ) + ( ) + ( 1 ) + ( 1 ) + 1]
𝑟2
2
𝑟𝑑3
𝑟𝑑1
𝑟 6
1 6
𝑟 6
𝑟 6
1 + 𝐸1 [( 1 ) + ( ) + ( 1 ) + ( 1 ) ]
𝑟2
2
𝑟𝑑3
𝑟𝑑1

59.

60.
𝑟 6
𝑟 6
𝑟 6
𝑟 6
𝐸1 [( 1 ) + ( 1 ) + 1 + ( 1 ) + ( 1 ) ]
𝑟2
𝑟𝑑1
𝑟𝑑2
𝑟2
𝑟 6
𝑟 6
𝑟 6
𝑟 6
1 + 𝐸1 [( 1 ) + ( 1 ) + ( 1 ) + ( 1 ) ]
𝑟2
𝑟𝑑1
𝑟𝑑2
𝑟2

61.

62.
6

𝐸1 [ 1 + (

𝑟1 6
𝑟
1 6
𝑟 6
) + ( 1 ) + ( ) + ( 1) ]
𝑟𝑑2
𝑟𝑑4
2
𝑟2

1 + 𝐸1 [ (

𝑟1 6
𝑟
1 6
𝑟 6
) + ( 1 ) + ( ) + ( 1) ]
𝑟𝑑2
𝑟𝑑4
2
𝑟2

6

63.

64.
N/A
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Table A-2. Parallelogram-shaped hexamer configurations and FRET
efficiency for each donor. Same configurations as in table 2, but with non-significant FRET
terms removed.
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Configurations

Geometric

Configuration #

1.

FRET Efficiency Per Donor

0

2.

𝐸1 (

𝑟1 6
)
𝑟𝑑1

1 − 𝐸1 + 𝐸1 [(

𝑟1 6
) ]
𝑟𝑑1

, 𝐸1 ,

𝑟 6
𝐸1 ( 1 )
𝑟2

𝑟 6
1 − 𝐸1 + 𝐸1 [( 1 ) ]
𝑟2

3.

4.

𝐸1 (

𝑟1 6
)
𝑟𝑑1

1 − 𝐸1 + 𝐸1 [(

𝑟1 6
) ]
𝑟𝑑1

, 𝐸1 ,

𝐸1 (

𝑟1 6
)
𝑟𝑑2

1 − 𝐸1 + 𝐸1 [(

𝑟 6
𝐸1 ( 1 )
𝑟2

,
,
𝑟1 6
𝑟 6
) ] 1 − 𝐸1 + 𝐸1 [( 1 ) ]
𝑟𝑑2
𝑟2

𝑟 6
𝐸1 ( 1 )
𝑟2

5.

𝑟 6
1 − 𝐸1 + 𝐸1 [( 1 ) ]
𝑟2

6.
𝐸1 ,

𝐸1 (

𝑟1 6
)
𝑟𝑑1

1 − 𝐸1 + 𝐸1 [(

7.
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𝑟 6
𝐸1 ( 1 )
𝑟2

,
𝑟1 6
𝑟 6
) ] 1 − 𝐸1 + 𝐸1 [( 1 ) ]
𝑟𝑑1
𝑟2

𝑟 6
𝑟 6
𝐸1 [( 1 ) + ( 1 ) ]
𝑟2
𝑟𝑑1
, 𝐸1 ,
𝑟1 6
𝑟 6
1 − 𝐸1 + 𝐸1 [( ) + ( 1 ) ]
𝑟2
𝑟𝑑1
𝐸1 [(

8.

6

𝑟1 6
𝑟
) + ( 1) ]
𝑟𝑑1
𝑟2
6

1 − 𝐸1 + 𝐸1 [(

𝑟1 6
𝑟
) + ( 1) ]
𝑟𝑑1
𝑟2

, 𝐸1

6

𝑟 6
𝑟
𝐸1 [( 1 ) + ( 1 ) ]
𝑟2
𝑟𝑑2

𝐸1 ,

6

𝑟 6
𝑟
1 − 𝐸1 + 𝐸1 [( 1 ) + ( 1 ) ]
𝑟2
𝑟𝑑2

,

9.
6

𝐸1 ,

6

𝑟 6
𝑟
1 − 𝐸1 + 𝐸1 [( 1 ) + ( 1 ) ]
𝑟2
𝑟𝑑2

𝑟1 6
𝑟 6
) + 1] 𝐸1 [1 + ( 1 ) ]
𝑟𝑑1
𝑟𝑑2
,
,
,
𝑟1 6
𝑟1 6
𝑟 6
1 − 𝐸1 + 𝐸1 ( ) 1 + 𝐸1 ( )
1 + 𝐸1 ( 1 )
𝑟𝑑1
𝑟𝑑1
𝑟𝑑2
𝐸1 (

10.

𝑟 6
𝑟
𝐸1 [( 1 ) + ( 1 ) ]
𝑟2
𝑟𝑑2

𝑟1 6
)
𝑟𝑑1

𝐸1 [(

𝑟 6
𝐸1 ( 1 )
𝑟2

𝑟 6
1 − 𝐸1 + 𝐸1 ( 1 )
𝑟2

11.

12.

13.

𝑟 6
𝐸1 ( 1 )
𝑟2

𝑟 6
𝐸1 [1 + ( 1 ) ]
𝑟2
,
,
𝑟 6
𝑟 6
1 − 𝐸1 + 𝐸1 ( 1 ) 1 − 𝐸1 + 𝐸1 ( 1 )
𝑟2
𝑟2
𝑟 6
𝑟 6
𝐸1 [1 + ( 1 ) ]
𝐸1 ( 1 )
𝑟2
𝑟𝑑2
,
𝑟1 6
𝑟 6
1 + 𝐸1 ( ) 1 − 𝐸1 + 𝐸1 ( 1 )
𝑟2
𝑟𝑑2

160

14.

𝑟 6
𝐸1 [( 1 ) + 1]
𝑟2
,
,
𝑟1 6
𝑟 6
1 − 𝐸1 + 𝐸1 ( ) 1 + 𝐸1 ( 1 )
𝑟𝑑1
𝑟2

15.

𝑟 6
𝑟 6
𝐸1 [( 1 ) + 1]
𝐸1 ( 1 )
𝑟2
𝑟2
,
𝑟 6
𝑟 6
1 + 𝐸1 ( 1 ) 1 − 𝐸1 + 𝐸1 ( 1 )
𝑟2
𝑟2

16.

𝐸1 (

𝑟1 6
)
𝑟𝑑1

𝑟1 6
𝑟 6
𝑟 6
) + 1] 𝐸1 [1 + ( 1 ) ]
𝐸1 ( 1 )
𝑟𝑑1
𝑟𝑑2
𝑟𝑑1
,
,
,
𝑟 6
𝑟 6
𝑟 6
1 + 𝐸1 ( 1 )
1 + 𝐸1 ( 1 ) 1 − 𝐸1 + 𝐸1 ( 1 )
𝑟𝑑1
𝑟𝑑2
𝑟𝑑1

𝐸1 [(

𝑟 6
𝐸1 ( 1 )
𝑟2

17.

𝑟 6
1 − 𝐸1 + 𝐸1 ( 1 )
𝑟2

,

𝑟1 6
𝑟 6
) +( 1) ]
𝑟𝑑1
𝑟𝑑2
𝐸1 ,
,
𝑟 6
𝑟 6
1 − 𝐸1 + 𝐸1 [( 1 ) + ( 1 ) ]
𝑟𝑑1
𝑟𝑑2
𝐸1 [(

18.

19.

𝑟 6
𝑟 6
𝐸1 [( 1 ) + ( 1 ) ]
𝑟2
𝑟2
𝐸1 ,
𝑟 6
𝑟 6
1 − 𝐸1 + 𝐸1 [( 1 ) + ( 1 ) ]
𝑟2
𝑟2

20.

𝑟 6
𝑟 6
𝐸1 [( 1 ) + ( 1 ) ]
𝑟2
𝑟𝑑1
,
𝑟1 6
𝑟1 6
1 − 𝐸1 + 𝐸1 [( ) + ( ) ]
𝑟2
𝑟𝑑1

21.

𝑟1 6
𝑟 6
) + ( 1) ]
𝑟𝑑2
𝑟2
𝑟 6
𝑟 6
1 − 𝐸1 + 𝐸1 [( 1 ) + ( 1 ) ]
𝑟𝑑2
𝑟2
𝐸1 [(
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22.
𝑟 6
𝑟 6
𝑟 6
𝑟 6
𝐸1 [( 1 ) + ( 1 ) ]
𝐸1 [( 1 ) + ( 1 ) ]
𝑟2
𝑟𝑑1
𝑟𝑑2
𝑟2
,
,
𝑟 6
𝑟 6
𝑟 6
𝑟 6
1 − 𝐸1 + 𝐸1 [( 1 ) + ( 1 ) ] 1 − 𝐸1 + 𝐸1 [( 1 ) + ( 1 ) ]
𝑟2
𝑟𝑑1
𝑟𝑑2
𝑟2
𝑟1 6
𝑟 6
𝑟 6
𝑟 6
) + ( 1) ]
𝐸1 [( 1 ) + ( 1 ) ]
𝑟𝑑1
𝑟2
𝑟𝑑2
𝑟2
,
𝑟1 6
𝑟1 6
𝑟1 6
𝑟 6
1 − 𝐸1 + 𝐸1 [( ) + ( ) ] 1 − 𝐸1 + 𝐸1 [( ) + ( 1 ) ]
𝑟𝑑1
𝑟2
𝑟𝑑2
𝑟2
𝐸1 [(

23.
𝑟1 6
𝑟 6
𝑟 6
𝑟 6
) + 1 + ( 1 ) ] 𝐸1 [1 + ( 1 ) ] 𝐸1 [1 + ( 1 ) ]
𝑟𝑑1
𝑟2
𝑟𝑑2
𝑟2
,
,
𝑟 6
𝑟 6
𝑟 6
𝑟 6
1 + 𝐸1 [( 1 ) + ( 1 ) ] 1 + 𝐸1 [( 1 ) ] 1 + 𝐸1 ( 1 )
𝑟𝑑1
𝑟2
𝑟𝑑2
𝑟2
𝐸1 [(

24.

25.
𝑟1 6
𝑟 6
𝑟 6
𝑟 6
) + 1] 𝐸1 [( 1 ) + 1 + ( 1 ) ] 𝐸1 [1 + ( 1 ) ]
𝑟𝑑1
𝑟𝑑1
𝑟𝑑2
𝑟𝑑2
,
,
𝑟 6
𝑟 6
𝑟 6
𝑟 6
1 + 𝐸1 ( 1 ) 1 + 𝐸1 [( 1 ) + ( 1 ) ] 1 + 𝐸1 ( 1 )
𝑟𝑑1
𝑟𝑑1
𝑟𝑑2
𝑟𝑑2

𝐸1 [(

26.

27.
𝑟1 6
𝑟 6
𝑟 6
𝑟 6
) + 1 + ( 1 ) ] 𝐸1 [1 + ( 1 ) ] 𝐸1 [1 + ( 1 ) ]
𝑟𝑑1
𝑟2
𝑟𝑑2
𝑟2
,
,
𝑟1 6
𝑟1 6
𝑟1 6
𝑟 6
1 + 𝐸1 [( ) + ( ) ] 1 + 𝐸1 ( )
1 + 𝐸1 ( 1 )
𝑟𝑑1
𝑟2
𝑟𝑑2
𝑟2
𝐸1 [(

28.

29.
𝑟 6
𝑟 6
𝑟 6
𝐸1 [( 1 ) + ( 1 ) + 1]
𝐸1 ( 1 )
𝑟2
𝑟𝑑1
𝑟2
,
,
𝑟1 6
𝑟1 6
𝑟1 6
𝑟 6
1 − 𝐸1 + 𝐸1 ( ) 1 + 𝐸1 [( ) + ( ) ] 1 − 𝐸1 + 𝐸1 ( 1 )
𝑟𝑑1
𝑟2
𝑟𝑑1
𝑟2
𝐸1 (

30.

𝑟1 6
)
𝑟𝑑1
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31.
𝑟1 6
𝑟 6
𝑟 6
𝑟 6
𝑟 6
𝑟 6
) + ( 1 ) + ( 1) ]
𝐸1 [( 1 ) + ( 1 ) + ( 1 ) ]
𝑟𝑑1
𝑟𝑑2
𝑟2
𝑟2
𝑟𝑑1
𝑟2
,𝐸 ,
𝑟1 6
𝑟1 6
𝑟1 6 1
𝑟1 6
𝑟1 6
𝑟 6
1 − 𝐸1 + 𝐸1 [( ) + ( ) + ( ) ]
1 − 𝐸1 + 𝐸1 [( ) + ( ) + ( 1 ) ]
𝑟𝑑1
𝑟𝑑2
𝑟2
𝑟2
𝑟𝑑1
𝑟2
𝐸1 [(

32.

33.

34.

𝑟 6
𝑟 6
𝑟 6
𝑟 6
𝐸1 [( 1 ) + 1] 𝐸1 [1 + ( 1 ) ] 𝐸1 [( 1 ) + 1 + ( 1 ) ]
𝑟2
𝑟2
𝑟2
𝑟2
,
,
𝑟1 6
𝑟1 6
𝑟1 6
𝑟 6
1 + 𝐸1 ( )
1 + 𝐸1 ( ) 1 + 𝐸1 [( ) + ( 1 ) ]
𝑟2
𝑟2
𝑟2
𝑟2

35.
6

36.

37.

𝑟 6
𝑟
𝑟 6
𝑟 6
𝑟 6
𝑟 6
𝐸1 [( 1 ) + ( 1 ) + ( 1 ) ]
𝐸1 [( 1 ) + ( 1 ) + ( 1 ) ]
𝑟2
𝑟𝑑2
𝑟2
𝑟2
𝑟𝑑1
𝑟𝑑2
𝐸1 ,
,
6
6
6
6
6
6
𝑟
𝑟
𝑟
1 − 𝐸1 + 𝐸1 [ ( 1 ) + ( 1 ) + ( 1 ) ] 1 − 𝐸1 + 𝐸1 [(𝑟1 ) + ( 𝑟1 ) + (𝑟1 ) ]
𝑟2
𝑟𝑑1
𝑟𝑑2
𝑟2
𝑟𝑑2
𝑟2

𝑟 6
𝐸1 ( 1 )
𝑟2

𝑟1 6
𝑟 6
) + ( 1) ]
𝑟𝑑2
𝑟2
,
,
𝑟 6
𝑟 6
𝑟 6
1 − 𝐸1 + 𝐸1 ( 1 ) 1 + 𝐸1 [( 1 ) + ( 1 ) ]
𝑟2
𝑟𝑑2
𝑟2

38.

𝐸1 [1 + (

𝐸1 (

𝑟1 6
)
𝑟𝑑1

1 − 𝐸1 + 𝐸1 (

𝑟1 6
)
𝑟𝑑1

39.
6

40.

𝑟 6
𝑟
𝑟 6
𝑟 6
𝑟 6
𝑟 6
𝐸1 [( 1 ) + ( 1 ) + ( 1 ) ]
𝐸1 [( 1 ) + ( 1 ) + ( 1 ) ]
𝑟
𝑟
𝑟
2
𝑑2
2
𝑟2
𝑟𝑑1
𝑟𝑑2
𝐸1 ,
,
6
6
6
𝑟1 6
𝑟1 6
𝑟1 6
1 − 𝐸1 + 𝐸1 [( ) + ( ) + ( ) ] 1 − 𝐸1 + 𝐸1 [(𝑟1 ) + ( 𝑟1 ) + (𝑟1 ) ]
𝑟2
𝑟𝑑1
𝑟𝑑2
𝑟2
𝑟𝑑2
𝑟2
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41.

42.

𝑟 6
𝑟 6
𝑟 6
𝑟 6
𝐸1 [( 1 ) + ( 1 ) + 1]
𝐸1 [( 1 ) + ( 1 ) ]
𝑟2
𝑟𝑑1
𝑟𝑑2
𝑟2
,
,
𝑟 6
𝑟 6
𝑟 6
𝑟 6
1 + 𝐸1 [( 1 ) + ( 1 ) ] 1 − 𝐸1 + 𝐸1 [( 1 ) + ( 1 ) ]
𝑟2
𝑟𝑑1
𝑟𝑑2
𝑟2
𝑟 6
𝑟 6
𝐸1 [( 1 ) + ( 1 ) ]
𝑟2
𝑟𝑑1
𝑟1 6
𝑟 6
1 − 𝐸1 + 𝐸1 [( ) + ( 1 ) ]
𝑟2
𝑟𝑑1

43.
𝑟1 6
𝑟 6
𝑟 6
𝑟 6
) + 1 + ( 1 ) + ( 1 ) ] 𝐸1 [1 + ( 1 ) ]
𝑟𝑑1
𝑟𝑑2
𝑟2
𝑟𝑑2
,
𝑟1 6
𝑟1 6
𝑟1 6
𝑟 6
1 + 𝐸1 [( ) + ( ) + ( ) ] 1 + 𝐸1 ( 1 )
𝑟𝑑1
𝑟𝑑2
𝑟2
𝑟𝑑2
𝐸1 [(

44.

45.
𝑟1 6
𝑟 6
𝑟 6
𝑟 6
) + ( 1) ]
𝐸1 [( 1 ) + ( 1 ) ]
𝑟𝑑2
𝑟2
𝑟2
𝑟𝑑1
,
𝑟 6
𝑟 6
𝑟 6
𝑟 6
1 − 𝐸1 + 𝐸1 [( 1 ) + ( 1 ) ] 1 − 𝐸1 + 𝐸1 [( 1 ) + ( 1 ) ]
𝑟𝑑2
𝑟2
𝑟2
𝑟𝑑1
𝐸1 [(

46.

47.
𝑟1 6
𝑟 6
𝑟 6
𝑟 6
) + 1] 𝐸1 [( 1 ) + ( 1 ) + 1 + ( 1 ) ]
𝑟𝑑1
𝑟2
𝑟𝑑1
𝑟𝑑2
,
𝑟 6
𝑟 6
𝑟 6
1 + 𝐸1 [( 1 ) + ( 1 ) + ( 1 ) ]
𝑟1 6
𝑟2
𝑟𝑑1
𝑟𝑑2
1 + 𝐸1 ( )
𝑟𝑑1

𝐸1 [(

48.

49.

𝑟 6
𝑟 6
𝑟 6
𝑟 6
𝐸1 [( 1 ) + ( 1 ) + 1] 𝐸1 [1 + ( 1 ) + ( 1 ) ]
𝑟2
𝑟𝑑1
𝑟𝑑2
𝑟2
,
𝑟 6
𝑟 6
𝑟 6
𝑟 6
1 + 𝐸1 [( 1 ) + ( 1 ) ] 1 + 𝐸1 [ ( 1 ) + ( 1 ) ]
𝑟2
𝑟𝑑1
𝑟𝑑2
𝑟2
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50.

51.

52.

𝑟 6
𝑟 6
𝑟 6
𝑟 6
𝐸1 [( 1 ) + 1 + ( 1 ) + ( 1 ) ] 𝐸1 [ ( 1 ) + 1]
𝑟2
𝑟𝑑2
𝑟2
𝑟2
,
𝑟 6
𝑟 6
𝑟 6
𝑟 6
1 + 𝐸1 [( 1 ) + ( 1 ) + ( 1 ) ] 1 + 𝐸1 ( 1 )
𝑟2
𝑟2
𝑟2
𝑟2

53.

54.

𝑟 6
𝑟 6
𝑟 6
𝑟 6
𝐸1 [ 1 + ( 1 ) ] 𝐸1 [ ( 1 ) + ( 1 ) + 1 + ( 1 ) ]
𝑟2
𝑟2
𝑟𝑑1
𝑟2
,
𝑟 6
𝑟 6
𝑟 6
𝑟 6
1 + 𝐸1 ( 1 ) 1 + 𝐸1 [ ( 1 ) + ( 1 ) + ( 1 ) ]
𝑟2
𝑟2
𝑟𝑑1
𝑟2

𝑟1 6
𝑟 6
𝑟 6
𝑟 6
) + ( 1 ) ] 𝐸1 [ 1 + ( 1 ) + ( 1 ) ]
𝑟𝑑2
𝑟2
𝑟𝑑2
𝑟2
,
𝑟 6
𝑟 6
𝑟 6
𝑟 6
1 + 𝐸1 [( 1 ) + ( 1 ) ] 1 + 𝐸1 [( 1 ) + ( 1 ) ]
𝑟𝑑2
𝑟2
𝑟𝑑2
𝑟2

55.

𝐸1 [ 1 + (

56.

𝑟 6
𝑟 6
𝑟 6
𝑟 6
𝐸1 [( 1 ) + ( 1 ) + 1 ] 𝐸1 [( 1 ) + ( 1 ) + 1 ]
𝑟2
𝑟𝑑1
𝑟2
𝑟𝑑1
,
𝑟1 6
𝑟1 6
𝑟1 6
𝑟 6
1 + 𝐸1 [( ) + ( ) ] 1 + 𝐸1 [( ) + ( 1 ) ]
𝑟2
𝑟𝑑1
𝑟2
𝑟𝑑1

57.

𝑟 6
𝑟 6
𝑟 6
𝑟 6
𝐸1 [( 1 ) + ( 1 ) + ( 1 ) + ( 1 ) ]
𝑟2
𝑟𝑑1
𝑟𝑑2
𝑟2
,
𝑟1 6
𝑟1 6
𝑟1 6
𝑟 6
1 − 𝐸1 + 𝐸1 [( ) + ( ) + ( ) + ( 1 ) ]
𝑟2
𝑟𝑑1
𝑟𝑑2
𝑟2
𝑟 6
𝑟 6
𝑟 6
𝑟 6
𝐸1 [( 1 ) + ( 1 ) + ( 1 ) + ( 1 ) ]
𝑟2
𝑟𝑑1
𝑟𝑑2
𝑟2
𝑟 6
𝑟 6
𝑟 6
𝑟 6
1 − 𝐸1 + 𝐸1 [( 1 ) + ( 1 ) + ( 1 ) + ( 1 ) ]
𝑟2
𝑟𝑑1
𝑟𝑑2
𝑟2
𝑟 6
𝑟 6
𝐸1 [( 1 ) + ( 1 ) + 1]
𝑟2
𝑟𝑑1
𝑟 6
𝑟 6
1 + 𝐸1 [( 1 ) + ( 1 ) ]
𝑟2
𝑟𝑑1

58.
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59.

60.
𝑟 6
𝑟 6
𝑟 6
𝑟 6
𝐸1 [( 1 ) + ( 1 ) + 1 + ( 1 ) + ( 1 ) ]
𝑟2
𝑟𝑑1
𝑟𝑑2
𝑟2
𝑟1 6
𝑟1 6
𝑟1 6
𝑟 6
1 + 𝐸1 [( ) + ( ) + ( ) + ( 1 ) ]
𝑟
𝑟
𝑟
𝑑1
𝑑2
2
2

61.

62.
𝑟1 6
𝑟 6
) + ( 1) ]
𝑟𝑑2
𝑟2
𝑟 6
𝑟 6
1 + 𝐸1 [ ( 1 ) + ( 1 ) ]
𝑟𝑑2
𝑟2
𝐸1 [ 1 + (

63.

64.
N/A

A-2 Expression for the FRET efficiency for circular octamer shaped
complexes
So far, I discussed the Eapp

expression for the quaternary structures of linear, square or

parallelogram geometries. Just to add a different flavor, a circular octamer oligomer is considered,
in this section.
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Figure A- 1 Cconfiguration of a circular octamer model. The figure shows one fo the confiugration,
which has seven donors (turquoise color) and one acceptor (yellow). 𝒓, 𝒓𝟏 , 𝒓𝟐 , 𝒓𝟑 and 𝒓𝟒 represent the
distances between the donors from the acceptor. 𝒊 and 𝒋 represent the donors and acceptor respectively.

The FRET efficiency for this confugration is given by
1

𝐸𝑎𝑝𝑝 = 7 ∑7𝑖=1 𝐸𝑖𝑗 ,

(2.31)

which exapands to the following
𝐸𝑎𝑝𝑝

1
𝛤 𝐹𝑅𝐸𝑇 ⁄( 𝛤 𝑟 + 𝛤 𝑛𝑟 )
𝛤1𝐹𝑅𝐸𝑇 ⁄( 𝛤 𝑟 + 𝛤 𝑛𝑟 )
= (2
+2
7 1 + 𝛤𝐹𝑅𝐸𝑇 ⁄( 𝛤 𝑟 + 𝛤 𝑛𝑟 )
1 + 𝛤1𝐹𝑅𝐸𝑇 ⁄( 𝛤 𝑟 + 𝛤 𝑛𝑟 )
+2

1

𝛤2𝐹𝑅𝐸𝑇 ⁄( 𝛤 𝑟 +
+ 𝛤2𝐹𝑅𝐸𝑇 ⁄( 𝛤 𝑟

𝑛𝑟 )

𝛤
+
+ 𝛤 𝑛𝑟 ) 1

𝛤3𝐹𝑅𝐸𝑇 ⁄( 𝛤 𝑟 +
+ 𝛤3𝐹𝑅𝐸𝑇 ⁄( 𝛤 𝑟

𝑛𝑟 )

(2.32)

𝛤
).
+ 𝛤 𝑛𝑟 )

The factor two in front of the first, second and third fractions account for the fact that FRET
efficiencies for donors one and seven, two and six, three and five with one acceptor are identical,
assuming circular symmetry of the problem, i.e., that either static or dyanamic averaging of the
orientation factor applies(1). Since the second , third and the fourth term are manifold less than the
first term, therefore, in the first order approximation the above equation can be writte as
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𝐸𝑎𝑝𝑝

2 𝛤 𝐹𝑅𝐸𝑇 ⁄( 𝛤 𝑟 + 𝛤 𝑛𝑟 )
⋍
7 1 + 𝛤𝐹𝑅𝐸𝑇 ⁄( 𝛤 𝑟 + 𝛤 𝑛𝑟 )

(2.33)

But the pairwise FRET efficency is given by
𝛤 𝐹𝑅𝐸𝑇 ⁄( 𝛤 𝑟 + 𝛤 𝑛𝑟 )
𝐸𝑝 =
1 + 𝛤𝐹𝑅𝐸𝑇 ⁄( 𝛤 𝑟 + 𝛤 𝑛𝑟 )

(2.34)

2
𝐸𝑎𝑝𝑝 ⋍ 𝐸𝑝
7

(2.35)

Hence

Similarly the expressions for other configurations of ciruclar octamer can be obtained. The
configurations which will give distinct FRET efficiency are summarized in Table 2.4.
Table C-2: Eapp peaks predicted by circular octamer model

𝑬𝒂𝒑𝒑 = 𝒇(𝑬𝒑 )

Peak
Number

Configurations
𝟐
𝑬
𝟕 𝒑

1

2

𝟏
𝑬
𝟑 𝒑

3

𝟐
𝑬
𝟑 𝒑
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4
𝟏
𝟐

5

𝑬𝒑

𝑬𝒑 𝟐+𝑬𝒑
𝟑 𝟏+𝑬𝒑

6
𝟐𝑬𝒑 𝟐+𝑬𝒑
𝟓 𝟏+𝑬𝒑

7

8

9

𝟐
𝑬
𝟑 𝒑

𝟒
𝑬
𝟓 𝒑

𝑬𝒑 𝟐+𝑬𝒑
𝟐 𝟏+𝑬𝒑

169

11

𝑬𝒑

12
𝟐𝑬𝒑 𝟑+𝟐𝑬𝒑
𝟓 𝟏+𝑬𝒑

13

𝟐𝑬𝒑 𝟐+𝑬𝒑
𝟑 𝟏+𝑬𝒑

14

𝟐 + 𝑬𝒑
𝟏 + 𝑬𝒑
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Appendix B
B-1 S1R metahistograms fitted by the mixture of dimers and monomers
for 8, 10 or 11 donors/pixel
B-1-1 S1R-no-lignand-treated metahistogram fitted by the mixture of dimers and
monomers for 8 or 10 donors/pixel

Figure B-1 Metahistogram for S1R, without ligand treatment, fitted with a theoretical model
representing the mixture of dimers and monomers model for 8 donors per pixel. Reduced fitting
residual for the fitting is 24.8.
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Figure B-2 Metahistogram for S1R, without ligand treatment, fitted with a theoretical model
representing the mixture of dimers and monomers model for 10 donors per pixel. Reduced fitting
residual for the fitting is 37.38.
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Figure B-3 Dependence of reduced fitting residual on number of donors per pixel, for S1R, without
ligand treatment, metahistogram fitting.
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B-1-2 Metahistogram for S1R, -treated with haloperidol, fitted by the mixture of
dimers and monomers for 8 or 10 donors/pixel

Figure B-4 Metahistogram for S1R, treated with haloperidol, fitted with a theoretical model
representing the mixture of dimers and monomers model for 8 donors per pixel. Reduced fitting
residual for the fitting is 25.78.
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Figure B-5 Metahistogram for S1R, treated with haloperidol, fitted with a theoretical model
representing the mixture of dimers and monomers model for 10 donors per pixel. Reduced fitting
residual for the fitting is 8.95.
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Figure B-6 Dependence of reduced fitting residual on number of donors per pixel, for S1R, treated
with haloperidol, metahistogram fitting.
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B-1-3 Metahistogram for S1R, -treated with pentazocine, fitted by the mixture of
dimers and monomers for 7 or 9 donors/pixel

Figure B-7 Metahistogram for S1R, treated with (+)-pentazocine, fitted with a theoretical model
representing the mixture of dimers and monomers model for 9 donors per pixel. Reduced fitting
residual for the fitting is 17.75.
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Figure B-8 Metahistogram for S1R, treated with (+)-pentazocine, fitted with a theoretical model
representing the mixture of dimers and monomers model for 11 donors per pixel. Reduced fitting
residual for the fitting is 21.64.
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Figure B-9 Dependence of reduced fitting residual on number of donors per pixel, for S1R, treated
with (+)-pentazocine, metahistogram fitting.
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Appendix C
C-1 Metahistograms for transfection ratios
Metahistogram for different acceptor transfection ratio ([D]/[A]) show peaks in different regions
of the Eapp range, as shown in Figure C-1. The reason behind is, that different [D]/[A] ratios favor
different configurations of the donors and acceptors. For example, a ratio of 3-to-1 will more likely
generate the tetrameric complexes with three donors and one acceptors than any other
combinations, such as combining in equal number of donors and acceptors within a complex.

Figure C- 1 Metahistograms for donor to acceptor transfection ratios. Three transfection ratios are
3-to-1, 1-to-1, and 1-to-3, and the corresponding metahistograms are shown by blue, purple and
green curves, respectively.
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For this reason, samples of different transfection ratios were used, to give all the combination of
donors and acceptors a fair chance to show up in the histogram peaks, which translate to the
metahistogram peaks.

C-2 Fitting for metahistogram for rhodopsin with dimers and monomers
model
Dimers and monomers model was the best fitting model in sogma-1 receptor (S1R) as shown in
chapter 5. We tested the same model for rhodopsin as well. The fittings with this model are
shown in Figure C-2.

Figure C- 2 Eapp metahistogram expressing, same as in Figure 6.3, fitted with a mixture of
dimer and monomer model. The values for the number of donors per pixel (n) and the FRET
efficiency of the dimer (Ed) as two of the fitting parameters are 15 and 0.750 respectively. The
reduced fitting residual is 6.56.
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Based on the reduced fitting residual, this model did not fit as well as the parallelogram model,
as shown in Figure 6.3.

C-3 Error calculation for tetramer to dimer ratio by bootstrapping
Eapp vs. total concentration (c) model was fitted into the data for three, four and five ranges of the
total concentration. Tetramer to dimer ratio (ρ) was calculated, for the fitting of the model into the
three four and five ranges. For each category of ranges, dissociation constant (𝐾𝑡→𝑑 ) was
calculated. Error in the best fit value for ρ was calculated using bootstrapping method, which is
described as follows. For each concentration subrange, 150 subsamples were generated by
randomly choosing pairs of data points (Eapp and XA) with replacement, from the original data of
said concentration range. A value of ρ was then obtained for each of the 150 subsamples by fitting
each subsample with the model for Eapp vs. XA, as described in chapter 6. The standard deviation
of ρ was then calculated from the distribution of 150 ρ values obtained for a given range. The
average and standard deviation of ρ was determined for multiple concentration ranges by the
bootstrapping method and these values were fitted with equation C-1 for each category of
concentration ranges; the goodness of fit was judged using a reduced Chi-square statistic. This
procedure was repeated for the cases when the experimental data was broken into 3, 4, and 5
concentration subranges. The 𝐾𝑡→𝑑 value for the category of concentration subranges with the
lowest reduced Chi-square value was accepted as best fit value of 𝐾𝑡→𝑑 . Error in 𝐾𝑡→𝑑 was
calculated for each data point in ρ vs. c plot, by applying the method of error propagation to the
expression of 𝐾𝑡→𝑑 which depends on ρ and c as given below
𝐾𝑡→𝑑 =

4𝜌2

𝑐
+ 2𝜌

(C-1)

The net error in 𝐾𝑡→𝑑 was calculated by averaging the error in 𝐾𝑡→𝑑 for each data point of ρ vs. c
plot.
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C-3-1 Values of the reduced Chi-square and the dissociation constant for three and
four ranges
The reduced Chi-square value for three and four ranges were 0.74 and 1.67. The values of the
dissociation constant for the three and four ranges were 82.20 ± 36.64 and 76.01 ± 30.24.

C-4 Parallelogram 12-mer configurations and FRET efficiency for each
donor
Only the configurations of the 12-mer of the geometry as shown in Figure 6.9, for which Eapp value
is higher than 0.70 are shown in this table. Donor and acceptor molecules are shown by green and
yellow filled circles respectively. These configurations have their Eapp values falling in the range
which contains the metahistogram peaks which could not be fitted by the tetramer model alone.
Table C- 1 Configurations for 12- mer, with Eapp > 0.70. Donor and acceptor molecules are
shown with green and yellow filled circles respectively.

1.

Configurations

Geometric

Configuration #

FRET Efficiency Per Donor

𝑟1 6
𝑟 6
𝑟 6
𝑟 6
𝑟 6
𝑟 6
) + ( 1 ) + ( 1 ) + ( 1 ) + ( 1 ) + ( 1 ) + 1 + 1]
𝑟𝑑1
𝑟2
𝑟𝑑2
𝑟𝑑1
𝑟2
𝑟𝑑2
𝑟 6
𝑟 6
𝑟 6
𝑟 6
𝑟 6
𝑟 6
1 + 𝐸1 +𝐸1 [ ( 1 ) + ( 1 ) + ( 1 ) + ( 1 ) + ( 1 ) + ( 1 ) + 1]
𝑟𝑑1
𝑟2
𝑟𝑑2
𝑟𝑑1
𝑟2
𝑟𝑑2
𝐸1 [ (

2.

3.

𝑟1 6
𝑟 6
) + ( 1) ]
𝑟𝑑2
𝑟2
,
𝑟 6
𝑟 6
1 + 𝐸1 [ 1 + ( 1 ) + ( 1 ) ]
𝑟𝑑2
𝑟2
𝐸1 [ 1 + 1 + (
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𝑟1 6
𝑟 6
𝑟 6
𝑟 6
𝑟 6
𝑟 6
) + ( 1 ) + ( 1 ) + 1 + ( 1 ) + ( 1 ) + ( 1 ) + 1]
𝑟𝑑1
𝑟2
𝑟𝑑2
𝑟𝑑1
𝑟2
𝑟𝑑2
𝑟1 6
𝑟1 6
𝑟1 6
𝑟1 6
𝑟1 6
𝑟 6
1 + 𝐸1 + 𝐸1 [ ( ) + ( ) + ( ) + 1 + ( ) + ( ) + ( 1 ) ]
𝑟𝑑1
𝑟2
𝑟𝑑2
𝑟𝑑1
𝑟2
𝑟𝑑2
𝐸1 [ (

4.

𝑟1 6
𝑟 6
𝑟 6
𝑟 6
𝑟 6
) + ( 1 ) + ( 1 ) + ( 1 ) + ( 1 ) + 1 + 1]
𝑟𝑑1
𝑟2
𝑟𝑑1
𝑟2
𝑟𝑑2
,
𝑟 6
𝑟 6
𝑟 6
𝑟 6
𝑟 6
1 + 𝐸1 + 𝐸1 [ ( 1 ) + ( 1 ) + ( 1 ) + ( 1 ) + ( 1 ) + 1]
𝑟𝑑1
𝑟2
𝑟𝑑1
𝑟2
𝑟𝑑2
𝐸1 [ (

𝑟1 6
𝑟 6
) +( 1) ]
𝑟𝑑1
𝑟𝑑2
,
𝑟 6
𝑟 6
1 + 𝐸1 [ 1 + ( 1 ) + ( 1 ) ]
𝑟𝑑1
𝑟𝑑2
𝐸1 [ 1 + 1 + (

𝑟 6
𝑟 6
𝑟 6
𝑟 6
𝐸1 [( 1 ) + ( 1 ) + ( 1 ) + ( 1 ) + 1 ]
𝑟2
𝑟𝑑2
𝑟𝑑1
𝑟2
,
𝑟1 6
𝑟1 6
𝑟1 6
𝑟 6
1 + 𝐸1 + 𝐸1 [( ) + ( ) + ( ) + ( 1 ) ]
𝑟2
𝑟𝑑2
𝑟𝑑1
𝑟2

5.

𝑟1 6
𝑟 6
𝑟 6
𝑟 6
𝑟 6
𝑟 6
) + ( 1 ) + ( 1 ) + 1 + ( 1 ) + ( 1 ) + ( 1 ) + 1]
𝑟𝑑1
𝑟2
𝑟𝑑2
𝑟𝑑1
𝑟2
𝑟𝑑2
𝑟1 6
𝑟1 6
𝑟1 6
𝑟1 6
𝑟1 6
𝑟 6
1 + 𝐸1 + 𝐸1 [( ) + ( ) + ( ) + 1 + ( ) + ( ) + ( 1 ) ]
𝑟𝑑1
𝑟2
𝑟𝑑2
𝑟𝑑1
𝑟2
𝑟𝑑2
𝐸1 [(

6.

𝑟1 6
𝑟 6
𝑟 6
𝑟 6
𝑟 6
𝑟 6
) + ( 1 ) + ( 1 ) + ( 1 ) + ( 1 ) + ( 1 ) + 1 + 1]
𝑟𝑑1
𝑟2
𝑟𝑑2
𝑟𝑑1
𝑟2
𝑟𝑑2
,
𝑟 6
𝑟 6
𝑟 6
𝑟 6
𝑟 6
𝑟 6
1 + 𝐸1 + 𝐸1 [( 1 ) + ( 1 ) + ( 1 ) + ( 1 ) + ( 1 ) + ( 1 ) + 1]
𝑟𝑑1
𝑟2
𝑟𝑑2
𝑟𝑑1
𝑟2
𝑟𝑑2
𝐸1 [(

𝑟1 6
𝑟 6
𝑟 6
𝑟 6
𝑟 6
𝑟 6
) + ( 1 ) + ( 1 ) + 1 + ( 1 ) + ( 1 ) + ( 1 ) + 1]
𝑟𝑑1
𝑟2
𝑟𝑑2
𝑟𝑑1
𝑟2
𝑟𝑑2
𝑟1 6
𝑟1 6
𝑟1 6
𝑟1 6
𝑟1 6
𝑟 6
1 + 𝐸1 + 𝐸1 [( ) + ( ) + ( ) + 1 + ( ) + ( ) + ( 1 ) ]
𝑟𝑑1
𝑟2
𝑟𝑑2
𝑟𝑑1
𝑟2
𝑟2
𝐸1 [(
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